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1. List of abbreviations 
 
A Adenin 
AJ adherens junctions 
attB bacterial attachment site 
attP phage attachment site 
BCIP 5-bromo-4-chloro-3`-indolyphosphate p-toluidine salt 
BSA bovine serum albumine 
C Cytosin 
Cldn Claudin 
CV caudal vein 
DA dorsal aorta 
ddH2O double-destilled water 
DIG digoxigenin 
DLAV dorsal longitudinal anastomotic vessel 
DMSO dimethylsulfoxid 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleotide 
dpf days post fertilization 
EC endothelial cell 
EDTA ethylenediaminetetraacetic acid 
EGFP enhanced green fluorescent protein 
EVL enveloping layer 
FITC fluorescein isothiocyanate 
fli Friend leukemia integration 
flk Fetal liver kinase 
flt Fms related tyrosin kinase 
G Guanosine 
h hours 
HMF horizontal myoseptum 
hpf hours post fertilization 
Hyb hybridization 
ISV intersegemental vessel 
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kdr Kinase insert domain receptor 
LB medium lysogeny-broth medium 
LDA lateral dorsal aorta 
mg milligram 
µg microgram 
ml milliliter 
µl microliter 
MO morpholino 
mRNA message Ribonucleic acid 
NBT nitro-blue tetrazolium chloride 
NEB New England Biolab 
ON over night 
PBDT phosphate-buffered saline-DMSO-Tween20 
PBS phosphate-buffered saline 
PBST phosphate-buffered saline-Tween 20 
PBSTX phosphate-buffered saline-Tween 20- Triton-X 100 
PCR polymerase chain reaction 
PCV posterior cardinal vein 
PFA paraformaldehyde 
PTU propylthiouracil 
RNA ribonucleic acid 
RT room temperature 
SA segmental artery 
SDS sodium dodecyl sulfate 
SJ septate junctions 
SSC saline sodium citrate 
SSCT SSC with  
SV segmental vein 
SV40 simian virus 40 
T Thymin 
TER trans epithelial resistance 
TJ tight junctions 
TSA Tyramide Signal Amplification 
TSS Transformation and Storage Solution 
1. List of abbreviations 
 3 
VE-cadherin (VE-cad) Vascular endothelial cadherin 
VEGF Vascular endothelial growth factor 
VEGFR Vascular endothelial growth factor receptor 
Wnt Wingless-type MMTV integration site family member 
ZO Zonula occludens 
ZONAB ZO-1–associated nucleic acid binding proteins 
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2. Abstract 
 
During sprouting angiogenesis several cellular activities are required such as 
cell shape changes, cell migration, cell proliferation and cell rearrangement. 
These processes have to be tightly regulated in order to allow cellular 
dynamics on one side and maintain tissue integrity on the other side. Cell-cell 
contacts are the main mediators of dynamic cell behaviors during 
morphogenesis. These contacts are composed of adherens and tight 
junctions. 
To better understand the role of tight junctions during the morphogenetic 
events of angiogenesis, I have analyzed the function of the endothelial 
specific Cldn5b during the process of intersegmental vessel (ISV) formation. 
Although MO-mediated knock-down of cldn5b does not alter the initial 
outgrowth of endothelial cells (ECs) from the dorsal aorta (DA), it does lead to 
a halt of EC migration at the level of the horizontal myoseptum (HMS). 
Furthermore, neighboring ISVs do not connect within the dorsal-longitudinal-
anastomotic vessel (DLAV) and detach from the DA. In contrast, the adherens 
junction specific protein VE-cadherin rather exerts a cell rearrangement 
function. The different expression pattern of Cldn5b and VE-cadherin support 
these findings. While VE-cadherin is expressed in every EC of the ISV, 
Cldn5b is temporally downregulated in early sprouting ECs. Furthermore, a 
clear reduction of cell number in the ISVs was observed in cldn5b morphants. 
The latter observation, together with a possible reduction in adhesion between 
ECs, is suggested to cause the phenotypes observed in cldn5b knock-down 
embryos. Together, this study suggests for the first time a possible role of a 
Cldn during a morphogenetic event. 
Additionally, I generated mutant fish lacking cldn5b gene function by using 
Zinc-Finger Nucleases. The analysis of these mutant fish will help to 
understand the functional role of a core component of tight junctions during 
vertebrate blood vessel development. However, the preliminary analysis 
shows only a very weak ISV phenotype compared to cldn5b morphants. I will 
discuss several ideas explaining the discrepancy between cldn5b morphants 
and mutants.   
3. Introduction 
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3. Introduction 
 
The development of specialized organs is a hallmark of multicellular animal 
evolution. The development of tubular organs brought the advantage of 
improved physiological processes and environmental adaptation. Tubular 
organs like the tracheal system in Drosophila melanogaster (Drosophila), the 
kidney, lung, mammary gland and the vasculature of vertebrates serve the 
transport of liquids and gases throughout the body. During development, 
these organs increase their surface area in a process known as branching 
morphogenesis, which in turn leads to the optimization of exchange between 
these organs and the body. The branching of some tubular organs is very 
stereotypical with branches always at the exact same positions. For instance, 
although the branchial tree in the mammalian lung consists of thousands of 
airway branches, it was shown that early the mouse lung has a reproducible 
architecture (Metzger et al., 2008). In other organs branching is rather 
stochastic as for example in the mammary gland (Watson and Khaled, 2008).  
Several studies have started to address interesting questions regarding the 
nature of branch formation. What drives branch formation? Where and when 
are branches initiated? How do branches extend in length? Which molecules 
are required for branch formation? Some aspects of branch formation were 
found to be similar among many branched tubular organs including the 
initiation of branch formation. Here, local extrinsic signaling cues are involved. 
For example, in the tracheal system of Drosophila, the epithelial cells express 
the fibroblast-growth factor receptor Breathless (Btl), which senses its ligand 
Branchless (Bnl) expressed in the surrounding tissue (Ghabrial and Krasnow, 
2006; Klambt et al., 1992; Sutherland et al., 1996). The formation of the 
vasculature or the branchial trees of the lung also depends on extrinsic 
signaling cues like Vascular endothelial growth factor (Vegf) and Fibroblast-
growth factor 10 (Fgf10), respectively (Bellusci et al., 1997; Cardoso and Lu, 
2006; Coultas et al., 2005; Leung et al., 1989). Upon activation of the 
respective signaling pathways, some epithelial cells send out filopodia and 
start to migrate towards the ligand source. Some cells adopt the identity of a 
tip cell and drive the migration and elongation processes forward. The other 
3. Introduction 
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cells become stalk cells, which are less responsive to the signaling cue. Such 
behavior can be observed in the fly tracheal system during the highly 
stereotypic process of dorsal branch intercalation. In this case tip cells at the 
top of the branch create the pulling force driving dorsal migration (Caussinus 
et al., 2008; Ribeiro et al., 2004). Although the details of branch formation in 
every tubular organ are different, all of these organs have several cellular 
activities in common. These are the migration of cells, their proliferation as 
well as the cell shape changes and the rearrangement of cells within the 
branch. 
One branched tubular organ, which is especially well suited for the analysis of 
branch formation is the vascular system. It consists of different kind of tubes 
of certain architecture that are highly ramified and interconnected. The 
vascular system is the first organ to arise in vertebrates. It serves the 
transport of nutrients, gases and metabolic wastes, but it is also required for 
hormonal communication and immune responses of the body. Furthermore, 
the functionality of the vasculature is crucial for the development and function 
of most other organs. Defects in the vasculature often lead to a delay and 
abnormal development of other organs, which can lead to embryonic death.  
In humans the cardiovascular system is divided into the pulmonary circulation 
and the systemic circulation. In the pulmonary circulation, oxygen deprived 
blood from the body enters the heart through the vena cava and flows from 
there through the pulmonary arteries to the lung. From here the oxygenated 
blood goes back to the heart through the pulmonary veins, from where it flows 
to the rest of the body through the aorta. In the systemic circulation 
oxygenated blood is pumped through the body vessels. The oxygen depleted 
blood flows then back to the heart. Certain prerequisites are needed for the 
different vessels to function properly. The aorta, which has to stand high 
pressure and carries large volumes of blood, consists of a wall of many cell 
layers in thickness and is outlined by many cells in diameter. Also the vena 
cava has a big diameter. The second biggest vessels are the arteries and 
veins followed by the arterioles and venules, which consist of a few cells in 
diameter. The smallest vessels, the capillaries form the connection between 
arterioles and venules. They are made of one cell only, which allows for 
exchange of gases and nutrients between the blood and surrounding tissue. 
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The wall of all blood vessels of the vasculature is made up of endothelial cells 
(ECs). They are surrounded by a basal lamina on the outer surface. While 
arteries are often ensheathed by a dense layer of smooth muscle cells and 
pericytes to ensure dilation and constriction of the vessels, veins are rather 
free of these cells. 
The development and anatomy of the embryo vasculature is highly conserved 
among vertebrates. In both the mouse and the zebrafish embryos the DA and 
PCV constitute the main vessels of the body, which are connected by 
intersegmental vessels (ISVs) and dorso-longitudinal anastomotic vessels 
(DLAV) (Fig. 1A, B, D). The pattern and development of the vasculature are 
also conserved in terms of genetic determination (Thisse and Zon, 2002). An 
example of this is the expression of gata-1 in all cells that will become blood 
cells during both mouse and zebrafish embryogenesis (Heicklen-Klein et al., 
2005; Whitelaw et al., 1990). Another example of conservation comes from 
the transcription factor scl, which is expressed in the common progenitors for 
cells making the blood and blood vessels (Gering et al., 1998; Kallianpur et 
al., 1994). Furthermore, the heart determining factor nkx2.5 can be found in 
zebrafish as well as mouse embryos (Lints et al., 1993; Tu et al., 2009). 
Several model organisms are used to study the complex development of the 
vasculature system such as mice (Mus musculus), chicken (Gallus gallus) and 
frogs (Xenopus laevis). Zebrafish (Danio rerio) has become a more relevant 
model system over time. It belongs to the ray-finned fishes (Actinopterygii) 
and is a suitable model organism to study vertebrate development. Compared 
to mice and chick, zebrafish can be kept in high stock densities. Fertilization 
takes place externally and embryos develop rapidly. Most importantly, 
zebrafish embryos are optically clear, which allows easy visualization of 
developmental processes. In recent years, imaging techniques for live 
observation have been especially developed. The vasculature can now be 
visualized by the expression of reporter genes encoding enhanced green 
fluorescent protein (EGFP) in endothelial cells (ECs) (Lawson and Weinstein, 
2002). The functional circulatory loop within the vasculature can be observed 
by microangiography, the injection of fluorescent dye into the functional 
circulation (Weinstein et al., 1995). Studying specific gene functions in 
vascular development by gene knock-down/ knock-out can not only lead to 
3. Introduction 
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defects in blood vessel formation but also in heart development leading to a 
lack of blood flow. In mice this would lead to embryonic lethality. Because 
zebrafish embryos can live without blood flow until the end of embryogenesis, 
gene knock-down/ knock-out analysis can be easily performed. 
The vasculature of the zebrafish embryo is relatively simple. The heart pumps 
the blood directly into the main aortae of the head, the lateral dorsal aortae 
(LDA). These aortae merge in the cranial trunk to one big vessel, the dorsal 
aorta (DA), which carries the blood to the posterior part of the embryo (Fig. 1 
B, D). The posterior cardinal vein (PCV) carries the blood back to the heart 
and to the major vein of the head, the primordial hindbrain channel (PHBC). In 
the trunk two smaller vessels connect the DA and PCV: the intersegmental 
vessels (ISVs), which later differentiate into segmental arteries (SA) and 
segmental veins (SV) and the dorsolongitudinal anastomotic vessel (DLAV) 
(Fig. 1 D). The capillaries of the head form a very complex network of arteries 
and veins (Fig. 1 C) (Isogai et al., 2001).  
 
 
Figure 1: The vasculature in mouse and zebrafish embryos. (A) Immunohistochemichal staining for 
PECAM-1 visualizing the vascular system in a 10 day old mouse (photo Ralf Adams). (B-D) Transgenic 
reporter gene expression of flk1:EGFP (green) and visualization of the blood vessel lumen by quantum 
dot injection (red in C and D). ISV: intersegmental vessel, BA: branchial arches, DLAV: dorso-
longitudinal anastomotic vessel, PHS: primary head sinus, AA: aortic arches, CCV: common cardinal 
vein, PCV: posterior cardinal vein, DA: dorsal aorta, SV: segmental vein, SA: segmental artery, CV: 
caudal vein. Images taken from (Ellertsdottir et al., 2010). 
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The primary vascular network (the DA and PCV) is formed by the process of 
vasculogenesis, which is the coalescence of individual endothelial cells and 
the subsequent vessel formation of a lumenized vessel. Further expansion of 
the vascular network is brought about by the process of angiogenesis, where 
new capillary vessels are formed out of an already existing vessel 
{Ellertsdottir, 2010 #7}. This process can be divided into sprouting 
angiogenesis and intussusceptive angiogenesis {Patan, 2000 #356}. The 
latter is defined by the division of an existing vessel along its longitudinal axis 
into two separate vessels {Makanya, 2009 #355}. During and after the 
formation of the primary and secondary vessels this primitive network is 
remodeled extensively. This leads to the rearrangement of vascular segments 
in number and location allowing for a functional adaptation of the network. 
One example of remodeling is the process of anastomosis, whereby 
previously branched blind-ending vessels connect to each other to form a new 
circulatory loop. At the same time vascular fusion results in the formation of 
larger vessels and concomitantly larger vessels can disappear by the process 
of pruning and/or remodeling to create smaller vessels. 
In the following chapters I will describe the process of vasculogenesis and 
sprouting angiogenesis and how a patterned vascular network is put together 
during development. 
 
 
3.1 Vascular development 
 
3.1.1 Vasculogenesis – formation of the dorsal aorta and 
posterior cardinal vein 
 
3.1.1.1 Differentiation of endothelial cells 
The development of blood vessels and cellular blood components is highly 
connected. Endothelial cells (ECs), which make up the vasculature and 
hematopoietic cells, such as erythrocytes descend partially from a common 
progenitor, the hemangioblast, but also from distinct progenitors, the 
angioblast and hematopoietic stem cells, respectively (Risau and Flamme, 
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1995; Vogeli et al., 2006; Warga et al., 2009). These progenitors arise from 
the lateral plate mesoderm from where they migrate towards the midline. Here 
they assemble into a cord that adopts the form of a tube making the first main 
vessel of the embryo. The first progenitors that are determined to become 
endothelial cells or hematopoietic cells express several transcription factors 
like fli1, flk1, scl, gata2 and an unknown factor called cloche (Brown et al., 
2000; Detrich et al., 1995; Liao et al., 1998; Liao et al., 1997; Liu et al., 2008; 
Pham et al., 2007). While these cells migrate to the midline they start to 
separate spatially and differentiate into two different cell types. On one hand, 
the dorsal cells become hematopoietic cells and express fli1 and scl, but no 
flk1. On the other hand, the ventral cells are the endothelial cells that express 
fli1, flk1, but no scl. A driving factor for the migration of ECs towards the 
midline is vascular endothelial growth factor (vegf), the key growth factor in 
vascular development. Vegf expression is induced by shh, which is expressed 
in the notochord. The deletion of vegf in mouse and Xenopus results in the 
lack of angioblast migration and the abnormal formation of axial vessels 
(Carmeliet et al., 1996; Cleaver and Krieg, 1998). In zebrafish embryos 
however, VEGF, although inducing angioblast cell fate, is not responsible for 
angioblast migration (Jin et al., 2005). So far only the endoderm was found to 
influence the temporal regulation of primary tube formation, as it is thought to 
be a substrate for migrating angioblasts (Jin et al., 2005). The anterior 
endoderm of the head, however, has an even stronger impact on angioblast 
migration. Here, the angioblasts migrate towards the chemokine signal cxcl12, 
which is expressed in the anterior endoderm and which they sense through 
the receptor cxcr4. Knock-down of both of these genes or the whole 
endoderm lead to a total lack of lateral dorsal aorta (LDA) formation 
(Siekmann et al., 2009).  
 
3.1.1.2 Aorta and venous tube formation 
Angioblast migration towards the midline occurs in two waves. The first wave 
of cells starts to migrate at 14 hpf, the second wave of cells migrates at 16 hpf 
(Fig. 2 A). At 18 hpf the cells assemble into a cord-like structure at the midline 
between the hypochord and the underlying mesoderm (Fig. 2 B) (Eriksson 
and Lofberg, 2000; Jin et al., 2005). Shortly after this, the cells start to get 
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polarized shown by the localization of Zonula Occludens-1 (ZO-1) and 
Claudin 5 (Cldn5) to cell-cell contacts. At this point cells start to rearrange. 
Through the process of cord hollowing an aortic lumen is formed, which is 
apparent at 20 hpf and is lined by a wall of one cell layer (Jin et al., 2005). 
The aortic lumen enlarges by cells changing from a spherical to an elongated 
shape. The endothelial cells are polarized by now and Fibronectin is localized 
at the basal sides of the vessel. At this timepoint the PCV has not formed yet. 
At 17 hpf ephrinB2a, a marker for arterial cell fate, gets expressed in the 
dorsal cells of the vascular cord. Therefore the first wave contains some 
angioblasts that differentiate into arterial and venous cells. The second wave, 
however, contains cells that contribute to the formation of the PCV only (Jin et 
al., 2005). Additionally, Herbert et al., (2009) found that the PCV forms by 
ventral sprouting of angioblasts from the DA. This process is called selective 
cell sprouting and is blocked when arterial-venous differentiation is impaired 
(Herbert et al., 2009). The lumen of the PCV also starts to form by a cord 
hollowing mechanism, but unlike the aorta expands by erythrocyte invasion 
(Herbert et al., 2009) (Fig. 2 C). At 28 hpf both main vessels are fully 
luminized (Fig. 2 D). 
 
 
Figure 2: Model for vasculogenesis stages in the zebrafish embryo. Angioblasts originating from 
the lateral plate mesoderm migrate in two waves towards the midline of the embryo (A). They assemble 
into a vascular cord between the hypochord and the underlying endoderm (B). While ephrinB2a 
expressing cells become the DA, Ephrinb4a expressing cells sprout ventrally to form the PCV (B). The 
DA lumen forms by cord hollowing, while venous ECs sprout ventrally, coalesce around the blood cells 
and eventually form a tube (C). At 28 hpf both the DA and PCV are fully functional (D). nt: neural tube, 
nc: notochord, h: hypochord, s: somites, en: endoderm, DA: dorsal aorta, PCV: posterior cardinal vein. 
Taken from (Ellertsdottir et al., 2010). 
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3.1.1.3 Arterial-venous differentiation 
At first, with the help of tracer injection experiments it was thought that arterial 
or venous cell fates can be assigned by the direction of blood flow in an 
existing blood vessel (Jargiello and Caplan, 1983). However, several recent 
studies prove that arterial and venous cell fate determination is already 
established before the onset of blood flow and is therefore genetically 
determined (Herzog et al., 2005; Zhong et al., 2001). In the zebrafish embryo 
the notochord expresses sonic hedgehog (shh) (Stemple et al., 1996), which 
induces the expression of vegf-a in the somites (Lawson et al., 2002). Vegf-a 
binds to the vascular endothelial growth factor receptor-2 (VEGFR-2/fetal liver 
kinase (flk)-1) on angioblasts leading to the activation of notch5 signaling and 
the subsequent induction of arterial cell fate. In mouse knock-out studies, the 
deletion of one VEGF allele leads to a decrease in aorta diameter; deletion of 
both alleles abolished aorta formation completely (Carmeliet et al., 1996).
It is thought that cells located in the dorsal part of the vascular cord are 
exposed to a higher level of Vegf, therefore express more notch5 and become 
arterial cells. The more ventral cells however receive very little Vegf signal 
and therefore do not express notch5 and adopt a venous cell fate (Lawson et 
al., 2002). Notch5 induces the expression of ephrinB2 (efnB2a), an arterial 
marker, and suppresses the induction of EphrinB4 (EphB4), a venous marker, 
via the bHLH transcription factor gridlock (Lawson et al., 2001; Zhong et al., 
2001; Zhong et al., 2000). Although ephrinB2 knock-out experiments in mice 
reveal a normal development of the main vessels (Wang et al., 1998), in 
zebrafish morpholino knock-down experiments all ECs clearly adopt venous 
identity (Herbert et al., 2009). Transplantation experiments showed that the 
differential expression of EphB4 and efnb2a leads to a repulsion of arterial 
and venous cells (Herbert et al., 2009). 
Another gene specifically expressed in venous cells and repressed by notch 
signaling is fms-related tyrosine kinase (flt)-4.  Mind-bomb mutants, in which 
notch signaling is defective, present an expanded flt-4 expression into the 
aorta (Lawson et al., 2001).  
Moreover, it was shown that not only does the aorta suppress venous cell 
fates, but also vice versa. Knock-out studies of the transcription factor 
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COUPTFII in mice showed its role in repressing notch in the vein and 
therefore ensuring vein identity (You et al., 2005).  
3.1.2 Angiogenic network formation 
As mentioned above several remodeling and rearrangement processes lead 
to the formation of a complex vascular network. This network does not only 
ensure blood supply to all possible organs and distant places of the body, but 
is also a prerequisite for other developmental processes such as the 
formation of other organs that arise later during development. Therefore, the 
vascular network has to be highly organized, which is exactly what can be 
observed in the developing fish embryo. All embryos have the same kind of 
vessels arising at the same position and at the same timepoint. This 
remarkably stereotyped formation and patterning of blood vessels between 
embryos is ensured by genetic hardwiring. 
 
3.1.2.1 ISV formation via the process of angiogenesis 
One type of vessel, which develops in a highly stereotypical manner, is the 
ISV. Its morphogenesis is reproducible from vessel to vessel and from embryo 
to embryo. 
The ISVs form via the process of sprouting angiogenesis, the sprouting and 
growth of new vessels out of preexisting vessels (Childs et al., 2002; Isogai et 
al., 2003; Risau, 1997). Temporally, ISVs develop from anterior to the 
posterior end of the trunk. At 20 hpf, on each lateral side of the embryo 
primary sprouts emerge from the aorta adjacent to the somite boundaries 
(Fig. 3 A). They grow out dorsally between notochord and somites or neural 
tube and somites at later stages (Fig. 3 B). During the dorsal outgrowth, the 
ECs send out extensive filopodial extensions, especially at the tip of the 
branch. While the sprout grows along the somite boundary until it reaches the 
level of the horizontal myoseptum (HMS), it commences to grow 
perpendicular to the body axis from there onwards. As the sprouts reach the 
dorsal roof of the neural tube, they ramify anteriorly and posteriorly, elongate 
further and connect and fuse to the neighboring ISV (Fig. 3 C). This process 
starts at around 27 hpf and ultimately leads to the formation of the dorso-
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longitudinal anastomotic vessel (DLAV). At this stage the two parallel DLAVs 
of each lateral side are distinct vessels. At the end of this primary network 
formation only the anterior-most ISVs have started to make a lumen (Isogai et 
al., 2003) and a connection to the PCV is lacking completely (Fig. 3 D). 
The completion of the circulatory loop is brought about by the connection of 
some of the ISVs to the PCV. For this to happen, from 32 hpf onwards, 
secondary sprouts emerge from the PCV (Fig. 3C). These sprouts grow 
dorsally in very close proximity to the already existing ISV. Half of these 
secondary sprouts make a connection to the ISV, which always occurs in the 
first third of the ISV above the DA (personal communication, Anna Lenard) 
(Fig. 3 D). Several remodeling processes lead to the formation of a functional 
vessel including the regression and disappearance of the ventral part of the 
old connection between DA and ISV (personal communication Anna Lenard) 
(Isogai et al., 2003). This new vessel, connected to the PCV, is called an 
intersegmental vein (SV), a vessel connected to the DA is called 
intersegmental artery (SA) (Fig. 3 E). 
The other half of the secondary sprouts also elongates dorsally, but does not 
connect to the ISVs. These sprouts stop to grow dorsally at the level of the 
horizontal myoseptum and grow towards the anterior and posterior where they 
connect to the neighboring sprouts. Together, they form the parachordal 
chain, which will later give rise to a part of the lymphatic system (Hogan et al., 
2009; Yaniv et al., 2006).   
 
Figure 3: Model of intersegmental vessel formation in the zebrafish trunk. First sprouts emerge 
from the aorta at 22 hpf (A). While growing dorsally, the ECs send out filopodial extensions. When 
reaching the dorsal roof of the neural tube, the sprouts grow anteriorly and posteriorly, where they 
connect to the neighboring ISVs (B,C). Between 32 hpf and 42 hpf a lumen is formed (D). Secondary 
sprouts emerge from the PCV from 32 hpf onwards and connect to the primary vessel, which will 
become a segmental vein (C,D). Eventually the blood flows through this circulatory loop (E). DA: dorsal 
aorta, PCV: posterior cardinal vein, DLAV: dorso-longitudinal anastomotic vessel, SA: segmental artery, 
SV: segmental vein. Taken from (Ellertsdottir et al., 2010). 
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The anterior-posterior order of arteries and veins occurs at random. Only the 
anterior most ISVs in the head show a stereotypic distribution (Bussmann et 
al., 2010; Isogai et al., 2001; Isogai et al., 2003).  
Several studies have investigated the morphology of a growing ISV in detail 
(Blum et al., 2008; Childs et al., 2002; Isogai et al., 2003; Lawson and 
Weinstein, 2002). Earlier studies assumed that the ISV consists of three 
endothelial cells: one being a reverse T-shaped cell embedded in the aorta, 
the second one being a T-shaped cell embedded in the DLAV and the third 
one being the connection between the two (Childs et al., 2002). A more recent 
study proposed that a sprout consists of three to four cells, one tip and two to 
three stalk cells (Abb. 4 B). Cell divisions during ISV formation lead to a final 
number of 3-7 endothelial cells per ISV, the majority of which consists of 4 or 
5 cells, though (Blum et al., 2008). This study has further used mosaic 
analysis and immunohistochemical analysis of cell junctions to show the 
paired assembly of ECs along the dorsal-ventral axis of the ISV (Blum et al., 
2008). A region of the ISV containing no or one line of junctional staining 
perpendicular to the body axis, resembles a unicellular vessel; a region with 
more than one line of junctional staining resembles a multicellular vessel. 
 
3.1.2.2 Molecular regulation of sprout formation and outgrowth 
In line with the hardwiring of the morphogenetic events during ISV formation, 
the regulation of these events on the genetic level is also very stereotypical.  
As mentioned earlier the primary function of blood vessels is the transport of 
oxygen and nutrients to various places in the body. Interestingly, the lack of 
oxygen in a body region also regulates the formation of new blood vessels 
(reviewed in (Fraisl et al., 2009)). In particular, genes of the family of hypoxia-
inducible transcription factors (HIF) are capable of responding to changes in 
oxygen level. When activated they induce the expression of vascular 
endothelial growth factor (VEGF) in target areas and its receptor, vascular 
endothelial growth factor receptor (VEGFR)-2 (fetal-liver kinase-1 (flk-1)), in 
endothelial cells (Elvert et al., 2003; Gerhardt et al., 2003). 
VEGFs and their receptors are the main driving forces of vasculogenesis, 
angiogenesis and lymphangiogenesis (reviewed by (Lohela et al., 2009)). 
While the receptors are expressed by the ECs (Liao et al., 1997), VEGFs itself 
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are expressed by the surrounding tissue such as the somites (Pollard et al., 
2006).  
The main factors for the induction of angiogenesis are VEGF-A (VEGF) and 
its receptor VEGFR-2. Upon binding of the ligand, the receptor dimerizes and 
autophosphorylation occurs (Guo et al., 1995). The phospholipase C (PLC) 
γ/protein kinase C (PKC) pathway gets activated and leads to the generation 
of inositol trisphosphate. This in turn activates the c-Raf-MEK-MAP kinase 
cascade (Takahashi et al., 2001; Xia et al., 1996), which induces EC growth, 
migration and proliferation (Wang et al., 2008). Knock-down experiments in 
mice showed that flk-1 is necessary for vasculogenesis, blood island 
formation and organized blood vessel formation (Carmeliet et al., 1996; 
Ferrara et al., 1996; Shalaby et al., 1995). Endothelial cells send out filopodia 
and migrate towards a VEGF gradient. Studies in the mouse retina could 
show, that disruption of this gradient by interfering with the interaction 
between VEGF and the extracellular matrix (ECM) inhibited vascular branch 
formation (Ruhrberg et al., 2002). How VEGF and other factors drive 
angiogenesis by inducing filopodia and tip cell formation will be discussed in 
section 1.2.2.4. 
Signaling via the ligands VEGF-B and PlGF has a different impact on 
angiogenesis. Knock-out of these two ligands does not cause any phenotype 
during development (Bellomo et al., 2000; Carmeliet et al., 2001). Deletion of 
their receptor VEGFR-1 (fms-like tyrosine kinase 1, Flt1), however, leads to 
embryonic lethality due to excessive angioblast and endothelial cell 
proliferation (Fong et al., 1995; Fong et al., 1999; Kearney et al., 2002). 
Therefore it was assumed and shown that VEGFR-1 and especially the 
secreted form sFlt-1 functions as a negative regulator of VEGFR-2 by acting 
as a ligand sink to modulate the amount of VEGF-A (Kendall and Thomas, 
1993; Roberts et al., 2004). The relatively weak tyrosine kinase activity of 
VEGFR-1 and the high affinity to VEGF-A support this idea (Autiero et al., 
2003; Hiratsuka et al., 2005; Park et al., 1994). 
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3.2.2.4 Tip cell selection 
The determination of patterning within a vessel is also genetically hard-wired. 
The most prominent features of migrating endothelial sprouts are the filopodial 
extensions of the tip cells. The stalk cells do not possess any or only few 
filopodia, pointing to a specialized role of tip cells during sprout outgrowth. It 
was shown, for example, during retinal angiogenesis that tip cells respond 
differently to VEGF-A than do stalk cells. While tip cells respond by sending 
out filopodia and migrating towards the VEGF-A source, stalk cells respond by 
proliferating (Gerhardt et al., 2003). It has been found that endothelial tip cells 
express different genes than stalk cells allowing for the response to guidance 
cues more readily than stalk cells. Several studies in zebrafish, mouse retina, 
tumor angiogenesis and 3D endothelial cell culture found the most important 
factor in determining tip cell specification to be the Notch pathway (Phng and 
Gerhardt, 2009). In mammalian endothelial cells the ligand Dll4 binds to the 
receptor Notch. Upon proteolytical cleavage of Notch the resulting Notch 
intracellular domain (NICD) activates several target genes with the help of 
basic helix-loop-helix (bHLH) transcription factors. While dll4 is expressed in 
the tip cells, Notch signaling is most prominent in the stalk cells (Hellstrom et 
al., 2007; Jakobsson et al., 2010; Lobov et al., 2007). Inhibition of the notch 
signaling pathway by deleting notch1 or dll4 function results in excessive 
branching in the mouse retina as well as in the zebrafish ISVs (Hellstrom et 
al., 2007; Leslie et al., 2007; Lobov et al., 2007). Overexpression of Notch on 
the other hand leads to a total lack of endothelial sprouts (Siekmann and 
Lawson, 2007). Several studies found that the excessive sprouting in notch 
knock-down scenarios is accompanied by the upregulation of endothelial tip 
cell markers like Pdgfb, Unc5b, flk and flt4 and is therefore caused by an 
increased tip cell formation (Hellstrom et al., 2007; Suchting et al., 2007; 
Tammela et al., 2008). This is supported by transplantation experiments in 
zebrafish ISVs, which showed that notch deficient cells more readily become 
the tip cell, while notch overexpressing cells contributed to the aorta and did 
not migrate (Siekmann and Lawson, 2007).  
A few lines of evidence support the idea that Notch signaling influences 
VEGFR signaling during tip cell selection. The knock-down of notch cause flt4 
expression to increase in all endothelial cells (Siekmann and Lawson, 2007; 
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Tammela et al., 2008). Also, is the expression of VEGFR-1 and 2 is altered in 
Notch deprived cells. In wt conditions, VEGFR-2 is expressed more 
abundantly in the tip cell, while VEGFR-1 is expressed stronger in the stalk 
cells. Jakobson et al. (2010) showed by knock-down experiments that VEGF 
induces Dll4 expression in the tip cell, which in turn activates Notch signaling 
in the adjacent stalk cell (Fig.4). Here VEGFR-2 expression is downregulated 
and VEGFR-1 expression upregulated. This leads to a decreased VEGF 
response in the stalk cells (Fig. 4 green cell). Cells with the highest dll4 and 
therefore VEGFR-2 expression sense more VEGF and become tip cells (Fig. 
4 red cell) (Jakobsson et al., 2010). However, time-lapse imaging showed the 
shuffling of cells between the tip and stalk both in vitro and in vivo. This 
suggests that a constant re-evaluation of signaling circuits occurs, as cells 
meet new neighbors during vessel outgrowth and remodeling (Jakobsson et 
al., 2010). 
 
Figure 4: Model of VEGF-Notch/Delta 
signaling in endothelial cells of the 
branching tip. A cell expressing by chance 
more Dll4 enhances VEGFR-2 expression and 
reduces VEGF-R1 expression. This cell 
responds stronger to the extracellular VEGF 
signal than its neighboring stalk cell and leads 
the migration process. In the stalk cell notch 
expression is induced via the tip cell, which 
leads to reduction of VEGFR-2 expression and 
enhancement of VEGFR-1 expression. 
Therefore this cell does not respond to VEGF 
signaling as strongly as the tip cell. Taken from 
(Jakobsson et al., 2010). 
 
Additional evidence comes from the upregulation of soluble Flt-1 (sFlt-1) by 
Notch activation (Harrington et al., 2008). Furthermore, deletion of flt-1 results 
in misguided emerging sprouts, which can be rescued by the expression of 
sFlt-1 immediately adjacent to the endothelial sprout (Chappell et al., 2009). 
This indicates a role for sFlt-1 in guiding the tip cell away from the parent 
vessel by sequestering extracellular VEGF and the response to VEGF 
adjacent to the tip cell. 
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3.2.2.3 Environmental cues and endothelial pathfinding 
Intrinsic cues are not the only factors determining the patterning of the 
vascular network. Extrinsic guidance cues also regulate the pathfinding of 
endothelial sprouts. 
As mentioned above, ISV sprouting and outgrowth always occur at the same 
position – the somite boundary - in zebrafish and mice vessel. ISVs also grow 
stereotypically at the same time. Several factors that are known to provide 
positional cues for axonal outgrowth have been found to influence the 
guidance of endothelial cells along their path (Eichmann et al., 2005; Gelfand 
et al., 2009; Weinstein, 2005).  
The PlexinD/Semaphorin system represents one of these guidance cues. The 
Semaphorin (Sema) receptor PlexinD1 is almost exclusively expressed in 
endothelial cells. The out-of-bounds (obd) zebrafish mutant that lacks 
PlexinD1 function shows premature sprout formation and abnormal 
positioning of these sprouts along the axis of the aorta (Childs et al., 2002; 
Torres-Vazquez et al., 2004). Mouse mutants for PlexinD1 also have a strong 
disorganization of the somitic vasculature (Gitler et al., 2004; Gu et al., 2005). 
The role for the ligand Sema is not as well understood (Gu et al., 2005; 
Torres-Vazquez et al., 2004; Yee et al., 1999). While the knock-out of 
sema3E in mice phenocopies the effect of PlexinD1 mutants, the same 
molecule in zebrafish has the opposite effect. Here the knock-down of 
sema3E causes a delayed outgrowth of ISVs (Lamont et al., 2009). Therefore, 
different semaphorin ligand/receptor pairs show antagonistic effects on the 
timing of sprout formation during zebrafish development.  
Another neuronal signaling pathway known to regulate angiogenic outgrowth 
is the Netrin/Unc5b system. The receptor Unc5b is expressed in arterial cells. 
The ligand Netrin1, on the other hand, is expressed at the neural keel and the 
horizontal myoseptum in zebrafish embryos (Park et al., 2005). Netrin1 was 
found to be an angiogenic factor due to its capability to induce the proliferation 
and migration of ECs and vascular smooth muscle cells (Park et al., 2004). 
However, other studies however showed that inhibition of Unc5b/Netrin1 
signaling causes the formation of an excess of filopodial extensions and 
vessel branches leading to the conclusion that Netrin1 is an anti-angiogenic 
factor (Bouvree et al., 2008; Larrivee et al., 2007; Lu et al., 2004). The 
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different outcomes of these experiments most likely represent the bipotential 
ability of Netrins to work as repulsive as well as attractive signals.  
Next to guidance cues that determine the path and timing of sprout outgrowth, 
another prerequisite is needed for proper angiogenic behavior of ECs. Space 
has to be generated to allow for EC migration, tissue invasion and vascular 
lumen formation. This is brought about by the degradation of basement 
membrane and removal of ECM (van Hinsbergh and Koolwijk, 2008). In 
particular, the membrane type1- matrix metalloproteinase (MT1-MMP) and 
other MMPs are well known to degrade Collagen type IV and other ECM 
proteins (Chun et al., 2004). However, the fact that ECs most probably use 
their filopodia to generate an attachment site, points to a reason why proper 
angiogenesis also does not work completely without ECM proteins. In 
zebrafish, a role for CollagenIX was described in the formation of the vascular 
plexus in the caudal fin (Huang et al., 2009). Additionally, several genes 
encoding ECM components such as Laminins and Perlecan have been found 
to more active in tip cells (del Toro et al., 2010).  
All of the conserved genetic pathways described so far determine the 
establishment of the circulatory system before the onset of blood flow. 
However, it was shown that also the blood flow itself is required for the 
modulation of the vascular network. A particular vessel called AAx connecting 
two aortic arches to the LDA in zebrafish only starts to develop after the onset 
of blood flow the inhibition of blood flow totally abolishes the formation of this 
vessel (Nicoli et al., 2010). They showed that in this case flow induces the 
expression of the transcription factor klf2α, which in turn drives expression of 
the micro RNA miR-126. This in turn allows for Vegf-mediated induction of 
angiogenesis and the formation of the AAx vessel (Nicoli et al., 2010).  
Another study demonstrated a similar defect after the ablation of blood flow 
for the central arteries (CtA) of the brain. These vessels do form and connect 
to the basilar artery (BA) without blood flow. This is mediated by the 
chemokine signaling of cxcl12b and its receptor cxcr4a. Only after perfusion 
of these vessels, they loose their angiogenic potential through the 
downregulation of the receptor. Ablating blood flow in these vessels causes 
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the CtAs to keep their angiogenic behaviors like the formation of filopodial 
extensions (Bussmann et al., 2011).  
Therefore, blood flow does not only induce the formation of new vessels, but 
also leads to the maturation of newly formed vascular connections.  
 
 
3.2 Junctional proteins in development 
 
Branched tubular organs are characterized by their composition of epithelial 
cells, which manifest an apical-basal polarity. The apical sides of these cells 
face the lumen and the basal sides face towards the surrounding tissues. 
Each of these sides usually fulfills special functions associated with the role of 
the specific organ. Therefore, the apical-basolateral diffusion of membrane 
components has to be restricted. The compartmentalization of the 
membranes is brought about by junctional proteins that connect to their 
equivalent junctions of neighboring cells. In addition to providing a membrane 
diffusion barrier, junctions allow the separation of the lumen and the 
surrounding tissue enabling the organ to function properly.  
 
3.2.1 Junctional proteins in endothelial cells 
Next to desmosomes and gap junctions, epithelial and endothelial cells harbor 
two major types of junctions, adherens junctions (AJs) and tight junctions 
(TJs) (Legan et al., 1992; Simon and Goodenough, 1998). The latter two 
consist of transmembrane proteins that hold adhesion functions. AJs are 
intracellular scaffolding proteins that mediate the connection with neighboring 
cells through homophilic interactions (Bazzoni and Dejana, 2004; Hartsock 
and Nelson, 2008). Epithelial cells are often cuboidal and have a long lateral 
membrane. Here the apically localized AJs and TJs are separate with TJs 
localizing more apically than AJs within the membrane. Endothelial cells 
however are elongated and have a thin spot of lateral membrane that contains 
TJs and AJs in an intermingled fashion (Simionescu et al., 1975). The main 
function of AJs is the establishment, maturation and maintenance of 
3. Introduction 
 22 
endothelial cell-cell contacts. TJs on the other hand, are required for 
paracellular transport of solutes and for sealing the epithelium. 
Some junctional proteins are specifically expressed in endothelial cells; these 
are the Vascular endothelial cadherin (VE-cadherin) at AJs and Claudin 5 at 
TJs (Fig. 5). Further transmembrane proteins help to build the AJ and TJ 
complexes. Vascular endothelial protein tyrosine phosphatase (VE-PTP), 
Platelet endothelial cell adhesion molecules (PECAMs) and N-Cadherin 
contribute to the AJ complex. Additional Claudins, Occludin, Junctional 
Adhesion Molecules (JAMs), ESAM and Nectin are further transmembrane 
components of TJs (Fig. 5).  
All of the transmembrane proteins mentioned above bind to intracellular 
cytoskeletal and signaling proteins. The connection to the cytoskeleton 
ensures stability of the junction and is required for its dynamic rearrangement 
(see 1.2.3) (Dudek and Garcia, 2001; Lampugnani et al., 2002; Sheldon et al., 
1993). Proteins like Afadin and Ponsin connect Nectin directly to F-actin (Fig. 
5) (Takahashi et al., 1999). Other proteins like Zonula Occludens-1 (ZO-1) act 
as scaffolds, as they bind via their PDZ domain to the tight junction proteins 
Claudin, Occludin and JAMs, but also to cytoskeletal binding proteins like 
cortactin, cingulin and α-catenin (Fanning et al., 1998; Itoh et al., 1999a; 
Matter and Balda, 2003; Stevenson et al., 1986; Wittchen et al., 2000). ZO-1 
also binds to other ZO proteins, namely ZO-2 and 3 and to the signaling 
molecule ZO1-associated nucleic-acid binding (ZONAB) (Fig. 5) (Balda and 
Matter, 2000; Haskins et al., 1998; Itoh et al., 1999b). ZONAB is one example 
of a junctional protein that can translocate to the nucleus and regulate 
transcription of specific genes, in this case ZONAB regulates the expression 
of genes involved in cell proliferation (Balda et al., 2003). The most studied 
example of a signaling molecule, however, is β-catenin, which is usually in 
tight association to VE-Cadherin (Fig. 5), but once it translocates to the 
nucleus as a result of Wnt pathway activation, it induces expression of 
CyclinD1 or TCF. Thereby it regulates cell growth, apoptosis and cell 
differentiation (Ben-Ze'ev and Geiger, 1998; Bienz and Clevers, 2000).  
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Figure 5: Schematic drawing of junctional proteins in endothelial cells. ECs harbor tight 
and adherens junctions. They contain transmembrane proteins that connect neighboring ECs 
via homophilic interactions. Proteins specifically expressed in ECs are Claudin5 (TJs) and 
VE-cadherin (AJs). Many junctional proteins bind to intercellular proteins like ZO-1 or α/β-
catenin. These provide a connection to the cytoskeleton and are responsible for signaling into 
the nucleus. After (Dejana, 2004). 
 
3.2.2 The formation of an epithelium 
Cells that build blood vessels are not polarized from the start. Only while the 
vasculature develops, mesodermally derived cells become polarized and 
transform into endothelial cells. The formation of cell-cell contacts and the 
development of junctions in epithelial and endothelial cells occur in a series of 
events. In cell culture experiments, it was shown that while migrating towards 
an inductive signal, epithelial cells send out filopodia. These filopodial 
extensions connect to filopodia of neighboring cells and junctional proteins are 
deposited at contact sites forming the first primordial AJ (pAJ) (Adams et al., 
1996; McNeill et al., 1993). Several of these pAJs result in a zipper-like 
appearance, which fuse upon further maturation and make a linear contact 
region (McNeill et al., 1993). During this maturation process more and more 
junctional proteins are recruited and localize to the junctions. A functional 
epithelium requires the formation of AJs and TJs. In cell culture the first 
junctional proteins to accumulate between cells are Nectins (Sato et al., 2006; 
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Takai et al., 2008). It was shown in epithelial cell culture experiments, that 
Partitioning-defective-3 (Par-3) binds to Nectins and recruits Cadherins as 
well as afadin, α-catenin, β-catenin to the junctional domain. Afterwards, TJ 
proteins such as ZO-1 and JAMs accumulate (Asakura et al., 1999; Ebnet et 
al., 2001; Ooshio et al., 2007). With further maturation Occludin and later 
Claudins localize to the junctions. PAR-3 and atypical protein kinase C 
(aPKC) are recruited to the tight junctions and ensure the initiation of the tight 
junction complex (Suzuki et al., 2002). Generally it is believed that AJs form 
first and initiate the generation of TJs. ZO-1 is one of the first scaffold 
proteins, because it localizes to early AJs and recruits other TJ proteins to this 
site. Later, the AJ proteins are sorted out from this spot and ZO-1 specifically 
localizes to TJs (Ando-Akatsuka et al., 1999). In some cell lines the AJ 
complex is indispensable for proper TJ formation (Gumbiner et al., 1988; 
Ikenouchi et al., 2007). However, also the PAR3-aPKC-PAR6 complex is 
crucial for TJ maturation from AJs. It probably regulates the localization of TJ 
components by phosphorylation or indirectly by inducing asymmetric 
distribution of other membrane components (Hurov et al., 2004; Suzuki et al., 
2004). AJ proteins, however, are not only used as a scaffold for TJ formation, 
they also induce the expression of TJ proteins. Experiments with mouse 
endothelial cells revealed a direct link between the formation of VE-cadherin 
containing AJs and the upregulation of Claudin 5. Clustering of VE-cadherin 
leads to sequestration of β-catenin to the membrane, which causes the 
transcriptional repressor complex of FoxO1, TCF-4 and β-catenin not to form, 
therefore enabling the transcription of Claudin 5 (Taddei et al., 2008).  
It is not known if the step-wise process of junction maturation also occurs 
during angiogenesis. However, immunohistochemical analysis of the first 
contact formation of neighboring ISVs reveal that VE-Cadherin and ZO-1 are 
among the first proteins to accumulate at contact sites of filopodia (Blum et 
al., 2008).  
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3.2.3 Junctional remodeling as a driving force for 
morphogenesis 
A mature epithelium is not considered to be fixed and immobile. Cells within 
the epithelium remain mobile most of the time. The ability of junctions to be 
continually assembled and disassembled is crucial for tissue-reorganization, 
cell death or cell division and epithelial maintenance (Guo et al., 2007). Even 
more so is the development of an epithelial organ very dynamic. Constant 
junctional turnover in order to shorten or lengthen junctional strands is needed 
for the cellular processes occurring during organ development, such as cell 
shape changes, cell division, cell migration and cell rearrangement (Baer et 
al., 2009; Baum and Georgiou, 2011). On one hand, this is ensured by the 
internalization and recycling of junctional proteins (Le et al., 1999) (Shaye et 
al., 2008) (Matsuda et al., 2004) (Tiklova et al., 2010). E-Cadherin was shown 
to be endocytosed in a clathrin-dependent manner in epithelial cultured cells 
and in vivo its trafficking is required for intercalation processes occurring 
during tracheal development in Drosophila (Le et al., 1999) (Shaye et al., 
2008). On the other hand, the dynamics of AJs and TJs is brought about by 
the potential of certain proteins to diffuse within the junctional strand. While AJ 
proteins or the tight junction proteins Occludin and ZO-1 diffuse rapidly, 
Claudin is rather stably localized at the membrane (Sasaki et al., 2003; Shen 
et al., 2008). These different diffusion properties might represent the specific 
functions of certain proteins within a junctional strand. 
During morphogenetic processes in development, all kinds of junctional 
remodeling linked to cell rearrangement and cell shape changes can be 
observed. For example, in the Drosophila wing epithelium, cells change from 
an irregular to a hexagonal shape. This process is tightly linked to junctional 
rearrangement; some cell-cell contacts have to be enlarged and maintained, 
while others have to shorten or dissolve (Classen et al., 2005). Another 
example of junctional remodeling is seen in the formation of the dorsal branch 
during trachea development. While at the onset of dorsal branch formation 
cells are set up in a side-to-side arrangement with intercellular junctions only, 
at the end of the remodeling process cells have intercalated, they are 
elongated and most intercellular AJs have been replaced by autocellular AJs. 
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This junctional remodeling occurs throughout the process of intercalation, 
which requires cells to wrap around the lumen and initiate initial autocellular 
junctions (Ribeiro et al., 2004).   
The dynamics of junctional remodeling during angiogenesis are less well 
understood, but were described for the process of anastomosis. Anastomosis 
is the connection of two separated vessels, which in this case are the 
neighboring ISVs. During this process ZO-1 and VE-Cadherin accumulate as 
a dot at the first contact between filopodia. This dot develops into a ring, 
which becomes bigger the more the neighboring cells crawl over each other 
and the bigger their contact area gets (Blum et al., 2008).  
 
3.2.4 The role of VE-Cadherin in morphogenesis 
Cadherins have been shown to play significant roles during cell 
rearrangement in morphogenetic processes like dorsal closure or tracheal 
tube formation in Drosophila (Gorfinkiel and Arias, 2007; Ribeiro et al., 2004; 
Tanaka-Matakatsu et al., 1996; Uemura et al., 1996). Shotgun mutants, that 
partially lack the DE-Cadherin protein, show severe morphological defects 
during the fusion of adjacent tracheal metamers. The fusion cells fail to 
accumulate junctional proteins at the contact point and do never adhere to 
each other (Tanaka-Matakatsu et al., 1996).  
The role of VE-cadherin in angiogenesis has started to be studied in more 
detail. VE-cadherin mutations in mice lead to impaired vessel remodeling and 
maturation, which causes early death during embryogenesis (Carmeliet et al., 
1999; Crosby et al., 2005). In cell culture VE-cadherin was shown to have pro- 
and anti-angiogenic functions. It is known to bind directly to VEGFR-2, which 
leads to the retension of the receptor at the membrane; thereby it is not 
internalized into signaling compartments leading to limited cell proliferation 
(Lampugnani et al., 2006). Furthermore, VE-cadherin suppresses angiogenic 
sprouting by inhibiting Rac1-dependent migration (Abraham et al., 2009). 
However, another study with mouse allantoids showed the pro-angiogenic 
function of VE-cadherin. In wt situations, ECs can crawl over an existing 
sprout to form a new tip. This highly motile behavior of migrating cells was 
blocked by inhibiting the function of VE-cadherin (Perryn et al., 2008). In vivo, 
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VE-cadherin also seems to have an angiogenic function. During zebrafish 
blood vessel formation morpholino (MO) knock-down of VE-cadherin causes a 
reduction in vascular integrity and the lack of lumen formation in segmental 
arteries (Wang et al., 2010). Furthermore, filopodial extensions of neighboring 
ISVs, although touching and retracting over a long period of time, never 
established a functional contact leading to impaired ISV formation (Montero-
Balaguer et al., 2009).  
 
3.2.5 Claudins seal epithelia 
Claudin family members are the main components of epithelial/endothelial 
tight junctions and consist of at least 27 members in mammals (Furuse, 2010; 
Mineta et al., 2011). In transmission electron microscopy, TJs appear as 
attachments of opposing membranes without an intercellular gap (Farquhar, 
1963; Goodenough and Revel, 1970). The main function of TJ proteins is the 
restriction of protein diffusion within the lateral membrane as well as the 
formation of a paracelllular diffusion barrier. Claudins are transmembrane 
proteins with four transmembrane domains, two extracellular domains and a 
cytoplasmic N- and C-terminus. Several studies identified the different roles of 
these domains in the capability of forming an epithelial barrier. The “tightness” 
of such a barrier is defined by different properties of paracellular transport. 
Determining the trans epithelial electrical resistance (TER), the charge 
selectivity and permeability of non-charged solutes as well as size 
discrimination provide information about the “tightness” of an epithelium 
(Powell, 1981). Leaky tight junctions do not support steep gradients of ions 
and therefore form a low TER (Van Itallie and Anderson, 2004b). These 
means of measure helped to find that the first extracellular domain of each of 
the Claudins defines their paracellular tightness and selective ion permeability 
of the junction (Colegio et al., 2003). With this domain Claudins form a pore 
by connecting to Claudins of neighboring cells. It is believed that when equally 
charged residues line this pore, the pore is open and it is permeable for either 
cations or anions as is the case for Claudin 2, 7 or 15 (Alexandre et al., 2005; 
Amasheh et al., 2002; Van Itallie et al., 2003). Unequally charged residues, 
however, lead to paracellular tightness like for Claudin 4, 5 or 8 (Krause et al., 
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2008; Krause et al., 2009; Van Itallie et al., 2001; Wen et al., 2004; Yu et al., 
2003). The second extracellular domain has the function to hold the opposing 
cell/Claudin and regulate the narrowing of the paracellular cleft (Krause et al., 
2009; Piontek et al., 2008). Some Claudin subtypes, like Claudin 3 with 
Claudin 1 and 2, can connect in trans to each other in a heterotypic way, 
others cannot (e.g. Claudin 1 with Claudin 2) (Furuse et al., 1999). This 
heterogeneity of Claudin connections in cis and trans creates a diversity of 
channel and barrier properties for different cell types (Furuse et al., 1999). 
Connections to other tight junction proteins are brought about by the C-
terminus of Claudins. The C-terminus contains a conserved sequence, which 
resembles a PDZ-binding domain through which Claudins bind to the PDZ-
domains of ZO-1 – ZO-3 (Itoh et al., 1999a). For some Claudins the C-
terminus was shown to be required for its apical membrane localization 
(Arabzadeh et al., 2006; Ruffer and Gerke, 2004). Furthermore, several 
phosphorylation sites and a palmitoylation site are required for the localization 
of Claudins to the junctions (Aono and Hirai, 2008; Ishizaki et al., 2003; Van 
Itallie et al., 2005).  
The requirements of certain tissues for specific barrier functions is in part 
reflected by the expression pattern of different Claudins. Claudin 2 is 
expressed in the leaky epithelia of the proximal renal tubule and in the 
Bowman`s capsule of the kidney (Kiuchi-Saishin et al., 2002; Reyes et al., 
2002). Claudin 1 is expressed in tissues that resemble tight epithelia like the 
epidermis and the distal nephron of the kidney (Furuse et al., 2002; Reyes et 
al., 2002). Several pathological conditions in humans and mice are attributed 
to mutations in claudin genes. In mice a deletion of claudin 1 causes early 
death of new-borns due to extensive water loss over the epidermis (Furuse et 
al., 2002). Changes in the expression of claudin 1, 5 and 8 lead to barrier 
dysfunctions of the gut and cause Crohn`s disease (Zeissig et al., 2007). 
Furthermore, a mutation in claudin 14 causes autosomal recessive deafness 
(Wilcox et al., 2001) (Ben-Yosef et al., 2003). 
The endothelial specific gene cldn5 was also found to cause barrier defects in 
mice, humans and zebrafish (Morita et al., 1999). In humans, claudin 5 is one 
of 45 genes deleted in Velo-cardio-facial syndrome. This disease is 
characterized by several disorders like craniofacial anomalies or conotruncal 
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heart defects. How the deletion of claudin 5 in particular contributes to the 
pathological condition is unknown (Sirotkin et al., 1997). Claudin 5 most 
importantly has a function in forming the blood-brain-barrier (BBB). The BBB 
is made of ECs that restrict the diffusion of solutes from the blood into the 
extracellular fluid of the central nervous system (CNS). Deletion of claudin 5 in 
mice leads to a size-selective loosening of the BBB. Neither the brain 
morphology nor the formation of TJs itself are impaired in these mutants. 
However, after perfusion of differently sized molecules into the blood system, 
only the mutant showed diffusion of the small molecules into the brain (Nitta et 
al., 2003). Zebrafish express two claudin 5, claudin 5a (cldn5a) and claudin 5b 
(cldn5b). Cldn5a is expressed in the neuroepithelium (http://zfin.org), where it 
is essential together with the Na,K-ATPase for the brain ventricular lumen 
expansion (Zhang et al., 2010). The role for cldn5b in zebrafish development 
is not known so far. 
 
3.2.6 The role of Claudins in morphogenesis 
Next to their role in barrier formation, some Claudins were also found to 
influence morphogenetic processes. The SJ proteins Megatrachea and 
Sinuous are not only known for their barrier function in all epithelial tissues of 
the Drosophila embryo (Behr et al., 2003; Stork et al., 2008; Wu et al., 2004). 
They are also important for normal development of the tracheal shape, as 
mutations in these genes reveal elongated and tortuous tracheal branches 
(Behr et al., 2003; Wu et al., 2004). In mice Claudin 4 and 6 are essential for 
blastocyst formation. Inhibition of their gene functions causes a lack of 
blastocoel cavity and an abnormally rounded shape of blastomeres (Moriwaki 
et al., 2007). In zebrafish, Claudins carry out functions in morphogenesis. MO 
knock-down of Claudin-15 results in a multiple lumen phenotype of the gut 
(Bagnat et al., 2007). A study of the zebrafish blastoderm revealed a function 
for Claudin-E during morphogenesis. Claudin-E is expressed by the 
enveloping layer (EVL), which moves vegetally over the yolk during epiboly. 
Knock-down of Claudin-E causes a slow and uneven advancement of the EVL 
and blastoderm resulting in delayed epiboly. This is probably caused by 
reduced tension on the EVL (Siddiqui et al., 2010). 
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3.3 Aim of the thesis 
 
Cell-cell contacts mediate many dynamic cell behaviors during developmental 
processes like the formation of the vascular network. These cell-cell contacts 
contain among others tight junction proteins, whose role in the morphogenetic 
processes of angiogenesis remains largely unknown. Endothelial cells in mice 
specifically express Cldn5 as the key component of tight junctions. Therefore, 
I analyzed the role of Cldn5 during angiogenesis in zebrafish. For this 
purpose, I studied the effect of MO-mediated knock-down on the formation of 
ISVs using live-imaging techniques. Furthermore, I generated cldn5b mutant 
fish for the analysis of the gene function during angiogenesis.  
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4. Materials and Methods 
 
4.1 Companies 
All chemicals were obtained from the following companies: 
Applichem   BD Biosciences 
BioRad   Difco laboratories 
Eurogentec   Fluka 
Invitrogen   Machery-Nagel 
Merck    Roche 
Schwartz   Sigma-Aldrich 
    
4.2 Buffer, Media and Solutions 
0.1 M Glycin pH 2.2 75mg glycin in 10ml PBST 
0.3 M Sucrose solution 102.69g/l sucrose in 1xPBS, heat until 
dissolved 
0.3M Succrose-Solution 102,69g/l Succrose in 1x PBS 
1% Agarose Agarose in 1xTAE/TBE 
10% (2mM) PTU 
(Phenylthiourea) 
304 mg PTU (RT) in 1 l eggwater, stir on at 
4°C, store at 4°C 
10%SDS 10% sodium dodecyl sulfate in ddH2O 
1x SSCT add Tween-20 to 0,1% final conc. in 1x SSC 
2% Paraformaldehyde (PFA) Dilute 4% PFA with 1x PBST 
20mg/ml Proteinase K Lyophilized powder is dissolved 20mg/ml in 
sterile 50mM Tris (pH8.0), 1.5mM calcium 
acetate. Divide stock solution into small 
aliquots and store at -20°C. 
20x-SSC 
 
NaCl 8,8g, NaCitrate 4,4g, H20 to 1l 
Adjust to pH7.0 
25x Tricaine 2g tricaine in 350 ml, set to pH 7.0 w TrisHCL 
(1M pH8.0). Fill up to 500ml. Aliquot. Store at 
-20°C. 
2mM EDTA 93,05g EDTA (RT), add 400ml ddH2O and 
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10M NaOH to pH 8.0. Fill up to 500ml with 
ddH2O. Autoclave. 
4% PFA 550ml ddH2O, warm under the hood to 60°C. 
Add 40g PFA, wear gloves, protection 
glasses, lab coat. Stir 5 – 40 min at 60°C. Add 
three to four drops of 2N NaOH, wait until 
cleared; if not, repeat. Take from heater, add 
333,3 ml 10x PBS (pH 7.22). Fill up to 1l; 
filtrate 
5% Bakto-Agar  5% Bakto-Agar in 0,3M Sucrose/PBS 
50-70% glycerol 50-70% glycerol in ddH2O 
70% Ethanol 70% Ethanol in ddH2O 
Ampicillin stock solution 
(50mg/ml) 
500mg Ampicillin (stored at 4°C) in 10ml H2O. 
Sterilized with 0.2mm filter. Aliquot and store 
at -20°C. 
Antibody solution in situs Anti-dig IgG(FAB2)- alkaline phosphatase 
1:3000 in blocking solution 
Blocking solution antibody 
staining 
2% goat serum and 5% BSA in PBST + 
1:1000 NaAzid  
Blocking solution in situs 2% sheep serum, 2mg/ml BSA in PBST + 
1:1000 NaAzid 
Blocking stock solution 
fluorescent in situ 
10% (w/v) blocking reagent  (Roche 
#1096176) dissolved in maleic acid buffer. 
Autoclave and store aliquots at –20 ˚C. 
Chloramphenicol stock 
solution (34mg/ml) 
340mg Chloramphenicol dissolved in 10ml 
100% EtOH. Aliquot and store at -20°C. 
DNA loading buffer (10x) Dissolve 15ml glycerol in 40ml ddH2O. 
Dissolve 100mg Orange G. Fill up to 50ml 
with water. Store at -20°C. 
eggwater 6 g seasalt in 20 l autoclaved ddH2O + 1% 
methylenblue 
Equilibration buffer 0,1M Tris-HCL pH9.5 + 0,5M NaCl  
Genomic DNA extraction 10mM Tris pH8   
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buffer 2mM EDTA  
0.2% TritonX-100  
0.5% SDS 
200 µg/ml Proteinase K (keep cool!) 
Hyb4 
 
20x-SSC 250ml 
Torula-RNA 500mg 
Heparin 50mg 
Tween-20 1ml 
H20  to 500ml 
Formamide   500ml 
Kanamycin stock solution 
(10mg/ml) 
100 mg Kanamycin dissolved in 10ml ddH2O. 
Filter sterilize. Aliquot and store at -20°C. 
LB (Lysogeny-broth) medium 10g peptone, 5g yeast extract, 10g NaCl in 
950 ml ddH2O. Shake until dissolved. Adjust 
to pH7.0 with 5N NaOH. Adjust to 1l with 
ddH2O. Autoclave. 
LB agar plates Add 15g Bacto agar per liter LB medium. 
Autoclave and add antibiotics at 50°C. Pour 
into petridishes. 
Maleic acid buffer 100mM maleic acid, 150mM NaCl, pH7.5 
Methylcellulose 3% Methylcellulose in eggwater. Dissolve at 
4°C. 
Methylenblue Dissolve 1g Methylenblue in 1l ddH2O. 
NaAzid 10% solution in ddH2O. Store at -20°C. 
PBDT 1x PBS, 1% DMSO, 0,1% Tween 20 
PBS NaCl               8     g 
KCl             0.2  g 
Na2HPO4(2H20) 1.8  g 
KH2PO4            0.24g 
Add H2O to 1l 
Adjust to pH 7,2 
PBST 10% PBS 
0.1% Tween 20 
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PBSTX 0.5% TritonX-100  
in PBST 
SOB-Medium 10g Tryptone, 2.5g Yeast extract, 2.5mM KCl, 
487 ml ddH2O. Autoclave. 
SOC 5ml of MgSO4 (1M), 5ml MgCl2 (1M) (both 
sterile filtered), 10ml Glucose (1M) + 500ml 
SOB. 
SSC 20x 8.8g NaCl, 4.4g NaCitrate, H2O to 1l, adjust to 
pH 7.0 
SSCT Dilute SSC 1/20, add Tween-20 to 0.1% final 
conc. 
Staining solution (in situs) 200 µl NBT/BCIP stock solution (Roche) in 
10ml equilibration buffer 
(or: 1 tablet NBT/BCIP in 10ml H20 (Roche)) 
TAE (Tris-acetate-EDTA 
electrophoresis buffer) 
242g Tris Base, 57.1ml Acetic Acid, 37.2g 
EDTA in 1l. Autoclave. 
TBE (Tris-borate-EDTA 
electrophoresis buffer) 
Dilute 200ml TBE (5x) in 800ml H2O 
TE (tris-EDTA) -buffer 10mM Tris HCl, 1mM EDTA in ddH2O. Adjust 
to pH8.0. 
TNT 100 mM Tris-HCl pH 7.5 
150 mM NaCl  
0.5% Tween20  
TNTB Blocking stock solution diluted 1:10 with TNT 
TSS 5g PEG 6000, 1.5ml 1M MgCl2, 2.5ml DMSO, 
add LB to 50ml. Filter sterilize (0.22µm). Store 
at 4°C. 
Tris HCl Dissolve 121.1g Tris base in 800ml ddH2O. 
Adjust to desired pH by adding HCl. 
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4.3 Molecular Biology Protocols 
4.3.1 Bacteria strains 
strain source 
E.coli DH5α Invitrogen 
E.coli 
OneShot®Mach1TMT1Rchemicaly 
competent cells 
Invitrogen 
E.coli OneShot®TOP10chemically 
competent cells 
Invitrogen 
 
E.coli OneShot®ccdB 
SurvivalTM2T1Rchemically competent 
cells 
Invitrogen 
E.coli XL1blue Invitrogen 
E.coli TOP10 electrocompetent cells Invitrogen 
 
4.3.2 Plasmids and cDNA clones 
plasmid comment source 
pENTR/D-TOPO® cloning vector, gateway 
cloning technology 
Invitrogen 
cldn5b cDNA IRBOp991A1057D  ImaGenes 
cldn5a cDNA IRBOp991E0139D ImaGenes 
p5E-UAS 10xUAS element and 
basal promoter for Gal4 
response, Gateway 
Kwan et al., 2007 
p5E-fli1ep Fli1a enhancer 
promoter, Gateway 
Driever, unpublished 
pME-nlsmCherry nuclear-localized 
mCherry 
Kwan et al., 2007 
pME-cldn5b wo stop Cldn5b without stop, 
Gateway 
this study 
pME-gal4ff Gal4ff this study 
p3E EGFP pA EGFP for C-terminal Kwan et al., 2007 
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fusions, Gateway 
pDestTol2CG2 attR4-R3 gateway with 
SV40 polyA flanked by 
Tol2 inverted repeats 
with cmlc2:egfp 
transgenesis marker, 
Gateway 
Kwan et al., 2007 
pDONRP2R-P3 3`donor vector; attP2R-
P3 flanking chlor/ccdB 
cassette 
Invitrogen 
pCS2FA-transposase for in vitro transcription 
of capped Tol2 
transposase mRNA 
Kwan et al., 2007 
pCS2+ cldn5b RNA 
expression vector 
for in vitro transciption of 
capped cldn5b mRNA 
this study 
pTolUAScldn5bEGFP C-terminal EGFP fusion 
to cldn5b under control 
of UAS 
this study 
pTolfliepnlsmCherry nuclear localized 
mCherry under control 
of fliep  
this study 
pTolfliepgal4ff Gal4ff expression under 
control of fliep 
Zygmunt et al., 2011; 
Totong et al., 2011; this 
study 
pCS2+ for in vitro transcription 
of mRNA 
Rupp, Affolter lab 
pCS2+ mKate for in vitro transciption of 
capped mKate mRNA 
this study 
pmKate2-N mKate2 expression, 
fusion 
Evrogen 
 
 
 
4. Materials and Methods 
 37 
4.3.3 PCR amplification 
 1µl  template 
 1µl  10mM dNTPs 
 10µl  Phusion 5x buffer 
 2.5µl  10µM Primer 
 0.5µl  (2U/µl) Phusion DNA polymerase (Finnzymes) 
 32.5µl  H2O 
 
4.3.4 Restriction enzyme digestion and gel extraction 
DNA    1µg – 5µg 
Restriction buffer 10x 1x 
Restriction enzyme   0,5 µl 
add H2O  to 20 – 100 µl 
The digested DNA was separated by agarose gel electrophoresis and the 
desired bands were cut out of the gel. They were purified with the Sigma Gel 
Extraction Kit according to the manual. 
 
4.3.5 Ligation and transformation 
Vector     100 ng 
PCR fragment  
T4 DNA ligase buffer (10x)  1,5 µl 
T4 DNA ligase (NEB)  1 µl 
Add H2O to    15 µl  
The reaction was incubated at 16°C overnight.  
Chemically competent E. coli were thawed on ice for two min. 1µl of DNA 
solution was added to the tube (2µl for TOPO reaction cloning). The bacteria 
were incubated for 30 min. Meanwhile, the water bath was preheated to 42°C. 
The bacteria were heat shocked at 42°C for 40sec and kept on ice for 2 min. 
Then 0.5 ml prewarmed LB or SOC medium was added to the bacteria, which 
were then recovered by shaking (200rpm) at 37°C for 30 min. They were 
plated on selective LB medium and grown at 37°C ovn.  
Clones were picked from the selective LB media plates and the plasmid 
isolated according to the manufacturers protocol (Sigma GenEluteTM Plasmid 
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Mini Kit). The constructs were tested by PCR or restriction enzyme digestion. 
For injection into fish or further use in Gateway reactions, larger bacterial 
cultures were inoculated and the plasmid isolated using the Sigma Plasmid 
Midi Kit. The isolated plasmid was sequenced. 
 
4.3.6 Generation of plasmids via the Gateway system 
4.3.6.1 Generation of Entry clones 
For the generation of middle entry clones the gene of interest was PCR 
amplified with Phusion DNA Polymerase (Finzymes). The forward primer 
contains a CACC 5` overhang for directional TOPO cloning into pENTR/D-
TOPO vector using the pENTR/D-TOPO cloning kit (Invitrogen). For further 
cloning the pENTR/D-TOPO manual (Invitrogen) was followed. 
For the generation of 3` entry clones PCR amplification of the gene of interest 
was performed using the pDONR P2R-P3 vector. Here the forward primer 
contained an attB2 site (GGGGACAGCTTTCTTGTACAAAGTGGNN) 5`of the 
gene specific sequence. The reverse primer contained a reverse attB3 site 
(GGGGACAACTTTGTATAATAAAGTTGN). The PCR product was not 
purified. For further cloning the LR Clonase Gateway Enzyme Mix and the 
according manual (Invitrogen) was used. 
After purification of the vectors (see midi preparation), they were verified by 
sequencing. 
 
4.3.6.2 Generation of Expression clones 
Multisite Gateway recombination reactions were performed as in the 
Invitrogen Multisite Gateway manual. All plasmids were diluted in TE buffer 
and reactions were performed with TE-buffer.  
 
4.3.6.3 Generation of Tol2 mRNA 
The pCS2FA-transposase plasmid was used as a template. 3 µg DNA was 
linearized with NotI and purified by ethanol precipitated (see section 4.3.9). 
RNA synthesis was performed using the mMessage mMachine SP6 Kit 
(Ambion). The RNA was purified by precipitation. 
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4.3.7 Generation of mRNA 
cDNA was linearized and mRNA was transcribed according to the 
manufacturer`s protocol of mMESSAGEmMACHINE. The RNA was purified 
by precipitation. 
 
4.3.8 Genotyping 
4.3.8.1 Fin clips 
materials:  
- 200 ml beaker with 100ml egg water + 4ml tricaine (25x) 
- 70% ethanol   - plastic spoon 
- razor blades   - plastic lid (single crossing cages) 
- net     - forceps 
- sterile eppendorf tubes on ice - genomic DNA extraction buffer 
 
protocol: 
Take one fish out of the tank with a net and put it into eggwater + tricaine. 
Wait until the fish is paralyzed, take it out carefully with a plastic spoon and 
put on a clean plastic lid. Take one razor blade and press on the tip of the fin. 
Use another razor blade to cut off the tip of the fin. Use forceps to put fin into 
eppendorf tube with 100 µl genomic DNA extraction buffer. Put the fish into a 
single fish cage with eggwater + methylenblue. 
 
4.3.8.2 Genomic DNA extraction 
- for fin clips: 
Incubate Eppendorf tubes at 55°C at 800 rpm for 4 hrs to ovn and spin down 
liquid. Denature proteinase K at 94°C for 10` and spin down debris for 30`at 
4°C. Dilute DNA 1:10 in H2O. 
- for embryonic pools: 
Set up 30- 40 crossings (single female + single male). Let embryos grow until 
1.5 – 2 dpf  and pool 5 embryos per well (in total 80 embryos per crossing). 
Remove egg water (as much as possible) on ice and add 100 µl genomic 
DNA extraction buffer per well (on ice). Incubate at 50°C 4hrs to ovn (much 
better ovn), take lid off the wells before taking out of incubator. Put 50µl of 
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DNA prep into new PCR 96 well plate and cover well with sealing tape. Then 
denature proteinase K at 94°C, 10` and dilute DNA 1:10 in H2O. 
 
4.3.8.3 PCR on genomic DNA 
- make master mix:    - protocol: 
5 µl   primer (10µM)   98°C 1` 
5 µl   dNTPs (2mM)   98°C 30`` 
5 µl   Titanium Taq Buffer   68°C 30` 
1 µl  Genomic DNA   68°C 10` 
0,5 µl   Titanium Tag    10°C f.e. 
28,5 µl H2O      
Add 50µl per well, then add genomic DNA and cover with sealing tape. 
 
4.3.8.4 Restriction enzyme digestion 
make master mix: 
5 µl   10x NEB Buffer 4   
0,5 µl   HinfI    
20 µl   DNA   
add to 50 µl  H2O    
When using genomic DNA of fixed embryos, use 30 µl DNA. 
Digest at 37°C for 2hrs. Add 20µl H2O to original PCR (for fixed embryos, do 
not add H2O). Analyze on TBE agarose gel by loading 20µl of digestion and 
10µl of PCR on gel. 
 
4.4 Immunohistochemistry and in situ hybridization 
4.4.1 Immunofluorescence whole mount antibody staining 
4.4.1.1 Primary antibodies 
Host Specificity/ dilution source 
mouse αhuman / mono ZO-1 / 1:200 Zymed 
rabbit αzebrafish / poly VE-cad /1:200 H.G. Belting 
mouse αhuman / mono Cldn5 / 1:150 Invitrogen 
Rabbit αzebrafish / poly Cldn5b PickCell Laboratories 
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Rabbit αzebrafish / poly Cldn5b PickCell Laboratories 
guineapig αzebrafish / 
poly 
Cldn5b PickCell Laboratories 
guineapig αzebrafish / 
poly 
Cldn5b PickCell Laboratories 
 
4.4.1.2 Secondary antibodies (all Invitrogen) 
Conjugate Specificity/ dilution source  
Alexa568 goat αrabbit IgG Invitrogen 
Alexa633 goat αrabbit IgG Invitrogen 
Alexa568 goat αmouse IgG Invitrogen 
Alexa633 goat αmouse IgG Invitrogen 
Alexa568 goat αguineapig IgG Invitrogen 
Alexa633 goat αguineapig IgG Invitrogen 
All Alexa conjugated antibodies were diluted 1:1000 in blocking solution. 
 
4.4.1.3 Immunofluorescence whole mount antibody staining 
All incubations were performed on a rocking platform. 
For prehybridization of antibodies, Incubate antiserum at final dilution in 
blocking solution with fixed embryos ovn at 4°C. Use at least 100 
embryos/5ml of antiserum solution. For antibody stainings fix embryos in 
2%PFA for 2hr at RT or ovn at 4°C. Then wash three times in PBST, 5`at RT. 
Permeabilize (depending on primary antibody) with PBSTX: 
15` 1dpf  30` 1,5 dpf 
60` 2dpf  90` 3dpf 
Block in 500µl of blocking solution, 2hrs at RT. Incubate primary antibody in 
blocking solution, ovn at 4°C. Wash 3x 5`at RT with PBST. Wash every hour 
with PBST. Incubate with secondary antibody 2hrs at RT or ovn at 4°C. Wash 
6x over 3-4hrs, even better: ovn. 
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4.4.2 Vibratom Sectioning and Antibody Stainings on Sections 
Materials 
- Cyanacrylat Glue (Roti®call1, Carl Roth GmbH) 
- Succrose-Solution   - Bakto-Agar 
- PBDT    - blocking solution 
 
Sectioning: 
1. Fixation of fish in 2%PFA 2hrs RT, on shaker, 3x5` washing in PBST 
2. Incubation in Succrose solution, 30` 4°C (this will improve the 
 connection of embryo and embedding medium) 
3. Embedding in Bakto-Agar 
 Keep this solution at 55°C, place embryos in 24well plate whole each, 
 add Bakto-Agar, orient embryo so that anterior is down, posterior up 
 and ventral away from you and dorsal towards you. Cut a square with 
 embryo out of the agarose 
4. Glue the solid block onto the round metal plates of the vibratom using 
 special Cyanacrylat glue 
5. Vibratom settings: 
 Feed: 150-200µm  Freq: 7.8 
 Speed: 5.5 
 Fill the sectioning box completely with PBS. Remove the sections using a 
cut brush; collect them in 24well plates in PBDT 
 
Antibody-Stainings: 
1. short wash with PBDT, this and all following steps in 24 well plate 
2. Blocking 60-100 min in blocking solution 
 Slow shaking at RT, Primary antibody incubation; ovn at 4°C 
3. Removal of primary antibody; washes 6x10`in PBDT, Secondary antibody 
incubation; 1h RT; slow shaking; keep dark! 
4. Removal of secondary antibody: washes 6x10`in PBDT (you can store 
these sections until analysis for 1-2 weeks at 4°C) 
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5. Mounting: single out the best sections, use whole agar slice or remove 
sections from agar, arrange them on a slide, remove liquid and add a few 
drops slow Fade, add cover slip without air bubble formation 
 
4.4.3 Whole-Mount in situ Hybridization 
 
Probes were generated using the DIG RNA labeling mix from Roche. 
Fixation: 
1. Fix embryos with 4% parformaldehyde in PBS overnight at 4°C, or for 3h 
RT (for 3 day old embryos). Over 20 somites dechorinate before fixing. 40 
embryos or less in 1ml PFA. 3x wash with PBST, 5 min each, at RT. 
2. Remove the embryos from their chorions using watchmaker forceps 
(easiest at this point, if they have not been dechorionated already). 
3. Transfer embryos to vials with 100% methanol (MeOH), equilibrate for 
5min with at least 4 changes of MeOH. Note: From this point on, the 
embryos remain in the same plastic tube until they are ready for 
rehybridization. 
4. Cool the embryos to -20°C for at least 30 min (embryos can be stored that 
way for months; this step is necessary for permeabilization of embryos 
even if you do not want to store them). 
Protocol A (0- bud stage): 
5. Directly from storage, replace MeOH with 200µl preHyb+ (depending on 
no. of embryos) 
6. Incubate for 1-3 h at 68°C (heat oven) 
7. Replace preHyb+ with Hyb+RNA-probe, (0,5µl-4µl in 200µl, depending on 
the probe (1:50 to 1:200). Incubate overnight at 68°C 
Protocol B (later stages, 24hpf onward): 
6. Rehydrate embryos in PBST (2x5min). 1-3 h at 68°C (heat oven) 
7. Replace PBST by proteinase K (20mg/ml stock solution) in PBST, dilution 
1/2000 for 24 hpf and older, 200µl for each probe 
8. Incubate: 25hpf: 8min, 28hpf: 10 min, 32hpf: 13min, 48pf: 30min 
9. Wash 2x in PBST. Fix for 20min at RT in 4% PFA 
10. Wash 1x5min in PBST, 1x1min in H2O and 1x5min in PBST 
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Hybridization: 
11. Incubate for 1-3h at 68°C (heat oven or water bath) 
12. Replace preHyb+ with Hyb+RNA-probe, (0,5µl – 4µl in 200µl, depending 
on the probe; 1:50 to 1:200), incubate over night at 68°C 
Probe removal and wash: 
13. Next morning, remove probe (probes can be reused twice). 
a) wash 1x20min in 0,5ml Hyb-, 68°C (all solutions should be 68°C) 
b) wash 2x20min in 0,5ml 2xSSCT, 50%Formamid 68°C 
c) wash 1x20min in 0,5ml 2xSSCT, 25% Formamid 68°C 
d) wash 2x20min in 0,5ml 2xSSCT, 68°C 
e) wash 3x30min in 0,5ml 0,2xSSCT, 68°C 
f) wash 1x5min in 0,5ml PBST, 68°C 
Incubation with anti DIG/FITC antiserum: 
14. Block with blocking solution at RT, minimum 1h 
15. Replace with 200µl of a 1/3000 dilution (0,375U/ml) of sheep anti-
digoxygenin alkaline phosphatase conjugated Fab-fragments (+NaN 
1:1000), incubate in antibody solution overnight with agitation at +4°C ON, 
or for 2h at RT 
Staining: 
16. Wash for at least 2h in PBST, changing solution 10 times (8x 15`, 2x30`). 
This is an important step to prevent background. 
17. Equilibrate 2x5`in equilibration solution (to prevent precipitation of salt in 
buffer) 
18. Stain with freshly made NBT/BCIP solution. Incubate embryos in staining 
solution at RT (if faster necessary at 37°C) in the dark and monitor with a 
dissecting microscope. 
19. Stop the reaction by removing the staining solution and washing the 
embryos in PBST. Store the embryos in PFA at +4°C in the dark 
20. Clearance for staining with high background: 
 Stop staining only once in PBST, 2x5` glycin, 4x5` PBST 
Mounting: 
21. For observation using a dissecting microscope, mount embryos in 
glycerol, 50-100% depending on the tissue observed (70% for expression 
4. Materials and Methods 
 45 
in brain and vessels). For longer storage, store in 4% PFA at 4°C, as 
embryos tend to get dark in glycerol 
 
4.4.4 Double whole-mount FISH using Alexa Tyramides 
 
The FITC/DIG labeled probes were generated using the RNA Labeling Mix 
from Roche. Different probe concentrations were tested beforehand.  
Solutions: 
- Hyb    - TNT  
- 20X SSC    - TNTB 
- 50% Formamide in 2x SSCT - Blocking Stock Solution 10x 
- 25% Formamide in 2x SSCT 
Fixation, Rehydration and Hybridization: 
- See section 4.4.3 
Washes and blocking: 
- Wash see section 4.4.3 (probe removal and wash) 
5'  TNT (this wash at RT). Block in TNTB at RT, at least 1 h.  
Detection of the FITC-labeled probe: 
- Mix a 1:500 dilution of the HRP-coupled anti-FITC (Roche) in TNTB. 
Replace TNTB from the previous step with the antibody mix and incubate ON 
at 4 ˚C. 
- Remove the antibody mix and wash 8x 15’ with TNT. 
Staining: 
- Spin down TSA substrate before making staining solution. For the reaction, 
dilute tyramide reagent 1:50 in Perkin Elmer amplification diluent buffer. 
- Incubate 30-60 minutes in TSA Plus Fluorescein Solution. During this 
incubation, we lay the microcentrifuge on its side. Reaction time must be 
determined empirically for each probe. Unfortunately, the staining reaction 
cannot be visually monitored as the substrate is fluorescent, and one will see 
ubiquitous green fluorescence throughout the staining reaction.  
- Wash 3x5`with TNT. 
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Bleaching: 
- Bleach with 1% hydrogen peroxide in TNT, 30’, to inactivate the peroxidase 
conjugated to the first antibody (for early stages 20’ are enough). 
- Wash 5x 5’ with TNT (big volumes! Hydrogen peroxide must be completely 
washed out). Block in TNTB at RT, at least 1 h. 
Detection of the DIG-labeled probe: 
- Mix a 1:1000 dilution of the HRP-coupled anti-DIG in TNTB (Roche). - 
Replace TNTB from the previous step with the antibody mix and incubate ON 
at 4 ˚C. Remove the antibody mix and wash 8x 15’ with TNT.  
Staining: 
- Spin down TSA substrate before making staining solution. For the reaction, 
dilute tyramide reagent 1:50 in Perkin Elmer amplification diluent buffer. 
- Incubate 30-60 minutes in TSA Plus TMR Solution. During this incubation, 
we lay the microcentrifuge on its side. Reaction time must be determined 
empirically for each probe. Unfortunately, the staining reaction cannot be 
visually monitored as the substrate is fluorescent, and one will see ubiquitous 
green fluorescence throughout the staining reaction.  
- Wash 3x 5’ with TNT. 
DON’T POSTFIX. 
Note: Use FITC before TMR reaction, develop week probe before strong 
probe 
 
4.5 Fish lines, maintenance and handling 
4.5.1 Fish maintenance 
Fish were maintained and bred according to standard protocols (Westerfield, 
2000).  
4.5.2 Fish lines 
Wildtype lines: 
Fish line Source/reference 
AB/EK W. Driever, Freiburg 
EK/TL W. Driever, Freiburg 
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 Transgenic lines: 
Fish line Source/reference 
Tg(UAScldn5bEGFP) this study 
Tg(fliep:GFF) (Asakawa and Kawakami, 2008) 
Lukas Herwig, this study 
Tg(fliep:GFF;UASmRFP) Zygmunt et al., 2011; Totong et al., 
2011; Lukas Herwig, this study 
Tg(fli1a:EGFP) (Lawson and Weinstein, 2002) 
Tg(fli1a:EGFP; gata1:dsRed) 
 
(Chico et al., 2008) 
Tg(fli1a:EGFP;fliep:nlsmCherry) this study 
Tg(fli1a:EGFP)cldn5bubs11 this study 
Tg(fli1a:EGFP)cdh5ubs8 Heinz-Georg Belting 
    
4.5.3 DNA/RNA and morpholino injection 
Microinjection needles were pulled with a Sutter Instrument Co. Agarose 
plates were made by pouring 1% agarose into petridishes and putting a 
plastic mold with striations on the surface. After polymerization the mold was 
removed. Eggwater was poured over the agarose and the plates were stored 
at 4°C. The microinjection needles were loaded with DNA/RNA with the help 
of a microloader (Eppendorf). Needles were connected to a FemtoJet 
microinjector (Eppendorf) or a hand injector. The tips of the needles were cut 
of with forceps. The DNA/RNA was injected into the yolk close to the cell or 
into the cell. 
4.5.4 Generation of transgenic fish lines 
Approximately 200 eggs (one cell stage) were injected with 60 pg DNA and 60 
pg Tol2 RNA. Embryos were screened for transient reporter gene expression 
between 24 hpf and 48 hpf. Fish transiently expressing the reporter gene 
were raised separately from the others. Founders were screened for germline 
transmission by screening at least 100 embryos for expression of the 
transgene.  
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4.6 Confocal microscopy 
4.6.1 Mounting and confocal microscopy of fixed embryos 
The trunk and tail of the embryo were cut off the head and yolk with a 
razorblade. The tail was embedded in vectashield (Vector Laboratories, Inc.) 
on an objective slide (ThermoScientific) and covered with a cover slip 
(Marienfeld Laboratory Glassware). Images were taken with the Leica SP5 
confocal microscope with the 20x objective, 20x objective with 2x zoom or the 
63x objective. A frame size of 512x512 pixel and 512x1024 pixel and a step 
size of 0.8 µm – 1 µm was used. Pictures were processed with Imaris® 
(Bitplane) and ImageJ.  
 
4.6.2 Mounting and confocal live imaging of living embryos 
0.7% low melting agarose was dissolved in egg water. For mounting it was 
melted in the microwave. After addition of 0.01% tricaine (pH7.5) and 1x PTU 
the agarose was kept at 55°C during mounting. Reporter gene expressing 
embryos were selected under the fluorescent binocular microscope (brand) 
and anesthesized with 0.01% tricaine in egg water. A big drop of agarose was 
put on the 10mm microwell of a 35mm petridish (No. 1.5 coverglass, 0.16-
0.19 mm thickness; Glass Bottom Culture Dishes from MatTek). Embryos 
were mounted in the agarose and covered with egg water containing 0.01% 
tricaine and 1x PTU. The Leica SP5 confocal microscope was used for 
imaging. The heating chamber was set to 28.5°C. All movies were taken with 
a frame size of 512x512 pixel and a stack thickness of between 80 – 110 µm. 
For Tg(fli1a:EGFP) fish, the 20x objective was used with a 2x zoom. For 
Tg(UAScldn5bEGFP) fish, the 63x objective was used. Movies were 
processed with Imaris® (Bitplane) and ImageJ. 
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Summary  
While many of the cellular and molecular mechanisms of angiogenesis have been 
intensely studied, very little is known about the processes that underlie vascular 
anastomosis. We have generated transgenic fish lines expressing an EGFP tagged 
version of the junctional protein ZO-1 to visualize cellular behaviors that occur during 
vessel fusion and lumen formation in vivo. These life observations of cell junctions 
during anastomosis and lumen formation show that endothelial cells perform distinct 
morphogenetic mechanisms, cell hollowing and cord hollowing to generate different 
types of vascular tubes. In the case of cell hollowing, the vascular lumen is formed by 
extension of the proximal lumen of the ISV and gives rise to a seamless, unicellular 
tube. This process is primarily driven by cell membrane invagination rather than 
vacuole formation. In the case of cord hollowing, new apical membrane 
compartments are brought together by cell rearrangements, which result in lumen 
coalescence and formation of a multicellular tube. Thus, DLAVs and ISVs consist of 
two different types of tubes: multicellular tubes that arise by cord hollowing and 
unicellular tubes that are generated by cell hollowing. 
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Results and Discussion 
Generation and expansion of vascular beds by vascular remodeling involves a variety 
of morphogenetic mechanisms such as angiogenic sprout and lumen formation, as 
well as blood vessel fusion (anastomosis) and their removal (pruning). Anastomosis is 
the essential process that converts otherwise non-productive dead-end sprouts into a 
functional vascular network. Angiogenic sprouts are guided by so-called tip cells, 
which are more motile and send out more filopodia than the trailing stalk cells [1]. 
During the first step of anastomosis, tip cells from neighboring sprouts establish 
contact with each other [2, 3]. Subsequently, endothelial cells (ECs) from neighboring 
sprouts form a continuous epithelium and their lumens are connected.  How these 
events are achieved and coordinated at the cellular level is not known. We have used 
the zebrafish dorsal anastomotic vessels (DLAV) as a model to analyze the cellular 
mechanisms that underlie vascular anastomosis in vivo. To this end we generated 
transgenic reporter lines that label endothelial cell junctions (fli1ep:GAL4ffubs2-4 and 
UAS:EGFP-ZO1ubs5-7, see supplementary material). These lines allowed us to follow 
individual cell junctions and, consequently, relative cell movements and cell shape 
changes, as they occur during vascular remodeling. 
 
The DLAV is formed in a seemingly stereotypic pattern by the anastomosis of 
neighboring segmental arteries (SA) [4]. Tip cells of individual SA that have reached 
the roof of the neural tube extend processes laterally both in rostral and caudal 
direction.  Some of these filopodia emanating from neighboring tip cells eventually 
contact each other, stabilize and integrate into the DLAV. During further 
development, a lumen extends through the SA and the DLAV (see Fig. 1A, S1A). We 
first examined the cellular architecture of DLAVs to determine whether this vessel is 
made of unicellular (intracellular) or multicellular (extracellular) tubes. By 
photoconversion of the fluorophore KAEDE in fli1ep:GAL4ffubs2;UAS:KAEDErk8 
embryos we labeled single cells within the DLAV and determined whether these 
spanned the circumference of the DLAV either entirely or partially (Fig. 1B,C). In 16 
out of 24 cases, we found cells enclosing the entire lumen representing a unicellular 
tube, whereas in 8 out of 24 cases labeled cells covered the vessel only partially, 
which is indicative for multicellular tubes. To test whether the different cellular 
arrangements correspond to the patterns of EC junctions, we performed 
photoconversion experiments and subsequently visualized adherens junctions by 
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immunofluorescence using an antibody against zf-VE-cadherin [5]. Consistently, we 
found that unicellular regions did not contain junctions (Fig. 1D,D’), whereas 
photoconverted cells nested within a multicellular region were demarcated by 
longitudinal lines of VE-cadherin (Fig. 1E,E’). To visualize endothelial cell contacts 
in vivo we generated a transgenic reporter line UAS:EGFP-ZO1ubs5-6 (Fig. S1B). In 
double transgenic embryos (fli1ep:GAL4ffubs2;UAS:EGFP-ZO1ubs5), we compared the 
localization of the EGFP-ZO1 fusion protein with the distribution of VE-cadherin and 
found that it specifically labels cell junctions, albeit in a mosaic fashion (Fig. S1C). 
Furthermore, we were able to confirm the heterogeneity in vascular architecture by 
the junctional patterns observed in vivo in fli1ep:GAL4ffubs2;UAS:EGFP-ZO1ubs5 
transgenic embryos. In these embryos we found regions that had predominantly ring-
shaped cell contacts (Fig. 1F) as well as regions that contained more complex 
junctional patterns (Fig. 1G). Thus, DLAVs (and also ISVs – data not shown) are 
heterogeneous in their architecture and can consist of different types of tubes: 
unicellular, multicellular tubes and tubes of mixed cellular arrangements.  
 
To analyze the cellular dynamics of DLAV formation, we first focused on the initial 
events of contact formation between neighboring tip cells. From studies using 
immunofluorescent detection of ZO-1 we had previously proposed a model in which 
interactions between tip cells lead to generation of junctional spots at the contact sites 
[5]. These spots elaborate into rings as the cells increase their mutual surface area. 
Analysis of VE-cadherin protein revealed identical patterns (Fig. 2A-C). Since this 
sequence of events was inferred from observations in fixed tissues, we wanted to test 
this model in an in vivo situation by performing confocal time-lapse analyses on our 
EGFP-ZO1 reporter. In essence, the pattern of EGFP-ZO1 was congruent with our 
previous observations, thus confirming the above model (Fig. 2D-F; movie S1). 
Moreover, junctional remodeling is extremely dynamic – the transformation from 
spots to rings occurs within less than 40 minutes.  
 
Whereas initiation of anastomosis appeared to be consistently associated with 
formation of ring-shaped junctions, the subsequent establishment of the DLAV 
showed considerably greater complexity and variety – in respect to (i) junctional 
remodeling, which corresponds to extensive cell rearrangements, (ii) the generation of 
a continuous endothelium with apical-basal polarity and (iii) lumen formation. After 
 5 
analysis of 15 time-lapse movies representing 19 fusion events, we were able to 
discern two distinct junctional behaviors, which represent two alternative cellular 
mechanisms that underlie DLAV formation.  
 
In some instances (7 events in 15 movies), we observed a mechanism that appears to 
be primarily driven by cell rearrangements (Fig. 3; movie S2). Here, cell contacts 
between at least 3 adjacent cells generate 2 (or more) junctional rings, which 
converge towards each other as the outer cells migrate over a central cell. This 
convergence ultimately results into novel contacts between the outer cells, the 
establishment of a new junction and the detachment of the medial cell at this site of 
contact (summarized in Fig. 5). Thus, the outcome of the process is the formation of a 
continuous apical surface concomitant with the fusion of local luminal spaces, which 
are contained within the junctional rings. In principle, this mechanism of luminal 
coalescence can act locally or, if occurring iteratively, may be used to lumenize 
longer stretches of tubes. Superficially, the mechanism we observe resembles cord 
hollowing mechanisms that have been described for the intestinal lumen in fish [6] 
and the dorsal aorta in mouse [7], both of which rely on de novo epithelial 
polarization and subsequent luminal coalescence to form a multicellular tube. 
Whereas the cellular mechanism of lumen coalescence in the dorsal aorta has not been 
described, lumen coalescence in the intestine has been. However, in details it appears 
different from the DLAV, as it seems to be driven by luminal expansion rather than 
cell rearrangements [6]. In contrast, a mechanism of remarkable similarity has been 
described for hollowing the notochord in the ascidian Ciona intestinalis [8]. In both 
systems, zebrafish DLAV and Ciona notochord, lumenization commences with the de 
novo establishment of apical domains at opposite sites of individual cells and is 
followed by cell movements and cell shape changes, which result in the formation of 
a continuous epithelium and the fusion of luminal spaces. To test, whether blood 
pressure is required for cell rearrangements during anastomosis, we blocked heartbeat 
by the injection of anti-sense morpholinos against cardiac troponin (tnnt2a) [9]. 
Whereas lumen formation in tnnt2a morphants proved difficult to monitor, we 
observed that the initial steps of anastomosis (i.e. the formation and elaboration of 
apical compartments) was relatively normal (see Fig S2A and movie S3). Further, cell 
movements appeared unaffected. 
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In the majority of time-lapse movies (12 events in 15 movies), we observed an 
alternate mechanism of vessel fusion that appears to be intrinsically connected to a 
different mechanism of lumen formation. In these instances, junctional rings did not 
move or extend towards each other, the cells exhibited much less migratory behavior 
and we did not find continuous adherens junctions along the vascular axis (Fig. 4, 
movie S4). Instead, the ECs maintained their junctional configuration throughout the 
process of lumenization.  Imaging the dynamics of lumen formation in vivo, either by 
intravascular quantum dot injection or by lack of cytoplasmic mRFP, revealed that the 
lumen extended between two separate apical patches and joined them by a cell 
hollowing mechanism (Fig.4, Fig.S2B, movies S4 and S5, summarized in Fig.5). This 
mechanism leads to a transformation of the “tip cell” into a “fusion cell”, which forms 
a unicellular tube containing an “intracellular” lumen. This was demonstrated by a 
blood cell serendipitously passing through the two junctional rings of a hollowed-out 
cell (insets in Fig. 4, movie S4). 
 
The “fusion cell” of the DLAV may be considered analogous to the “doughnut cell” 
that is important for tubular fusion within the Drosophila tracheal system and 
eventually forms a seamless tube [10-12]. In the case of the “doughnut cell” it has 
been shown that the intracellular tube is generated by cell shape changes, which 
eventually lead to an intracellular membrane fusion [13]. Future experiments will 
show whether a similar mechanism is also used in the vertebrate vascular system.  
The cell shape changes, which occur during anastomosis, are far more drastic than 
those in the Drosophila tracheal system. We observed asymmetric cell shape changes, 
since the tip cell became hollowed in a proximal to distal direction - that is from the 
lumenized side. Furthermore, the direction of cell hollowing was independent of the 
anatomical orientation and occurred either in a ventral to dorsal or dorsal to ventral 
direction (compare Fig.4, S2B, S2C and movies S4, S5 and S6). In all cases, the 
lumen was formed in a continuous fashion and we did not detect isolated luminal 
spaces within the cell. These observations suggest that blood pressure may be a 
driving force for this type of anastomosis and vessel formation.  
 
Using several combinations of labeling systems, we have shown that DLAVs and 
ISVs are both made up by different types of tubes, unicellular and multicellular. By 
observing cellular dynamics during anastomosis in vivo, we have further shown that 
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vascular anastomosis during DLAV formation can occur by very different 
morphogenetic mechanisms, either by cord hollowing processes generating a 
multicellular tube, or by a cell hollowing process resulting in a unicellular/seamless 
tube. In both cases, anastomosis is intrinsically connected with de novo lumen 
formation at the site of vessel fusion.  
 
Here, we have studied the anastomosis of ISVs, which results in the formation of a 
new vessel, the DLAV. Accordingly, the principles outlined may also serve as a 
paradigm for vessel formation in general. It has previously been suggested that 
tubulogenesis may occur differently in various types of blood vessels [3, 14-18]. In 
general it appears that larger caliber multicellular tubes such as the mouse or zebrafish 
dorsal aorta use a cord hollowing mechanism [7, 16, 18], whereas small unicellular 
tubes use a cell hollowing mechanism [17, 19]. Previous in vitro studies in three 
dimensional culture systems have suggested that endothelial cell hollowing is driven 
by the intracellular coalescence of vacuoles [20, 21]. Concurring with this view, 
vacuole coalescence has also been proposed as the chief mechanism in the formation 
of unicellular ISVs in zebrafish embryos [17, 22]. In contrast, our in vivo studies show 
that cell hollowing during unicellular tube formation is driven rather by cell shape 
changes than by vacuole coalescence. These discrepancies to the earlier studies may 
be explained in several ways. Firstly, the dynamics of cell hollowing suggest that 
blood pressure plays an important role in cellular invagination. Several studies have 
recently demonstrated an important role for blood pressure in vascular remodeling  
[23-25]. In vitro cell culture systems, by design, do not provide blood pressure and 
ECs are not likely to show such drastic cell shape changes in this context. Secondly, 
imaging of cell shape changes requires a system that allows the identification of 
single cells. Our system of labeling endothelial cell junctions in vivo has enabled us to 
trace the outline and shapes of individual cells and to separate intracellular from 
extracellular spaces. These observations are in agreement with our microangiography 
experiments and strongly suggest that the early lumens that are generated during 
unicellular tube formation consist of extracellular lumens rather than large 
intracellular vacuoles. Our model does not preclude a significant contribution of 
vacuoles or vesicles to vascular lumen formation, such as expansion of apical 
membrane surfaces and of the extracellular vascular lumen.  
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Taken together, we describe two novel cellular mechanisms that govern vascular tube 
formation and anastomosis. These mechanisms although used by the same type of 
blood vessel employ very different cellular activities, cell rearrangements or cell 
invagination, respectively, to form and connect novel lumens, and therefore lead to 
vessels of distinct cellular architectures. Both mechanisms are used at a comparable 
rate of instances, suggesting a stochastic selection of the process. Future experiments 
will explore the parameters, such as blood pressure, vessel size and cell motility and 
number, which may influence the choice of mechanism. 
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Figure Legends 
 
Figure 1:Anastomosis andheterogeneity of endothelial tubes. 
(A) High-resolution movie (63x lens, 2x zoom, 2 minutes between time points) shows 
steps during DLAV formation. Tip cells reach the dorsal side of the embryo and send 
filopodia in anterior and posterior directions (00:18, arrow).  The tip cells contact 
each other and form the DLAV (00:48). Later the lumen opens from the stalk and 
proceeds into the DLAV (arrow in 4:12 and 7:08). 
Different vessel architectures represented in B-G, D’ and E’ are found in the 
ISV/DLAV.Single photoconverted cells (red) show a unicellular/seamless (B) and a 
multicellular arrangement (C). Inserts (i-iii) in (B) and (C) show a surface calculation 
(i), a sagittal cross section (ii) and the coronal cross section (iii) at the sites indicated 
by crosshair; single photoconverted cells (red) show a intracellular (D) and a 
extracellular arrangement (E). Corresponding VE-cadherin immunostainings are 
shown in (D’) and (E’). Small rectangles (yellow) indicate regions of unicellular (D-
D’) and multicellular (E-E’) tubes; a unicellular tube outlined by EGFP-ZO1 fusion 
protein is shown in (F), extracellular/intracellular and mixed arrangements 
represented by EGFP-ZO1 protein are shown in (G). The yellow arrow in (F) points at 
delocalized EGFP-ZO1 protein in the cell membrane. This mislocalization is most 
likely due to high levels of protein expressed in these cells. (B, C, D and E) High-
resolution images (63x objective, 4x zoom) of 48hpf old embryos carrying a GAL4FF 
activatable UAS:Kaede transgene. Nuclei (n in figure) of single cells were converted 
by UV treatment. (F,G): High-resolution images (63x objective, 2x zoom) of 48hpf 
old embryos carrying the GAL4FF dependent UAS:EGFP-ZO1 (green) and 
UAS:mRFP (red) transgene. (D’),(E’): High-resolution images (63x objective, 2x 
zoom) of VE-cadherin immunostainings after photoconversion, cytoplasm (blue), α-
VE-cadherin (green), photoconverted cells (red). 
 
Figure 2: Initial contact formation during anastomosis. (A-C) VE-cadherin 
immunostainings of 30 hpf old fli:EGFP embryos. Spots, small and larger rings are 
shown in panel A, B and C respectively (see arrow). (D-F): picture series of 
supplementary movie S3 showing a time-lapse of a fli:GAL4FF; UAS:mRFP; 
UAS:EGFP-ZO1 embryo (time: 1h20’). An initial contact spot of EGFP-ZO1(arrow 
in A) is elaborated into a small (arrow in B) and subsequently into a larger loop 
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(arrow in C), thereby stabilizing the fusion cell contact (see movie S1). The yellow 
arrow in (F) points to delocalized EGFP-ZO1 in the cell membrane (compare Fig. 1 
and Fig. S1) 
 
Figure 3: Multicellular lumen formation. Picture series from movie S2 showing a 
time-lapse of a fli:GAL4FF; UAS:mRFP; UAS:EGFP-ZO1embryo (time: 9h 20’). A 
tip cell has formed contacts with an adjacent tip cell (on the right) and has contact 
with a stalk cell, which results in two loops of EGFP-ZO1(arrow in A). These loops 
extend and eventually meet (B,C). A’-D’ shows the junctional outline of participating 
cells (yellow: “central” cell, green: stalk cell, red: DLAV cell moving in from 
posterior (right)). The two initial cell contacts are shown in yellow/green and 
yellow/red, respectively. When stalk cell and the adjacent DLAV cell meet, they 
establish a new contact with “green/red” junctions (arrow in D, green/red line in D’). 
 
 
Figure 4: Anastomosis and fusion by cell hollowing. Picture series from 
supplementary movie S4 showing a time-lapse of a fli:GAL4FFubs2; UAS:mRFP; 
UAS:EGFP-ZO1ubs5 embryo (time: 10h 25’). A tip cell has formed initial contacts and 
subsequently forms loops of EGFP-ZO1 with its adjacent partner (arrow in A and B). 
The stalk shows a multicellular organization (two lines of EGFP-ZO1, arrowhead in 
B) and the lumen opens in this region (waved arrow in B). From (C) on the lumen 
invaginates into the fusion cell (follow arrow from C to E) and finally reaches the left 
loop of EGFP-ZO1, which is subsequently inflated (arrow in F). The lumen then 
continues to extend in the unlabeled fusion cell on the left (arrow in G).  Right after, a 
red blood cell passes the newly formed intracellular lumen (follow arrowhead from G 
to J). Insets show the blood cell passing behind the junction (G) and once in front of 
the junction (H).  
 
Figure 5: Distinct morphogenetic mechanisms of anastomosis and lumen 
formation in multicellular and unicellular blood vessels. (I) Neighboring tip cells 
deposit junctional proteins (VE-cadherin, ZO1) at the sites of contact formation (B). 
The contacted areas are expanded leading to a transformation of the initial junctional 
spots into rings. Individual tip cells are shown in green, blue and yellow, 
respectively). The ISV stalk can be either unicellular or multicellular. For simplicity, 
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a single adjoining stalk cell is shown in purple. Junctions are shown in two colors 
corresponding to the cell on either site of the cell contact. 
From here, two different morphogenetic mechanisms lead to two different types of 
tubes i.e. unicellular/seamless tubes (II) or multicellular tubes (III). (II) A lumen, 
which has extended from the dorsal aorta into the stalk, invaginates into the 
“fusion/tip” cell (blue) (A). (The lumen is visualized in a lighter shade of the color of 
the surrounding cell). As the lumen reaches the distal end of the fusion cell (B), it 
merges with the previously formed apical membrane compartments at the contact 
sites, presumably by membrane fusion (C). (III) (A’) to (C’) show longitudinal 
sections along the black line shown in (A). Several cells (shown here in purple, blue 
and yellow) enlarge intercellular contact surfaces (A). Further cell rearrangements 
generate novel contacts between the purple and yellow cell (B) and lead to a local 
detachment of the blue cell at the novel contact site (C). As a result, two local 
compartments (blue/purple and blue/yellow) merge into a single multicellular lumen.  
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Experimental procedures 
 
Construction of pT2fli1ep:GAL4FF vector 
A PCR fragment containing the ORF of the GAL4-VP16 derivative Gal4FF 
(GAL4FF) was amplified from the pT2KhspGAL4FF vector [26, 27] using following 
primers (fwd pr. 5’-caccatgaagctactgtcttc-3’ / rev pr. 5’-ttagttacccgggagcatatc-3’) and 
directionally TOPO-cloned into the entry vector pENTR™/D-TOPO® (Invitrogen). 
The resulting pENTR:GAL4FF entry clone was recombined with the endothelial-
specific destination vector pTolfli1epDest [28] via a Gateway LR reaction to yield the 
expression vector pTolfli1ep:GAL4FF. 
 
Plasmid Construction 
pT2UAS:EGFP-ZO1-cmlc:EGFP: A XhoI/AgeI 14xUASE1b fragment was PCR 
amplified using the following primers: (forward: 5’-
GTGACCTCGAGAAGCTTAGGCCTCCAAGG-3’ reverse 5’-
GTATCACCGGTTCGAGGGAATTCGTGTGG-3’), cut and cloned via triple 
ligation together with an EGFP-humanZO1 fragment isolated from pG1UAS:EGFP-
ZO1with AgeI/Asp718 into SalI/Asp718 cut vector pDestTol2CG2 (gift from Chi-Bin 
Chien). 
pG1UAS:EGFP-hZO1: A XhoI/AgeI-cut 14xUASE1b fragment, generated by PCR 
using the following primers (fwd. pr. 5’-
GTGACCTCGAGAAGCTTAGGCCTCCAAGG-3’ rev. pr. 5’-
GTATCACCGGTTCGAGGGAATTCGTGTGG-3’) and the pBUASE1b vector (gift 
from Reinhard W. Köster) as a template, was cloned into pG1 flk-1:EGFP-ZO1which 
was digested with SalI and AgeI. 
 
Generation of Tg(fli:GAL4FF;UAS:Kaede) transgenic fish 
To generate and easily identify fish lines stably carrying the pTolfli1ep:GAL4FF 
driver construct 25 pg of tol2 transposase mRNA synthesized in vitro with the 
mMessage Machine Kit (Ambion) and 25 pg of pTofli1ep:GAL4FF plasmid DNA 
were co-injected into approximately 150 1-cell stage Tg(UAS:Kaede)rk8 embryos 
[29]. Injected embryos were visually screened under an epifluorescent microscope 
and animals with strong Kaede fluorescence in the developing vasculature were raised 
to adulthood to obtain putative G0 founders with mosaic transgenic germlines. G0 
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adults were individually out-crossed to Tg(UAS:Kaede)rk2 fish and their F1 progeny 
screened visually as described. Individual G0s that yielded progeny with vascular 
Kaede expression were selected to establish three independent Tg(fli1ep:GAL4FF) 
lines with the allele designations Tg(fli1ep:GAL4FFUBS2, UBS3 and UBS4) (UBS3 and 
UBS4 were used in this study). 
 
Generation of Tg(UAS:EGFP-ZO1-cmlc:EGFP) transgenic fish line 
Approximately 150 embryos (EK/TL strain) were injected with pT2UAS:EGFP-ZO1-
cmlc:EGFP at one cell stage. The cmlc2:EGFP cassette was used to facilitate the 
identification of transgenic carriers in the absence of Gal4 expression. Embryos were 
screened for transient cardiac EGFP expression between 24 hpf and 48 hpf. Embryos 
showing strong transient expression were selected and raised separately. G0 
generation was crossed and screened for germ line transmission. We recovered 8 
transgenic carriers displaying EGFP expression in the heart. Three carriers 
(Tg(UAS:EGFP-ZO1-cmlc:EGFPUBS5, UBS6 and UBS7) showed mosaic GAL4FF 
dependent EGFP-ZO1expression in the vasculature and were used in this study. 
 
 
Immunofluorescence and Live imaging 
Antibody stainings 
Antibody stainings were done as previously described with minor modifications [5]. 
The following antibodies were used: rabbit anti-zf-CDH5 [5] 1:1000; Alexa-568 goat 
anti-rabbit IgG, 1:1000; Alexa-568 goat anti-mouse IgG, 1:1000; Alexa-633 goat anti-
mouse IgG, 1:1000 (All secondary antibodies were purchased from Invitrogen.). 
Images were taken with a Leica SP5 confocal microscope using a 63x glycerol 
immersion objective and analyzed using Imaris (Bitplane) and Image J software. 
 
Photoconversion 
To label individual ECs KAEDE photoconversion was done on a Leica Sp5 
fluorescent microscope by 20-second exposures using a solid-state laser (405nm). At 
2 dpf, when nuclei of individual ECs are easily discernible in ISVs having an inflated 
lumen, fli1ep:GAL4FF;UAS:Kaede transgenic embryos were anaesthetized with 
tricaine, mounted in 0.7% low melting agarose and a defined region of interest (ROI) 
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within individual nuclei was exposed to the violet light. Subsequently high resolution 
x,y,z stacks were acquired with a 63x glycerol immersion objective using the 
suggested slice thickness by the confocal software. Slice numbers ranged from 80 to 
200 slices per stack. 
 
In vivo time-lapse analysis 
Triple transgenic embryos were selected using a Leica MZ FLIII fluorescent 
stereomicroscope. Embryos were selected for mRFP ensuring the presence of the 
fli1ep:GAL4FF and UAS:mRFP transgene and for the presence of the heart marker 
cmlc2:EGFP. Selected embryos were anaesthetized using tricaine and mounted in a 
35 mm glass bottom petri dish  (0.17 mm, MatTek), using 0.7% low melting agarose 
(Sigma) containing 0.01% tricaine and 0,003% PTU. Embryos were imaged overnight 
on a Leica Sp5 confocal microscope using a 63x glycerol immersion objective with a 
numerical aperture of 1.2 with additional zoom of 1-1.3x. In some cases resonance 
scanning with an optical zoom of 1.7 was used. All movies have an initial frame size 
of 512x512 pixels. Routinely, z-stack consisted of 50-80 slices with a step size of 0.8-
1.0 µm. Stacks were taken every 5 minutes, unless noted differently.   
 
Quantum Dot-injection 
705 nm Quantum Dot (Invitrogen) were injected into the sinus venosus of mounted 
embryos at a concentration of 1:2. Special manufactured glass needles (Biomedical 
Instruments, Jena, Germany) with tip opening of 10 µm and beveled tip were utilized 
to reduce damage to the embryo.  
 
Fish maintenance and stocks 
Zebrafish were maintained at standard conditions [30]. Embryos were staged by hours 
post-fertilization (hpf) at 28.5 °C (Kimmel et al., 1995). Embryos derived from wild-
type fish (AB/EK and EK/TL), Tg(fli1ep:EGFP)y1 [2], TG(flk1:EGFP)S843 [18], 
Tg(UAS:Kaede)rk8 [29], Tg(UAS:mRFP1) [26] and Tg(fli1ep:GAL4FF)UBS2,UBS3,UBS4 
and Tg(UAS:EGFP-ZO1-cmlc:EGFP)UBS5, UBS6,UBS7 (this study) were used. 
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Sprouting angiogenesis expands the embryonic
vasculature enabling survival and homeostasis. Yet
how the angiogenic capacity to form sprouts is
allocated among endothelial cells (ECs) to guarantee
the reproducible anatomy of stereotypical vascular
beds remains unclear. Here we show that Sema-
PlxnD1 signaling, previously implicated in sprout
guidance, represses angiogenic potential to ensure
the proper abundance and stereotypical distribution
of the trunk’s segmental arteries (SeAs). We find
that Sema-PlxnD1 signaling exerts this effect by
antagonizing the proangiogenic activity of vascular
endothelial growth factor (VEGF). Specifically,
Sema-PlxnD1 signaling ensures the proper endothe-
lial abundance of soluble flt1 (sflt1), an alternatively
spliced form of the VEGF receptor Flt1 encoding
a potent secreted decoy. Hence, Sema-PlxnD1
signaling regulates distinct but related aspects of
angiogenesis: the spatial allocation of angiogenic
capacitywithin aprimaryvessel andsproutguidance.
INTRODUCTION
Blood vessels form a pervasive tubular network that distributes
oxygen, nutrients, hormones, and immunity factors. The first
blood vessels assemble de novo via EC coalescence or vasculo-
genesis. Later, they expand via angiogenesis, the growth of new
blood vessels from preexisting ones. In some locales, this
process is stereotypic and vascular sprouts form with evolution-
arily conserved and organ-specific distribution, abundance and
shapes (Carmeliet, 2005; Isogai et al., 2001; Isogai et al., 2003).
For example, zebrafish SeAs sprout bilaterally from the trunk’s
aorta just anterior to each somite boundary (SB) (Figure 1A).
SeA sprouts contain migratory, proliferative and filopodia-rich
arterial angiogenic ECs molecularly distinct from the sedentary
‘‘phalanx’’ ECs remaining in the aorta (De Bock et al., 2009; Siek-Developmann and Lawson, 2007; Torres-Va´zquez et al., 2004). Normally,
only aortic ECs near SBs acquire angiogenic capacity (Ahn et al.,
2000; Childs et al., 2002). It is thought that nonendothelial para-
crine VEGF signals promote angiogenic capacity, while Notch-
mediated lateral inhibition between ECs antagonizes it (Phng
and Gerhardt, 2009; Siekmann et al., 2008). However, the
mRNA expression of vegf-a and Notch pathway genes is incon-
sistent with the distribution of SeA sprouts. vegf-a is not tran-
scribed along SBs, but rather expressed dorsal to the aorta at
both the flanking somites’ centers and the hypochord, a midline
endodermal cell row. Notch pathway genes are expressed con-
tinuously along the aorta or broadly through the body (Hogan
et al., 2009b; Lawson et al., 2002; Leslie et al., 2007; Phng
et al., 2009; Siekmann and Lawson, 2007) (C.M.G., J.B., and
J.T.-V., unpublished data). Hence, other cascades likely modu-
late VEGF and/or Notch signaling at presprouting stages to
enable the stereotypical allocation of angiogenic capacity within
the aorta. Perturbing these unidentified cascades might change
the SeA sprouts’ reproducible number or distribution, the ratio of
aortic ECs that acquire angiogenic capacity, and/or the respon-
siveness of these cells to angiogenic cues.
Besides VEGF and Notch activity, proper SeA development
requires paracrine Sema-Plxn signaling. Type 3 semas (sema3s)
are repulsive guidance cues secreted by somites. Sema3s direct
SeA sprout pathfinding by modulating cytoskeletal dynamics via
the endothelial Sema3-receptor PlxnD1. Hence, sema3 or
plxnD1 inactivation yields similar SeA sprout pathfinding defects
in zebrafish and mice (Gay et al., 2011). Two observations made
in zebrafishmake Sema-PlxnD1 signaling a candidatemodulator
of angiogenic capacity. First, sema3 and plxnD1 expression
begins hours before SeAs sprout from the aorta at 21 hr post-
fertilization (hpf). Second, loss of Sema-PlxnD1 signaling
induces ectopic SeA sprout launching (Childs et al., 2002;
Torres-Va´zquez et al., 2004).
In wild-type (WT) animals SeA sprouts grow dorsally with
a chevron-like shape, bifurcate anteroposteriorly at the neural
tube’s roof level and interconnect with their ipsilateral neighbors
at 32 hpf forming the paired Dorsal Longitudinal Anastomotic
Vessels (DLAVs) (Isogai et al., 2003). In contrast, in plxnD1 (out
of bounds - obd) mutants and plxnD1 morphants, SeA sprouts
are misshaped and interconnect ectopically with their ipsilateralmental Cell 21, 301–314, August 16, 2011 ª2011 Elsevier Inc. 301
5. Results 
74 
5.1.3  
 
 
The novel transmembrane protein Tmem2 is essential for 
coordination of myocardial and endocardial morphogenesis 
 
Roland Totong, Thomas Schell, Fabienne Lescroart, Lucile Ryckebüsch, Yi-
Fan Lin, Tomas Zygmunt, Lukas Herwig, Alice Krudewig, Dafna Gershoony, 
Heinz-Georg Belting, Markus Affolter, Jesus Torres-Vazquez and Deborah 
Yelon 
 
Developmental – in press 
 
 
Contribution: 
Together with Lukas Herwig I generated the pTol(fli1ep:gal4ff)ubs4 transgenic 
zebrafish line using the Gateway® system (InvitrogenTM). I contributed to 
discussions during writing of the manuscript. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1RESEARCH REPORT
INTRODUCTION
The embryonic heart tube is initially a two-layered structure: the
outer layer of muscular myocardium contracts to propel circulation
and the inner layer of endothelial endocardium provides continuity
with the rest of the vasculature. Myocardial and endocardial cells
originate in neighboring regions of the lateral mesoderm
(Schoenebeck et al., 2007). During the process of cardiac fusion,
both cell types migrate medially in a synchronized fashion and
merge at the midline to assemble the heart tube (Bussmann et al.,
2007; Holtzman et al., 2007; Moreno-Rodriguez et al., 2006). At
later stages, cardiac maturation involves remodeling of both
juxtaposed layers during valve formation and trabeculation
(Armstrong and Bischoff, 2004; Hinton and Yutzey, 2010; Sedmera
et al., 2000). Despite the continual proximity of the myocardium
and endocardium, little is known about the mechanisms that
coordinate their development.
The coordination of myocardial and endocardial development
has been particularly well established in the context of
atrioventricular canal (AVC) formation. Both the myocardium and
endocardium undergo specialized differentiation in order to create
the characteristic morphology of the AVC and to establish the
endocardial cushions that will remodel into the atrioventricular
valve (Armstrong and Bischoff, 2004; Beis et al., 2005; Chi et al.,
2008; Hinton and Yutzey, 2010). Several studies indicate that
myocardial-endocardial communication regulates these spatially
coincident events (Armstrong and Bischoff, 2004; Hinton and
Yutzey, 2010). For example, chick explant experiments suggest that
signal transduction between atrioventricular myocardium and
atrioventricular endocardium induces endocardial cushion
formation (Mjaatvedt et al., 1987). Although several signaling
pathways have been implicated in promoting endocardial cushion
development (Armstrong and Bischoff, 2004; Beis et al., 2005;
Hinton and Yutzey, 2010), it is less clear which genes are
responsible for attenuating these signals so as to spatially restrict
atrioventricular differentiation.
Myocardial-endocardial coordination is also crucial during
cardiac fusion. The synchronization of myocardial and endocardial
migration suggests that both tissues respond to the same cues in the
extracellular environment. Some cues may emanate from the
endoderm: both myocardial and endocardial fusion are inhibited
when endodermal specification or morphogenesis is disrupted (e.g.
Holtzman et al., 2007; Kikuchi et al., 2001; Kupperman et al.,
2000). Additionally, either diminished or excessive deposition of
extracellular matrix (ECM) can hinder myocardial and endocardial
movement (e.g. Arrington and Yost, 2009; Garavito-Aguilar et al.,
2010; Trinh and Stainier, 2004). Furthermore, the myocardium and
endocardium may impact the behavior of one another.
Cardiomyocytes display aberrant migration patterns in the absence
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SUMMARY
Coordination between adjacent tissues plays a crucial role during the morphogenesis of developing organs. In the embryonic
heart, two tissues – the myocardium and the endocardium – are closely juxtaposed throughout their development. Myocardial
and endocardial cells originate in neighboring regions of the lateral mesoderm, migrate medially in a synchronized fashion,
collaborate to create concentric layers of the heart tube, and communicate during formation of the atrioventricular canal. Here,
we identify a novel transmembrane protein, Tmem2, that has important functions during both myocardial and endocardial
morphogenesis. We find that the zebrafish mutation frozen ventricle (frv) causes ectopic atrioventricular canal characteristics in
the ventricular myocardium and endocardium, indicating a role of frv in the regional restriction of atrioventricular canal
differentiation. Furthermore, in maternal-zygotic frv mutants, both myocardial and endocardial cells fail to move to the midline
normally, indicating that frv facilitates cardiac fusion. Positional cloning reveals that the frv locus encodes Tmem2, a predicted
type II single-pass transmembrane protein. Homologs of Tmem2 are present in all examined vertebrate genomes, but nothing is
known about its molecular or cellular function in any context. By employing transgenes to drive tissue-specific expression of
tmem2, we find that Tmem2 can function in the endocardium to repress atrioventricular differentiation within the ventricle.
Additionally, Tmem2 can function in the myocardium to promote the medial movement of both myocardial and endocardial cells.
Together, our data reveal that Tmem2 is an essential mediator of myocardial-endocardial coordination during cardiac
morphogenesis.
KEY WORDS: Zebrafish, Heart development, Atrioventricular canal, Cardiac fusion
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5.2 Generation of transgenic fish lines using the 
Gateway®/Tol2 system 
 
The Gateway system is a rapid and highly efficient, restriction enzyme-free 
way to generate any desired vector for expression of a protein of interest. 
Instead of restriction enzymes, a so-called clonase enzyme mix catalyzes a 
site-specific recombination event between particular sequences called 
attachment sites (att sites). These are modified versions of the att sites the λ 
bacteriophage uses to integrate its genome into the bacterial host genome. 
The Gateway® system uses different variants of att sites to ensure directional 
cloning. In general, an entry vector contains a gene of interest flanked by 
specific att sites. These are used to integrate this gene into a destination 
vector containing different, but compatible att sites. This destination vector 
furthermore can harbor any feature to express the gene of interest (for 
example in E.coli or tissue culture cells). The entry and destination vectors 
can be distinguished by different selection markers. 
An entry vector can be generated in three different ways (Fig. 6 A). First, a 
PCR fragment of the gene of interest has to be amplified using primers 
containing attB sites. This fragment is directly recombined into a pDONR 
vector containing attP sites via the BP clonase. Through this BP reaction attL 
sites are generated in the entry vector now containing the gene of interest. It 
should be noted that in the BP reaction the DNA fragment of interest is 
exchanged with a negative selection cassette present in the pDONR vector. 
This cassette contains the ccdB gene, whose expression is toxic for standard 
bacteria used in laboratories. Therefore, only entry vectors that contain a DNA 
fragment of interest can be amplified in bacteria. Second, the PCR fragment 
can be amplified using a 5` primer that contains a CACC overhang. This 
overhang is used for the directional integration of the fragment into the 
ENTR/TOPO vector via the topoisomerase. The ENTR/TOPO vector contains 
attL sites already. Third, conventional cloning via restriction enzyme digestion 
and ligation can also be used for the generation of an entry vector. In all 
cases the final entry vector contains the gene of interest flanked by attL sites. 
In the final step of gateway cloning, the LR reaction, the entry vector is 
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recombined with any destination vector (pDEST) of interest. Here, the LR 
clonase mediates the recombination between the attL sites in the entry vector 
and the attR sites in the pDEST vector (Fig. 6 A). The final expression 
plasmid contains the gene of interest flanked by attB sites and any feature to 
mediate expression. As this reaction can be performed with any desired 
destination vector, several expression plasmids can be generated 
simultaneously.  
The system described above is applicable if the destination vectors already 
contain the desired promoter or tag of interest. Another way of creating a 
vector for the desired tissue-specific expression of a native or fusion protein is 
multisite Gateway cloning. Here, the simultaneous cloning of multiple DNA 
fragments in a specific order and orientation is performed. In our lab the three-
way multisite Gateway system is used, where three different entry clones (5`, 
middle and 3` entry clone) containing the promoter, the gene of interest and 
the tag, respectively are recombined with each other (Fig. 6 B). The different 
entry clones are generated by the BP reaction described above. The final 
entry clones however all contain different versions of the attL and attR sites. 
These can only recombine with one other att site used in this system 
guaranteeing a defined order and orientation of entry clones (Fig. 6 B). Only 
the specific combination of recombination proteins of the LR Clonase II plus 
enzyme mix can perform this reaction. In summary, the three-way multisite 
Gateway system allows to combine any entry vectors of interest in any order 
possible, providing a large toolbox for expression vector generation. 
In the past several methods have been used to generate transgenic fish lines, 
e.g. injection of linearized DNA (Thermes et al., 2002). However, the 
transmission efficiency using these methods is rather low making the 
generation of transgenic fish highly laborious (Davidson et al., 2003; Stuart et 
al., 1988; Stuart et al., 1990; Thermes et al., 2002). A drastic increase in 
transmission efficiency of zebrafish can be achieved by the so-called Tol2 
system. This system is based on the Tol2 transposon from the medaka fish 
Oryzias latipes (Kawakami et al., 2004). In the Tol2 system the Tol2 
transposase mediates the random integration of any sequence, which is 
flanked by inverted repeats called Tol2 sites (Kawakami et al., 2000; 
Kawakami et al., 2004). To generate transgenic fish via the Tol2 system, an 
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uncut plasmid containing the gene/sequence of interest between Tol2 sites is 
co-injected with mRNA coding for the Tol2 transposase (Fig. 7). After raising 
these embryos to adulthood, their progeny can be screened for the successful 
integration of the construct into the genome, for example by expression of a 
fluorescent marker (Fig. 7). 
Two Tol2/Gateway kits have been generated for efficient cloning and 
integration of DNA constructs into the zebrafish genome. The first one 
contains the general toolbox of entry and destination vectors with different 
fluorescent and non-fluorescent tags as well as general promoters (Kwan et 
al., 2007). The second kit additionally contains destination vectors applicable 
for the expression within the blood vessel system of zebrafish embryos (e.g. 
plasmids already containing the endothelial specific promoter fli1) (Villefranc 
et al., 2007). Many of these vectors also possess the marker cmlc2:EGFP 
driving EGFP expression in the myocardium of the heart to facilitate the 
identification of transgenic fish.  
For some experiments presented in this work, I generated several entry and 
expression vectors listed in Materials and Methods 4.3.2. The final expression 
vectors are designed either for the Gal4/UAS system or allow endothelial 
specific expression of a sequence of interest. 
 
In order to determine the efficiency of the Tol2 system in my hands and with 
the conditions in our lab, I quantified the germline transmission for some of 
the constructs injected (fli1ep:mCherry, fli1ep:nlsmCherry, 
UAS:cldn5bEGFP;cmlc2EGFP). In total I screened the progeny of 77 
individual crossed G0 adult fish for the expression of the fluorescent or the 
heart marker (mCherry or cmlc2:EGFP) (min. n=80 embryos each cross). On 
average 45.3% of G0 adult fish produced F1 progeny showing the presence of 
the marker analyzed. In my hands, the transmission efficiency did not depend 
on the vector injected as all the constructs harbor the same vector backbone 
containing the elements for integration. These results correlate nicely with the 
published data for the germline transmission rate of about 50% using Tol2 
(Kawakami et al., 2004). 
As the genomic integration of DNA using the Tol2 system is random, it can 
lead to multiple insertions of the same plasmid. This fact can be easily 
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observed by various expression strengths of the fluorescent markers in F2 
embryos within one clutch. This observation is in agreement with the 
occurrence of multiple plasmid insertions using transposon-mediated DNA 
integration in other model organisms. For example, P-element-based random 
insertion of DNA into the Drosophila genome can lead to several 
simultaneous integration events (Venken and Bellen, 2007). 
The occurrence of several expression levels of the fluorescent marker was 
observed in F2 embryos derived from G0 adults injected with protein-fusion 
constructs as well as UAS-constructs. However, in contrast to F2 embryos 
carrying a protein-fusion transgene, expression of UAS-constructs in F2 
embryos can lead to a mosaic pattern (for example, EGFP was not observed 
in all ISVs although cross to fli1 ep-Gal4ff fish). In general, embryos with the 
strongest expression and the least mosaicism were chosen to generate a 
stable transgenic line. The mosaic expression has been observed earlier and 
seems to be the result of epigenetic silencing of the 10xUAS cassette used in 
the corresponding UAS plasmids (Goll et al., 2009). 
In summary, the Tol2 integration method combined with the Gateway cloning 
system provides a fast and efficient strategy to create a set of transgenic fish 
lines in a reasonable amount of time and labor.  
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Figure 6: Schematic overview of the principles of Gateway and multisite Gateway 
cloning. (A) Entry vectors suitable for the Gateway system can be generated by a BP 
reaction (box on the left), by conventional restriction/ligation (arrow in the middle) or by TOPO 
cloning (box on the right). In a final LR reaction (box at the bottom) a LR clonase will mediate 
the exchange of a sequence of interest (here ORF) flanked by attL sites in the entry vector 
and a cassette flanked by attR sites in the pDEST vector. The resulting final expression 
plasmid contains the sequence of interest and all necessary features for expression of this 
sequence in the experimental model system of choice. 
(B) In a three-way multisite Gateway experiment three different entry vectors (containing 
promoter, ORF and C-terminal tag) will integrate into a destination vector of choice at the 
same time. During the LR reaction the recombination of specific variations of attL sites only 
with compatible attR sites ensures the correct order of entry constructs. The resulting final 
expression vector contains all elements in the correct order. Modified after (Villefranc et al., 
2007). 
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5.3 Cldn5b is a vascular-specific gene 
 
A database search for junctional proteins that are expressed in a vascular 
specific fashion identified a transcript zgc:103419. Blast analysis revealed that 
this transcript is highly homologous to mammalian claudin5, which is 
specifically expressed in the vasculature. 
Bioinformatic analysis shows that the zebrafish genome contains two claudin5 
(cldn5) genes – cldn5a and cldn5b (Fig. 8 A, in collaboration with Bernhard 
Misof, Bonn, Germany). In contrast, non-fish vertebrate genomes ranging 
from frogs to humans possess only a single gene encoding a Claudin5 
protein. Cldn5a and cldn5b DNA sequences are highly similar with 75% 
sequence identity. The corresponding proteins share 72% identity at the 
amino acid level (Suppl. Data 8, Fig. 1). These findings are consistent with the 
proposed genome duplication that occurred during early teleost evolution. All 
teleosts tested contained cldn5 paralogs and genes within each paralogous 
group are more similar to each other than to any cldn5 of the other paralog 
group. 
In amphibians, avians and mammals cldn5 is specifically expressed in the 
endothelial cells of the vascular system (Liebner et al., 2000; Morita et al., 
1999). Expression analysis in zebrafish revealed that cldn5a mRNA is highly 
expressed in the embryonic nervous system, whereas cldn5b mRNA is 
restricted to the vasculature (Thisse, 2004).  
To investigate the spatial and temporal differences of cldn5b and cldn5a 
expression during embryonic development in more detail, I analyzed mRNA 
expression using in situ hybridization at different embryonic stages (Fig. 8 B-I, 
Fig. 9). In contrast to the control sense probe, the antisense probe for cldn5b 
mRNA revealed a specific signal starting at around the 20-somite stage (Fig. 
8 B-C vs. 8 D). At this stage a weak cldn5b signal is detectable in the head 
region as well as in a stripe along the trunk at the position of the forming aorta 
(arrows, Fig. 8 B). In 24hpf old embryos cldn5b is clearly expressed in blood 
vessels of the head (asterisks in Fig. 8 C and 8 E). In the vasculature cldn5b 
is transcribed by endothelial cells of the DA and the ISVs (Fig. 8 F-I, arrows in 
8 F-G). Expression of cldn5b is also detected in the PCV, which starts at 
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around 28hpf and increases as development proceeds (Fig. 8 G-I, 
arrowheads). At 30 hpf signal intensity of the cldn5b antisense probe is 
comparable in PCV and DA (compare PCV and DA in Fig. 8 H). At later 
stages (30-36 hpf), the forming DLAV is also characterized by cldn5b 
expression (Fig. 8 H-I, asterisks).  
In contrast to cldn5b expression, cldn5a mRNA is strongly transcribed in the 
brain and the spinal cord of the central nervous system throughout embryonic 
development (Fig. 9 A-E). Interestingly, cldn5b is enriched in the hindbrain 
(hb) and marks the midbrain-hindbrain boundary (Fig. 9 B, asterisk). At later 
stages, cldn5a is strongly expressed in the developing eye (Fig. 9 D-E, arrows 
in D). These findings are in agreement with a recent report showing that 
cldn5a is expressed in the brain and enriched in neuroepithelial cells adjacent 
to brain ventricles (Zhang et al., 2010). In younger embryos from 23 to 27 hpf 
weak cldn5a expression is detected in a stripe along the body axis beneath 
the spinal cord (sc) (Fig. 9 A-C). Higher magnification shows cldn5a 
expression in the DA (Fig. 9 A`-C`, arrows). However, detection of cldn5a 
mRNA in the DA is transient and lost in older embryos (Fig. 9 A`-C` vs. 9 D`-
E`). At 30 hpf the cldn5a expression is undetectable in the DA while 
concomitantly cldn5a mRNA is transcribed in the spinal cord at similar levels 
than before (Fig. 9 D` vs 9 C`). Taken together, although cldn5a is transiently 
expressed in the DA, cldn5b appears to be a vasculature-specific cldn5 gene 
during embryonic stages.  
To definitely confirm that cldn5b mRNA is indeed expressed in endothelial 
cells, I visualized at the same time cldn5b mRNA and fli1 mRNA - which is 
specifically expressed endothelial cells - via double-fluorescent in situ 
hybridization. Applying the tyramide signal amplification (TSA) system cldn5b 
mRNA was visualized with tetramethylrodamine (TMR) and fli1 transcripts 
with fluorescein isothiocyanate (FITC) (Fig. 10). Analysis of embryos at 24 hpf 
shows that the cldn5b and fli1 messages are indeed co-expressed (Fig. 10 A`-
A``). This clearly demonstrates that cldn5b is expressed in endothelial cells of 
the developing vasculature. During development the expression of many 
genes varies between mRNA and protein level. While mRNA expression 
tends to be more stable, the expression of proteins is more dynamic. In order 
to analyze the expression pattern and specific subcellular localization of  
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Figure 10: Cldn5b mRNA colocalizes with fli1a mRNA. (A-A``) Double fluorescent in situ 
hybridization in 24hpf embryos shows that fli1 (visualized by FITC, green) and cldn5b 
(visualized by TMR, red) are co-expressed in the endothelial cells of the vasculature.  
 
 
Cldn5b protein, different peptide antibodies were raised in rabbit and guinea 
pig against two epitopes in the zebrafish Cldn5b protein. These epitopes have 
the least similarity in aminoacid sequence with other Cldn proteins (Suppl. 
Data 8, Fig. 1). To test the antibodies` ability to recognize Cldn5b protein, I 
performed costainings for VE-cadherin (VE-cad) or ZO-1 protein with each of 
the peptide antibodies. I tested different staining protocols as well as different 
antibody concentrations. Compared to the efficient staining of VE-cad or ZO-
1, none of the peptide antibodies recognizes Cldn5b protein (compare Suppl. 
Data 8, Fig. 2 A` vs A``). Therefore, I tested another Cldn5 antibody that is 
commercially available. It is raised against the C-terminus of the human Cldn5 
protein. This antibody apparently recognizes both Cldn5 protein isoforms in 
endothelial cells as well as the neural tube and colocalizes with VE-cad in a 
junction-like pattern (Suppl. Data 8, Fig. 3).  
Therefore, I used this antibody to visualize the expression pattern of Cldn5 
during the development of ISVs in the zebrafish embryo. I performed 
immunohistochemical stainings for Cldn5 (green) and VE-cad (red) at different 
stages of ISV formation (Fig. 11). The embryos used for these experiments 
also expressed cytoplasmic EGFP under the control of the fli1a promoter (Fig. 
11 A, E, I, M). During all timepoints analyzed Cldn5 signal can be observed in 
the aorta as well as in the neural tube (Fig. 11 C, G, K, O, S) and at later 
stages Cldn5 protein is also expressed in the ISVs. Within the ECs Cldn5 
colocalizes with VE-cadherin at cell junctions (Fig. 11 L, P, T). However, 
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Cldn5 is almost absent from the PCV; only in some embryos a very weak 
signal can be observed (arrowhead in Fig. 11 G). Interestingly, in the vast 
majority of ISVs Cldn5 could not be detected during sprout formation and 
outgrowth (arrows in Fig. 11 C, D). At 24 hpf, when the vessels have started 
to grow dorsally, most ISVs lack Cldn5 protein expression (arrows in Fig. 10 
G, H). Only with further progression of ISV formation, Cldn5 protein becomes 
detectable in all cells of the ISVs (arrows in Fig. 11 K, L; Fig. 11 O, P, S, T).  
To analyze the different expression patterns of Cldn5 and VE-cad during ISV 
outgrowth in more detail, I detected Cldn5 (green) and VE-cad (red) 
expression in cross sections of fli1a:EGFP (blue) expressing embryos (Fig. 
12). To better visualize Cldn5b expression in cross sections, I masked the 
staining of Cldn5 and VE-cad outside of the vasculature using the surface 
rendering and masking option in the Imaris® imaging software (Bitplane, Fig. 
12 I-L vs M-P). Between 22hpf and 26hpf Cldn5 is only weakly expressed in 
the ISVs compared to the aorta (compare arrows in Fig. 12 C, D; G, H; K, L vs 
arrowheads). The expression level of VE-cad is similar between aorta and 
ISVs (Fig. 12 B, F, J). 
Taken together, Cldn5b protein is localized in endothelial cell junctions in the 
ECs of the aorta. Cldn5b mRNA and protein seem to have different 
expression patterns. While the mRNA is localized in all ECs of the ISVs, 
Cldn5b protein is removed from cell junctions during sprout formation, when 
ECs are undergoing extensive remodeling. However, it becomes redeployed 
during later stages of ISV and DLAV formation, suggesting a role for blood 
vessel maturation and/or stabilization. 
 
 
5.4 Analysis of the effects of cldn5b knock-down on 
angiogenesis 
 
To investigate the requirement of cldn5b during the process of angiogenesis, I 
depleted cldn5b function by anti-sense morpholino (MO) injections. Knock-
down via MO injection is an established method to evaluate the molecular 
functions of a particular gene (Summerton, 2007). These “RNA-type”  
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molecules bind to a specific RNA and through this either block its splicing or 
translation leading to a downregulation of the corresponding protein. MOs are 
injected into one-cell stage embryos and the subsequent knock-down is 
analyzed in the developmental stages of interest. Usually one translation- and 
one splice- blocking MO are used in parallel to validate the specificity of the 
MO knockdown. Because the cldn5b ORF only consists of one exon I used 
two different translation-blocking MOs. After testing the efficacy of the two 
different MOs, I decided to use morpholino #2 for all subsequent experiments 
(MO2; also see end of this sections). For phenotypic analysis of the cldn5b 
knock-down on ISV formation I concomitantly visualized the vasculature by 
fli1a:EGFP expression in these embryos. To show the efficacy of the MO 
knock-down, I looked for the absence of cldn5b mRNA as well as Cldn5b 
protein in MO injected embryos. For this purpose I compared in situ 
hybridization for cldn5b mRNA on standard control MO (std ctrl MO) injected 
as well as cldn5b MO injected embryos (Fig. 13). In control animals a robust 
mRNA signal can be observed in the aorta and ISVs (arrow and arrowhead in 
Fig. 13 A). In contrast, the mRNA expression level is strongly reduced in 
cldn5b MO injected animals probably caused by an enhanced instability of the 
mRNA, driven by error prone RNA degradation (compare arrowhead and 
arrow in Fig. 13 B vs A). To evaluate the effects of the cldn5b MO knock-down 
on the protein level, I performed immunohistochemical stainings for Cldn5 
(green) and VE-cad (red) in injected and uninjected fli1a:EGFP (blue) 
expressing embryos (Fig. 14). As shown above, in uninjected and std ctrl MO 
injected embryos, Claudin 5 protein is expressed in the neural tube (Fig. 14 
A``, B``) as well as in stripes along the axis of the ISVs, colocalizing with VE-
cad protein in the aorta and the ISVs (Fig. 14 A-B```). Upon injection of cldn5a 
MO, the Cldn5 signal in the neural tube is lost. The remaining signal in the 
vasculature represents Cldn5b protein expression in the aorta and ISVs (Fig. 
14 C``, C```). In contrast, injection of cldn5b leads to a loss of Cldn5 protein in 
the ISVs (arrowheads in Fig. 14 D``, D```) and a weaker signal in the aorta 
compared to control embryos (asterisks in Fig. 14 D``, D```). This indicates 
that the remaining signal in the neural tube (arrow Fig. 14 D``) and aorta 
(asterisk in Fig. 14 D``, D```) represent Cldn5a expression. The expression 
level of VE-cad in these embryos stays like in control embryos (compare Fig. 
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14 D` vs A`, B`). Embryos treated with both cldn5a and cldn5b MO lack Cldn5 
protein expression completely (Fig. 14 E``, E```). The lack of expression in the 
aorta and ISVs (asterisks Fig. 14 E``, E``` and arrowheads Fig. 14 E``, E```) 
as well as in the neural tube (arrows in Fig. 14 E``, E```) shows the efficient 
knock-down of cldn5a and cldn5b via MO injection. Furthermore, these results 
demonstrate that the α-human Cldn5 antibody specifically recognizes Cldn5a 
and Cldn5b protein.  
Interestingly, the knock-down of cldn5b leads to an irregular ISV patterning in 
contrast to cldn5a MO injected embryos where the ISV pattern is 
indistinguishable from wild type fish (see next section). It is important to note 
that the injection of MOs often causes cell death in some tissues, which is 
prevented by the simultaneous injection of p53 MO (Robu et al., 2007). Also 
in cldn5a MO injected animals, cell death occurs in the nervous system. 
Therefore, the injection is always performed with simultaneous injection of 
p53 MO in order to prevent this cell death (data not shown). The injection of 
cldn5b MO does not cause any cells death (data not shown). Furthermore, the 
concomitant injection of p53 MO with cldn5b MO does not alter the outcome 
of the phenotype and has therefore not been further used (data not shown). 
As mentioned above, I tested the efficacy of two different cldn5b MO both 
ablating translation of this gene. In a pre-screen I determined the most 
efficient concentration for each of the MOs by comparing their effect on the 
outgrowth of ISVs (sequences in Suppl. Data 8, list 1). In a further screen 
these MOs were compared to each other (Suppl. Data 8, Fig. 4). MO2 at a 
concentration of 0.2mM causes the stronger phenotype and was therefore 
used in all the following experiments.  
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5.4.1 Leaky vessels in cldn5b knock-down embryos cause 
hemorrhages 
 
As mentioned above, the ISV pattern in cldn5b MO injected embryos looks 
irregular. To study the general effect of cldn5b knock-down on embryonic 
development, I analyzed the overall anatomy of 54hpf old embryos. In order to 
do so, I compared cldn5b MO injected animals with uninjected embryos (Fig. 
15). Compared to control fish, cldn5b MO injected embryos show no gross 
anatomical defects (compare Fig. 15 A vs B, C). However, in some embryos 
the heart developed edema shown by an enlarged cardiac sac and/or showed 
an elongated and thin morphology (arrowhead in Fig. 15 F vs D, E). 
Additionally, in many cases cldn5b MO injected embryos showed expanded 
hindbrain regions (arrow in Fig. 15 E) that were often accompanied by 
accumulations of blood (data not shown). These hemorrhages were also 
visible in the head outside of the brain (arrow in Fig. 15 F) as well as in other 
regions of the embryo (data not show, see next section). The trunk and tail 
regions of cldn5b MO injected embryos are morphologically indistinguishable 
from wildtype embryos (compare Fig. 15 H, I, K, L vs G, J). 
In uninjected and std ctrl MO injected embryos blood flow is visible in the axial 
vessels as well as in the ISVs at 48hpf (see Suppl. movie 1 and 2). Most 
cldn5b MO injected embryos show blood flow in the axial vessels, but lack it in 
the ISVs (Suppl. movie 3). However, in these embryos rarely blood flow is 
visible also in the ISVs (data not shown). Furthermore, mainly in embryos 
showing heart edema or elongated hearts, blood flow was missing completely 
(Suppl. movie 4) or slow (data not shown).  
As shown in the previous experiments, cldn5b knock-down causes 
hemorrhages. As Cldn5 is known for its sealing function of the blood-brain 
barrier (BBB) (Nitta et al., 2003), I wanted to investigate further the role of 
cldn5b in sealing vessels in the zebrafish embryo. Using fish that express 
fli1a:EGFP (green) and gata1:dsRed marking erythrocytes in red, I compared 
the effect of cldn5b MO knock-down on the number of hemorrhages in 
uninjected and ctrl MO injected animals (50hpf, Fig. 16). Some embryos of the 
gata1:dsRed transgenic line show expression of dsRed positive cells at the  
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level of the notochord resembling a part of the expression pattern of this 
particular gata1 promoter (see arrowheads Fig. 16 F). These dsRed positive 
cells were not taken into account when counting the hemorrhages: instead 
clusters of dsRed positive cells outside of this expression pattern were 
counted. Compared to control embryos, which do not reveal any hemorrhages 
in the trunk and tail (wt: n=39; std ctrl MO: n=28 embryos), more than 37% of 
cldn5b morphants show one and more hemorrhages in the trunk and over 
40% show hemorrhages in the tail (37.8% and 43.2%, n= 37 embryos; 
compare Fig. 16 B, C, E, F vs H, I). In the head more then 50% of uninjected 
embryos show hemorrhages, while less than 5% of std ctrl MO (std ctrl MO) 
injected embryos showed hemorrhages in the head (53.8% and 3.6%, 
compare Fig. 16 A with D). In contrast, cldn5b MO injection causes 
hemorrhages in more than 60% of the embryos (64.9%, Fig. 16 G, J). In the 
specific example shown, the cldn5b morphant shows a strong reduction of 
erythrocyte number, which is probably caused by the loss of heart beat and 
blood flow and the subsequent accumulation of blood cells in one region of 
the embryonic body (data not shown). 
 
These data suggest a sealing function of cldn5b. To gain insights into the 
dynamics of this process, I visualized ECs and blood cells in living zebrafish 
embryos and compared the effect of clnd5b knock-down (Suppl. movie 7) with 
uninjected (Suppl. movie 5) and std ctrl MO injected embryos (Suppl. movie 6) 
(Fig. 17). The analysis started at around 33hpf. At this stage blood flow in 
uninjected fish and control morphants is visible in the axial vessels, but not yet 
in the ISVs. At roughly 38 hpf, a few blood cells start to enter the ISVs and 
soon later blood flow starts in these vessels (653`, 788`, upper panel, Fig. 17). 
Compared to control embryos the ISV morphology in cldn5b morphants is 
severely altered with premature stopping of sprout outgrowth. Lumen 
formation, however, is not affected. In this particular example almost no ISV is 
connected to the neighboring vessel. Also in cldn5b morphants blood flow is 
visible at 33hpf, but blood cells start to enter the ISVs earlier than in control 
embryos (compare 425` lower panel with 425` upper and middle panel, Fig. 
17). They accumulate in the vessel and burst out of the tip of the ISV (arrows 
in lower panel, 425`- 475`, Fig. 17). The  
5. Results 
 98 
 
 
 
 
 
 
 
 
5. Results 
 99 
 
5. Results 
 100 
erythrocytes then disperse in the surrounding tissue (arrowheads, lower 
panel, 620`, 787`, Fig. 17). This shows that the MO mediated knock-down of 
cldn5b decreases the vessel integrity causing severe hemorrhages to occur.  
 
5.4.2 Cldn5b is required for vessel outgrowth and stability 
 
As already mentioned before, vessel outgrowth is impaired in cldn5b function 
depleted embryos. To investigate this phenotype in more detail, I analyzed the 
ISV formation at different stages (Fig. 18). Using fli1a:EGFP expressing 
embryos, I compared cldn5b MO injected embryos to std ctrl morphants. In 
control embryos ISVs start to form at 22hpf and grow along the segment 
boundary until they reach the middle of the horizontal myoseptum (HMS) 
(indicated in red in Fig. 18 A, B, Fig. 18 E). From here on they do not follow 
the segment boundary anymore, but grow straight in the dorsal direction. At 
the roof of the neural tube the ISVs ramify into anterior and posterior 
directions and connect to the neighboring ISVs (Fig. 18 G). Until 48 hpf these 
vessels develop into functional tubes (Fig. 18 K). Very rarely ISV outgrowth is 
delayed in control morphants, which is corrected for in all of the cases until 
48hpf (Fig. 18 K). In cldn5b MO injected embryos the initial ISV formation and 
outgrowth is indistinguishable from control morphants with all ISVs growing 
posteriorly and some reaching the level of the HMS (compare arrows in Fig. 
18 C vs B). However, at 25hpf when in control morphants the ISV grow 
beyond the level of the HMS, most of the morphant vessels show an arrest of 
growth (compare arrows in Fig. 18 F vs E). At 30hpf, although many ISVs are 
still halted (arrow in Fig. 18 H), individual ISVs start to extend protrusions and 
grow beyond the middle of the HMS. These, however, are very thin 
extensions that seem to harbor only a small part of the cell content 
(arrowhead in Fig. 18 H). At 35 hpf, whereas in control embryos most of the 
ISVs are connected within the DLAV, in cldn5b MO injected animals only 
single vessels have reached the roof of the neural tube while many are still 
halted at the HMS (arrowheads and arrow in Fig. 18 J). Most vessels 
eventually grow further posteriorly, but often the anatomy is aberrant. In some 
vessels e.g. protrusions emerge that grow anteriorly and posteriorly at the 
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level of the HMS (orange arrowheads in Fig. 18 J). Furthermore, the 
connections of many vessels to the aorta become very thin (green 
arrowheads in Fig. 18 J). At 48hpf the DLAV is only partially made with 
several connections missing between neighboring ISVs (asterisks in Fig. 18 
L). Some ISVs are still arrested at the level of the HMS, which is never seen 
at this stage in control embryos (compare arrow in Fig. 18 L vs K). 
Furthermore, the connections between the ISV and DA are very thin (green 
arrowhead in Fig. 18 L). Analyzing ISV/DLAV formation reveals that the 
knock-down of cldn5b via MO injection leads not only to a halt of ISV 
outgrowth, but also to vessel instability. 
To analyze the dynamics of the morphological defects occurring in cldn5b 
morphants, I documented ISV outgrowth and DLAV formation in living 
embryos via time-lapse analysis (Fig. 19). In uninjected (Suppl. movie 8) and 
std ctrl MO injected animals (Suppl. movie 9) (A-E; F-J) ISVs have grown to 
the roof of the neural tube and ramified anteriorly and posteriorly (arrows in 
Fig 19 F, G). Eventually a functional vascular network is formed (Fig. 19 C-E). 
In contrast, in cldn5b MO injected embryos (Suppl. movie 10), an arrested 
growth is seen in most of the ISVs (arrow in Fig. 19 K), which eventually grow 
beyond the HMS. A connected DLAV is never made in this particular example 
(arrows Fig. 19 M, N), although an individual ISV grows posteriorly and seems 
to connect to the neighboring ISV, this connection is not maintained (asterisks 
Fig. 19 M-O). Interestingly, the ventral connection between ISV and DA starts 
to be very thin (arrowhead Fig. 19 M) and breaks completely with further 
development (arrowheads in Fig. 19 N, O), a phenotype never observed in 
control animals (arrow in Fig. 19 H). In other movies of a cldn5b MO injected 
embryo this loss of connection between the aorta and the ISV can be seen, 
too (Suppl. movie 11 and movie 12). Interestingly, in one of these embryos at 
a later timepoint the ventral end of one detached vessel gets contacted by a 
secondary sprout coming from the vein and subsequently makes a full 
connection via this sprout to the PCV (Suppl. movie 12). 
To determine the frequency of the morphological defects described above, I 
quantified the ISV outgrowth, missing connections within the DLAV and the 
detachment of ISVs from the DA in std ctrl and clnd5b MO injected animals.  
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The ISV growth defect was quantified by counting the growth of ISVs beyond 
the HMS at different developmental stages (HMS indicated in red in Fig. 18 A, 
B; Fig. 20 A). In uninjected embryos (dark grey bars Fig. 20 A) on average 7 
vessels grow further than the HMS at 24hpf (7.3/10 vessels +/-2.5, n=20 
embryos). At this stage the anterior vessels have grown further, while 
posterior vessels have not reached or have just reached the HMS. In cldn5b 
morphants however almost no vessel has grown further than the HMS (0.1/10 
vessels +/-0.2, n=20 embryos). This reflects the growth defects shown in Fig. 
18 F. At 30hpf on average 6 vessels (5.6/10 vessels +/-2, n=20 embryos) 
grows beyond the HMS compared to almost all of the vessels in control 
embryos (9.8/10 vessels +/-0.5, n=20 embryos) indicating a growth stop of 
vessels at the HMS. The number of vessels growing further than the HMS 
increases, but never reaches the number of control embryos. At 48hpf e.g. all 
vessels in std ctrl morphants have grown further (10/10 vessels +/-0, n=20 
embryos) and on average 8 vessels grew beyond the HMS in cldn5b MO 
injected embryos (8.1/10 vessels +/-0.3, n=20 embryos). Taken together, 
compared to control animals, a significant number of ISVs in cldn5b 
morphants halts its outgrowth at the HMS (compare Fig. 20 B, B` vs C, C`). 
The phenotype of missing connections within the DLAV was quantified by 
counting the DLAV connections between individual ISVs in ctrl as well as 
cldn5b morphants. In 44% of the DLAV connections a continuous assembly of 
neighboring ISVs was missing at 48hpf (4.4/10 vessels, n=27 embryos), 
which never occurred in control morphants (0/10 vessels, n=20 embryos) 
(compare Fig. 20 E, E` vs D, D`). Furthermore, 24% of all ISVs counted 
detached from the DA, which is never observed in control animals at this time 
point (2.4/10 vessels, n=27 embryos; compare Fig. 20 F, F` vs D, D`). 
Interestingly, this phenotype can be observed only from roughly 35hpf 
onwards, as in 36hpf old cldn5b MO injected embryos 10% of ISVs are 
detached from the aorta (1/10 vessels, n=20 embryos). 
As described above, some cldn5b MO injected embryos show reduced or 
absent bloodflow. Although the blockage of blood flow does not influence the 
primary network formation in wildtype animals, the ISVs do develop 
enlargements and ramifications in the dorsal part of the vessels at later 
timepoints (Isogai et al., 2003). Because most cldn5b morphants display  
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normal blood flow and show all of the observed phenotypes described above, 
the absence of blood flow does not seem to influence the outcome of the 
phenotype. Nevertheless, I performed an experiment, in which I quantified the 
occurrence of altered ISV formation in embryos with normal, slow and absent 
blood flow (example of ISV detachment in Suppl. Data 8, Fig. 5, data not 
shown). These experiments show no clear correlation between the 
penetrance of the ISV phenotype and the absence or presence of blood flow 
in cldn5b morphants. 
In summary, three different phenotypes can be observed in cldn5b 
morphants, the arrest of vessel outgrowth at the HMS, the missing 
connections within the DLAV as well as the detachment of ISVs from the DA. 
 
5.4.3 Cldn5b and cldn5a do not function redundantly during 
ISV formation 
 
As shown before (see chapter 5.2), cldn5a is expressed mainly in the nervous 
system, but between 23 hpf and 27 hpf it is also expressed in the DA. To 
analyze the role for cldn5a in ISV formation, I performed knock-down 
experiments for cldn5a, cldn5b and both concomitantly and quantified the 
resulting phenotypes (Fig. 21). In control embryos the ISVs have grown to the 
roof of the neural tube and are connected to their neighbors at 36hpf (arrow 
Fig. 21 A). As described above, in cldn5b morphants the ISVs have stopped 
growing at the HMS or are not connected to neighboring ISVs at this stage 
(arrow Fig. 21 B). Cldn5a morphants, however, show none of these 
phenotypes with all ISVs connected to their neighbors (arrow Fig. 21 C). Upon 
injection of both cldn5a and cldn5b MO, the ISV phenotype observed 
resembles that of cldn5b morphants (Fig. 21 D). The quantification of these 
phenotypes revealed a non-significant difference between cldn5b and 
cldn5b/cldn5a double morphants (Fig. 21 E, F). 
During the analysis of cldn5a and cldn5b function on ISV formation, I found 
that the morphology of the CV is altered in many embryos. First, they show a 
reduction of the dorso-ventral length of the CV. More interesting, the CV and 
DA are sometimes fused to one large vessel. In wildtype embryos the CV 
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plexus arises through cell sprouting, migration and anastomosis, which are 
governed by complex cell rearrangement events (Choi et al., 2011), which 
ultimately leads to the formation of a complex network of loops. In order to 
investigate the morphology of the CV in more detail I compared cross-
sections of the CV in std ctrl MO, cldn5b, cldn5a and cldn5a + cldn5b MO 
injected embryos (Fig. 22). Furthermore, I quantified the fusion of CV and DA 
in these embryos. In control embryos the CV shows a complex plexus, which 
is divided into many tubes at both anterior and posterior positions (Fig. 22 A, 
A`, A``). In cldn5b MO injected embryos, however, the length of the CV is 
highly reduced (Fig. 22 B). Cross sections in the anterior and posterior part of 
the CV show that it completely lacks the complexity of a control embryos` CV. 
Here it is composed of one vessel only (Fig. 22 B`, B``). The frequency of this 
phenotype was not analyzed, but is estimated to occur in at least half of the 
morphants. However, the CV and DA are separated vessels in all embryos 
observed (vessel fusion in 0% of embryos, 0/29 embryos). Also in cldn5a 
morphants the CV plexus is highly altered in morphology. The formation of a 
complex CV plexus is only observed in roughly 20% of the embryos. 
Furthermore, cldn5a morphants resemble the fusion of CV and DA that is 
never observed in control MO injected embryos (compare Fig. 22 C`` with A` 
and A``). This phenotype occurs in ∼18% of the embryos (7/38 embryos). In 
contrast, double morphants show a much stronger phenotype. The dorso-
ventral tube of the CV is often very thin and the CV and DA are fused in ∼53% 
of the embryos (24/45 embryos, Fig. 22 D, D`, D``). It should be noted that 
more cldn5a morphants than cldn5b morphants show a lack of blood flow in 
the axial vessels (29% vs 10%; n= 38, n= 29). In double MO injected embryos 
the lack of blood flow can be observed in 27% of the embryos. Therefore, 
cldn5a and cldn5b do not resemble overlapping functions in determining blood 
flow. However, there seems to be a correlation between the 
absence/reduction of blood flow and the fusion of CV/DA. In cldn5a 
morphants 100% of the embryos with a fused CV/DA show a loss or reduction 
of blood flow (7/7 embryos). In double morphants 62.5% of the embryos 
without separated CV and DA lack blood flow, but 37.5% of these embryos do 
have blood flow. In summary, cldn5b and cldn5a function non-redundantly  
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during ISV formation. However, in the context of CV plexus formation cldn5b 
and cldn5a have common functions. The organization of the CV into many 
loops and the separation of the CV from the DA are processes that require the 
concomitant functions of cldn5b and cldn5a functions. 
 
 
5.5 Normal cellular rearrangement in cldn5b 
morphants 
 
As described above, cldn5b knock-down stops ISV outgrowth at the HMS and 
delays or inhibits fusion of neighboring vessels resulting in the detachment of 
ISVs from the DA. One reason for this phenotype to occur might be the lack of 
cellular rearrangement. Furthermore, the expression and localization of other 
junctional proteins in cldn5b morphants might be altered. To test this 
hypothesis, I analyzed the localization of VE-cad and ZO-1. This is not only a 
means to study the cell outlines and the hence visualized ISV architecture, but 
also the expression levels of other junctional proteins (Fig. 23). In std ctrl 
morphants, VE-cad and ZO-1 are localized in stripes along the axis of the ISV 
displaying its` multicellular architecture (Fig. 23 A-D). At newly formed 
connections between neighboring ISVs, a ring of VE-cad and ZO-1 marks the 
contact area between two contacting cells (asterisk Fig. 23 B). Cldn5b MO 
injected animals, despite showing defects in ISV outgrowth, display a VE-cad 
and ZO-1 distribution comparable to control embryos (Fig. 23 E-H). The ISVs 
show single and double lines along the dorso-ventral axis (arrows in Fig. 23 
F). Additionally, a ring of junctions can be seen at the contact area between 
two connecting ISVs (asterisk in Fig. 23 F). These data are in agreement with 
the fact, that a lumen is formed within the stunted ISVs of cldn5b morphants. 
Furthermore, the level of expression of both VE-cad and ZO-1 are not altered 
compared to control embryos (compare Fig. 23 B vs F and C vs G). 
These data indicate, that cldn5b does not influence cellular rearrangement in 
the ISV. It also has no impact on the localization and expression level of VE-
cad and ZO-1.  
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5.6 Expression of Cldn5b:EGFP does not rescue the 
morphant phenotype 
 
Knock-down of gene functions by MO injection is known to be very specific. 
However, the risk of non-specific binding of the MO persists. In order to prove 
the specificity of the phenotype caused by cldn5b MO injection, I performed 
two rescue approaches. One method is the coinjection of MO together with 
the mRNA encoding the respective gene. The other approach is the 
endothelial specific expression of a Cldn5b:EGFP fusion construct. 
To ensure a proper rescue by cldn5b mRNA injection in cldn5b morphants, I 
injected a mRNA that was resistant to the MO. To visualize the successful 
injection of mRNA, I coinjected cldn5b together with mKate mRNA. However, 
the injection of these high concentrations of mRNA caused severe 
morphological defects in many embryos. Therefore, I injected mKate mRNA 
alone to analyze whether protein expression via the injection of mRNA is 
possible in my hands (Fig. 24 A-D``). The injection of mKate mRNA into one 
cell stage embryos, leads to a weak expression of mKate protein in the stages 
of 80% epiboly and 24hpf of embryogenesis (Fig. 24 A, C`-C``). In contrast, 
the injection of the control cldn5b mRNA does not cause any fluorescent 
signal in the living embryo (Fig. 24 B, arrow in D`-D``). These data show that it 
is possible with the protocols I used to ubiquitously express a protein via 
mRNA injections. Therefore, I used the same parameters to express cldn5b 
mRNA alone (Fig. 24 E-G). I injected cldn5b mRNA into one cell stage 
embryos and stained for Cldn5 protein in 24 hpf old embryos. In uninjected 
embryos, Cldn5 antibody staining is seen in the vasculature as well as in the 
neural tube (Cldn5b panel, Fig. 24 E). In the vasculature it colocalizes with 
VE-cad (VE-cad and merge panel in Fig. 24 E, E). The injection of cldn5b 
mRNA into wildtype embryos shows the same expression pattern with no 
obvious increase in expression level compared to uninjected embryos 
(compare arrows in green panel of Fig. 24 F vs E). The coinjection of cldn5b 
mRNA together with the MO did not show any enhancement of Cldn5 protein 
expression, either (compare arrows green panel of Fig. 24 G vs E). In these 
embryos, the phenotype caused by cldn5b MO injection was not rescued (Fig.  
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24 G; data not shown). In summary, the injection of cldn5b mRNA does not 
induce the expression of Cldn5b protein and does not rescue the morphant 
phenotype. 
In the second rescue approach I wanted to express a Cldn5b:EGFP fusion 
construct in the endothelial cells of cldn5b morphants using the Gal4/UAS 
system. Thus, I generated a transgenic UAS:cldn5b:EGFP line (Appendix 9.3) 
and crossed it to the driver line fli1ep:Gal4ff (this study, Appendix 9.1) leading 
to the expression of Cldn5b:EGFP in all ECs of the progeny. The fli1ep:Gal4ff 
line also harbors a UAS:mRFP construct for the concomitant visualization of 
the cytoplasm in endothelial cells. For the analysis of the potential rescue 
ability of the Cldn5b:EGFP fusion protein, I compared control embryos with 
cldn5b MO injected embryos in Cdln5b:EGFP expressing and non-expressing 
fish (Fig. 25). In control embryos the expression of the Cldn5b:EGFP fusion 
protein did not cause any ISV formation defect (compare Fig. 25 E-H vs A-D 
and M-P vs I-L). The injection of cldn5b MO causes an ISV outgrowth and 
connection phenotype, which cannot be rescued with the specific 
Cldn5b:EGFP expression in ECs (compare Fig. 25 Q-T vs U-X). To evaluate 
the rescue ability of the Cldn5b:EGFP fusion protein in further detail, I 
quantified the number of ISVs connecting to neighboring ISVs (Fig. 26). In 
control embryos 100% of the ISVs are connected within the DLAV (8/8) in 
Cldn5b:EGFP expressing (wt: n=88; std ctrl MO: n=72 vessels) and non-
expressing embryos (wt: n= 72; std ctrl MO: n= 48 vessels). In contrast, 
embryos injected with cldn5b MO and not expressing the fusion construct 
present only 2 connections within the DLAV (2/8 connections; n= 96 vessels). 
The siblings expressing Cldn5b:EGFP do show a slight increase in vessel 
connections (3.5/8 connections; n= 152 vessels), this is however not 
significantly different to non-expressing embryos (Fig. 26). 
In summary, the expression of the UAS:cldn5b:EGFP fusion construct does 
not rescue the cldn5b MO induced phenotype.  
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Figure 24: Insufficient expression of Cldn5b protein by mRNA injection. (A-D``) 
Expression of mKate protein in fli1a:EGFP expressing living embryos after mKate mRNA 
injection (A, C) compared to control cldn5b mRNA injected embryos (B, D) at 80% epiboly (A, 
B) and 24hpf (C, D) respectively. Upon injection of mKate mRNA, a red fluorescent signal can 
be observed (A, C`) compared to the absent fluorescent signal upon cldn5b mRNA injection 
(B, D`). (E-G) Immunohistochemical stainings for VE-cadherin and Cldn5 in uninjected (E), 
cldn5b mRNA injected (F) and cldn5b mRNA and MO injected embryos (G). The injection of 
cldn5b mRNA does not lead to the expression of Cldn5b protein (compare arrows in E vs F 
and G). 
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5.7 Reduced cell number and cell proliferation in 
cldn5b morphants – a cause for ISV formation 
defects?  
 
During the analysis of ISV formation in cldn5b morphants I observed a 
decrease in cell number compared to control embryos.  To investigate this 
phenotype in more detail I generated a transgenic line for fli1ep:nlsmCherry 
expressing a nuclear version of mCherry in all ECs (Appendix 9.2). Using this 
transgenic line I compared the number of nuclei in ISVs between uninjected, 
ctrl MO and cldn5b MO injected embryos (Fig. 27 A-C, D) by counting the 
nuclei in 8 vessels above the yolk extension. Uninjected and ctrl MO injected 
embryos revealed an average number of 5.7 nuclei per ISV at 56hpf (uninj.: 
5.7 +/- 1 nuclei, n=53 vessels; std ctrl MO: 5.7 +/- 0.76 nuclei, n=56; Fig. 27 A, 
B, D). This number was ranging from 3 to 6 nuclei per ISV with 29% 
containing 3 nuclei and 43% containing 6 nuclei per ISV (Fig. 27 E). In 
contrast, in cldn5b morphants the cell number per ISV is significantly altered. 
Here, embryos harbor on average only 4.1 nuclei per ISV (4.1 +/- 0.79 nuclei, 
n= 102 vessels; Fig. 27 C, D). The nuclei number in these morphants ranges 
from 0 to 5 with the majority of 50% of the ISVs harboring 2 nuclei (purple 
asterisks in Fig. 27 C, E). Taken together, cldn5b morphants clearly show a 
reduced cell number in the ISVs, the majority of which contains 2 nuclei only. 
The reduction in cell number can have different causes. Either cell 
proliferation is decreased or less cells migrate into the ISV or both events 
happen simultaneously. In order to study the cause for the reduced cell 
number, I performed time-lapse analysis on fli1a:moesin-EGFP; fli1ep:nls-
mCherry expressing uninjected and MO injected fish (Fig. 28). In these 
movies the cell nuclei entering and dividing within the ISV were analyzed and 
quantified by marking every red nucleus employing the manual tracking 
function of ImageJ (Fig. 28 A`, B`, C). In uninjected embryos (Suppl. movie 13 
and movie 14) between 3 and 4 cells enter the ISVs from the DA on average 
(3.5 +/- 1.22 nuclei; n=6 ISVs). Of these 3-4 cells, roughly one cell divides 
within the ISV (1.2 +/- 1 divisions, n=6 ISVs, Fig. 28 C). In cldn5b MO injected 
embryos (Suppl. movie 15 and movie 16) a significant  
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decrease of cells entering can be observed (2 +/- 0.9 cell nuclei, n=36 ISVs) 
of which almost no cell divides within the ISV (0.2 +/- 0.4 divisions, n=36 ISVs; 
Fig. 28 C).  
It should be noted that the total numbers of cell nuclei within an ISV vary 
between experiments (Fig. 27 vs Fig. 28). The total numbers in Fig. 27 were 
obtained in the trunk. The movies of Fig. 28 were taken in the tail region at a 
stage when major morphology changes do not occur anymore allowing for 
easier time-lapse analysis.  
Taken together, cldn5b morphants show a reduced number of cells per ISV 
resulting from less cells entering and dividing within the ISV. 
 
 
5.8 VE-cadherin is necessary for cell rearrangement 
during ISV formation 
 
In the previous chapters I have shown the functional analysis of the tight 
junction protein Cldn5b during angiogenesis. It is required for the ISV 
outgrowth, fusion to neighboring vessels and the connection to the DA. This 
indicates that normal tight junction function is required for ISV formation and 
maintenance. Tight junction proteins are not the only ones mediating cell-cell 
contacts. Adherens junctions are known for the initial contact formation 
between cells and the maintenance of this contact. To study the role of AJs 
during the process of angiogenesis I looked at the function of the EC-specific 
VE-cad. Therefor, I used MO knock-down approaches as well as a mutant 
lacking VE-cad function (generated in the lab, Heinz-Georg Belting, 
unpublished). The effects of the VE-cad knock-out were analyzed by 
performing time-lapse analysis on wildtype and homozygous mutant animals 
expressing fli1a:EGFP (Fig. 29). In wildtype embryos (Suppl. movie 17) the 
ISVs grow dorsally, connect to their neighboring ISVs and eventually form the 
final network of vessels (Fig. 29 A-G). On the other hand, in VE-cad mutants 
(Suppl. movie 18) the initial outgrowth of cells occurs normal (arrows in Fig. 
29 H). With further progression of ISV formation, connections that have been 
made between the ISVs and the DLAV become very thin and  
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disrupt (see arrows in Fig. 29 J-L). In some vessels these connections are 
reestablished (asterisks Fig. 29 M, N). Interestingly, it seems that many cells 
accumulate at the ventral part of the ISV (arrowhead in Fig. 29 J, M). Indeed, 
further experiments in which cell nuclei and junctional proteins were marked 
show a concentration of stalk cells in the ventral part of the ISV (personal 
communication, Heinz-Georg Belting). Furthermore, over time the dorsal part 
of the ISV flattens consisting only of one cell (arrowhead Fig. 29 N, also see 
arrows Fig. 30 C, personal communication, Heinz-Georg Belting). These data 
indicate a role for VE-cad in the rearrangement of ECs to form the final 
architecture of the ISV.  
 
5.8.1 VE-cadherin and Claudin5 function non-redundantly 
during ISV formation 
 
The analysis of cldn5b morphant embryos indicates that cldn5b is important 
for vessel outgrowth and vessel stability in the ventral part of the ISV. VE-cad 
however is necessary for the rearrangement of cells and vessel stability in the 
dorsal part of the ISV. Adherens junctions are know to be required for the 
expression and proper localization of tight junction components (St Johnston 
and Ahringer; Taddei et al., 2008). To study a putative functional relationship 
between AJ and TJ, I injected VE-cad and cldn5b MO into fli1a:EGFP 
expressing embryos (Fig. 30). In this experiment I kept the VE-cad MO 
concentration constant and used an increasing concentration of cldn5b MO. 
This experiment was performed shortly before the mutant was generated and 
characterized. VE-cad morphants show a phenotype similar to VE-cad 
mutants, albeit a bit milder (H.-G. B., personal communication). Compared to 
uninjected and std ctrl MO injected embryos at 48hpf, VE-cad MO injected 
fish show very thin connections within the DLAV (compare red arrow in Fig. 
30 C vs 30 A, B). Furthermore, the dorsal part of the ISV appears flattened 
compared to control embryos (compare red arrowheads Fig. 30 C vs 30 A, B). 
Double morphants show phenotypic defects characteristic for the knock-out of 
VE-cad and cldn5b. The VE-cad phenotype was not enhanced by the 
increased cldn5b MO injection. In addition these embryos show a detachment  
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of ISVs from the DA, a phenotype caused by the knock-down of cldn5b alone 
(green arrows, Fig. 30 E, F; compare to Fig. 19). These analyses strongly 
suggest that VE-cad and Cldn5b control different steps in ISV development 
independently and function non-redundantly in this context.  
 
5.8.2 VE-cadherin does not influence Cldn5 expression and 
localization in vivo 
 
Although it appears that VE-cad and cldn5b have different functions during 
primary vessel formation, it has been shown in endothelial cell culture that 
VE-cad blocks the transcriptional repression of the cldn5 locus in a β-
catenin/FoxO1/TCF4-dependent manner (Taddei et al., 2008), suggesting a 
tight linking of expression of Cldn5 and VE-cad in vitro. Whether VE-cad 
displays a similar function on Cldn5b expression in vivo, was analyzed by 
studying the expression and localization of Cldn5b protein in animals deficient 
for VE-cad (Fig. 31). In wildtype and heterozygous animals VE-cad 
expression is clearly visible in ISVs in a junctional pattern (arrows in Fig. 31 B, 
F). As expected homozygous VE-cad mutants lack VE-cad protein and 
display the ISV phenotype as described in Fig. 29. Cldn5 protein is found in 
the DA and ISVs in all genetic backgrounds at a comparable level to wildtype 
levels (compare arrows in Fig. 31 C, G, K). Furthermore, Cldn5 protein clearly 
localizes at cell junctions throughout individual ISVs as has been described in 
Fig. 11. Even in VE-cad deficient ISVs showing thin extensions and 
connection between two cells, Cdln5 is visible at these contact points 
(arrowheads in Fig. 31 K). Please note, that all genotypes were subsequently 
verified by PCR and restriction analysis. In summary, VE-cad does not 
influence the expression and localization of Cldn5 protein in vivo. 
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5.9 Generation and analysis of a cldn5b mutant 
 
While injection of cldn5b anti-sense morpholinos generated vascular specific 
defects in the zebrafish embryos, rescue of the phenotype by RNA or DNA 
injections proved to be difficult. Therefore, I cannot exclude that the observed 
morphant phenotypes are due to off-target effects (see discussion). 
Therefore, to analyze cldn5b function at the genetic level, I generated a 
genomic mutant fish line using the Zinc-Finger Nuclease (ZFN) system 
(Doyon et al., 2008; Ekker, 2008; Meng et al., 2008). This Zinc-Finger is a 
hybrid protein consisting of the Zinc-Finger domain as well as the FokI 
Nuclease. The ZFN is designed as an obligate heterodimer, each monomer 
contains 3 zincfinger modules and one half of the FokI nuclease domain. 
Heterodimerization of these monomers generates an active endonuclease 
with a DNA recognition sequence of 28 nucleotides on each side of the 
nuclease domain. The size of this recognition sequence ensures very rare 
restriction events – ideally the target size exists only once in the zebrafish 
genome. The double-strand break in the DNA generated by the ZFN is 
repaired by error-prone non-homologous end-joining. This leads to the 
generation of deletions or insertions. 
The cldn5b transcript consists of one exon of 654bp containing the entire 
open reading frame. Therefore, the Zinc-Finger Nuclease was designed to cut 
close to the start codon (Fig. 32). I tested the knock-out ability of the ZFN by 
transiently expressing the nuclease in embryos by mRNA injection and 
performing PCR analysis on the genomic DNA of 1-2 day old embyos. 
Sequence analysis revealed a HinfI restriction site in immediate proximity of 
the ZFN cutting site. Therefore a potential mutation in this region may 
generate a restriction enzyme polymorphism presenting the HinfI site (Fig. 32 
A). A PCR on the region of interest and the subsequent digestion of the PCR 
product with HinfI uncovered a mutation within the cldn5b locus. While the 
PCR product generated on DNA from uninjected embryos could be digested 
with HinfI, the PCR product from ZFN injected embryos could only partially be 
digested. Sequencing of the non-digestable PCR product revealed a 2bp  
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deletion within the cut site of the ZFN. Therefore, the ZFN is effective in 
generating mutations in the cldn5b locus in vivo.  
To isolate a mutation in the germline, I injected ZFN mRNA into embryos and 
raised them to adulthood. The offspring of this G0 fish was analyzed for a HinfI 
polymorphism as described above (for a detailed protocol please see 4.3.15). 
In total 80 embryos per G0 fish were pooled to groups of 5 and analyzed for 
the absence/presence of HinfI restriction. Out of 24 screened adult fish, 4 
showed a mutation in the offspring and therefore carried germ cells with a 
mutation in cldn5b (example of restriction enzyme digestion in Fig. 32 B). All 
embryos derived from these 4 G0 fish carried the same 2bp deletion (Fig. 32 
C). At the transcript level this deletion leads to a frameshift and a premature 
translational stop at aa35 (Fig. 32 D). This stop codon is located within the 
region coding for the first transmembrane domain of the protein. This should 
lead to the formation of a truncated Cldn5b protein lacking all but the first 
transmembrane domain (Fig. 32 D). 
Progeny of the identified G0 fish were raised to adulthood and screened for 
the cldn5b mutation by performing PCR/restriction analysis on genomic DNA 
derived from fin clip biopsies (also see protocol in 4.3.15). Individual fish 
containing the HinfI polymorphism were used to generate a mutant fish line for 
cldn5b.  
In summary, the Zinc-Finger Nuclease system was used to generate a 
mutations in cldn5b in zebrafish. 4 independently isolated alleles showed an 
identical 2bp deletion in the 5` region of the cldn5b ORF leading to the 
generation of a premature stop, which ablates 84% of the protein. 
 
5.9.1 Efficient knock-out in cldn5b mutants 
 
To verify the cldn5b knock-out, I analyzed the Cldn5b protein expression in 
wildtype, heterozygous and homozygous siblings of cldn5b mutants. The 
mutation in the cldn5b gene of these animals should lead to a strongly 
truncated version of the Cldn5b protein. The anti-human Cldn5 antibody used 
for this experiment recognizes an epitope at the C-terminus of the protein. 
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Based on the molecular analysis of the mutation, this epitope should be 
deleted in cldn5b homozygous mutants.  
The analysis for cldn5b knock-out was performed in mutants expressing 
fli1a:EGFP and injected with the cldn5a MO for better visualization of Cldn5b 
protein only (Fig. 33). In wildtype and cldn5b+/ubs11 fish, Cldn5b is expressed at 
the junctions of the ISVs and aorta as described in section 5.2 (arrows in Fig. 
33 C, G, D, H). In contrast, in cldn5bubs11/ubs11 embryos Cldn5 can not be 
detected (arrow in Fig. 33 K, L). VE-cad protein, however, is expressed in a 
similar level in all genetic backgrounds (Fig. 33 B, F, J). 
These data indicate, that the knock-out in cldn5b mutants effectively 
abrogates Cldn5b at the protein level. 
 
5.9.2 Cldn5b mutant embryos show an overall normal 
anatomy 
 
To study the general effect of the cldn5b knock-out on embryonic 
development, I analyzed the overall anatomy of cldn5b mutants (Fig. 34). 
Compared to wildtype and cldn5b+/ubs11 embryos, cldn5bubs11/ubs11 reveal an 
overall indistinguishable anatomy at 24hpf of development (compare Fig. 34 
A, B vs C). No gross anatomical defects can be observed in these embryos. 
They also do not show any developmental delay (Fig. 34 C). Also at 33hpf the 
overall anatomy of cldn5bubs11/ubs11 embryos is similar from cldn5b+/ubs11 fish 
(compare Fig. 34 E vs D).  
When analyzing the overall anatomy of the cldn5b mutant siblings, I found 
that the majority of embryos within one clutch showed bloodflow in the axial 
vessels. However, very few embryos were lacking blood flow throughout the 
body. Most of these embryos were missing blood flow at different time points 
during development. While some lacked blood flow at 1 dpf, others were 
missing blood flow at 2 dpf. Interestingly, all of these embryos however 
regained blood flow within a few hours. From the third dpf onwards, all 
embryos showed normal blood flow. 
To test whether transient defects in blood flow are associated with the 
mutation in cldn5b, I generated short movies of heart beat and blood flow  
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under the binocular microscope in cldn5b mutant siblings (Suppl. movies 19-
29). In most cldn5b+/ubs11 embryos heart beat and blood flow is clearly visible 
at 24hpf as well as 33hpf (Suppl. movies 19 – 22). In a few cldn5b+/ubs11 
embryos blood flow was missing though throughout the embryo (data not 
shown). In one particular example shown in the Suppl. movie 23, the heart 
beat looked similar to wildtype embryos. In contrast to other cldn5b mutant 
siblings missing bloodflow, this embryo showed blood flow in the main vessels 
of the head. Interestingly, the embryo, however, lacked blood flow in the trunk 
vessels completely (Suppl. movie 24). This was caused by a shunt in the 
head region where the two LDA merge to one DA. The heart beat and blood 
flow of the majority of cldn5bubs11/ubs11 embryos analyzed resembled that of 
wildtype animals (Suppl. movie 25 - 27). It should be noted, that 
cldn5bubs11/ubs11 embryos that showed blood flow in the axial vessels, always 
presented blood flow also in the ISVs at later timepoints comparable to 
wildtype embryos (data not shown). However, a few cldn5bubs11/ubs11 animals 
were lacking blood flow completely, although the heart was pumping (Suppl. 
movie 28, 29).  
Taken together, most homozygous mutant animals showed blood flow in the 
axial vessels and ISVs comparable to wildtype embryos. However, very few 
embryos were missing blood flow over a short period of time.  
All embryos of a clutch develop into larval stages. If however, homozygous 
fish survive until adulthood has to be determined in further experiments. 
 
5.9.3 ISVs develop normally in cldn5b mutants 
 
The knock-down of cldn5b via MO injections causes strong ISV formation 
defects with vessels halting during outgrowth, failing to connect to neighbors 
and detaching from the DA (see chapter 5.3.2). It could be shown for cldn5b 
mutants, that these embryos clearly lack Cldn5b protein expression in the 
vasculature (see chapter 5.8.1). Therefore, I analyzed the effect of cldn5b 
knock-out on the formation of ISVs. For this, I compared the morphology of 
ISVs in fli1a:EGFP expressing cldn5b mutant siblings at different 
developmental stages (Fig. 35). In wildtype embryos of 30hpf the ISVs have 
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started to grow in anterior and posterior directions. They have partially built a 
continuous connection within the DLAV (Fig. 35 A, arrow in Fig. 35 B). 
Cldn5b+/ubs11 animals reveal the same ISV pattern as in wildtype embryos 
(compare Fig. 35 D vs A and arrows in E vs B). To my surprise and in contrast 
to cldn5b knock-down embryos, also the ISVs in cldn5bubs11/ubs11 animals have 
started to ramify anteriorly and posteriorly at the roof of the neural tube 
(arrows in Fig. 35 H). They also form a partially connected DLAV resembling 
the morphology of wildtype embryos (compare Fig. 35 G, H vs A, B). At 50hpf 
the ISVs in wildtype and cldn5b+/ubs11 embryos have build a fully developed 
circuit. At this point also the parachordal chain (PAC) is visible (asterisk in Fig. 
35 C). Interestingly, embryos homozygous for the cldn5b mutation also show 
a complete circuit of ISVs and DLAVs (Fig. 35 I). They have also developed 
the PAC vessels at this timepoint (asterisk in Fig. 35 I). This stands in stark 
contrast to the phenotypes observed in cldn5b morphant embryos (compare 
to Fig. 18).  
In summary, cldn5b knock-out does not seem to influence the process of 
angiogenesis in the context of ISV formation.  
Also for cldn5b mutants the analysis of the dynamics of ISV formation was 
performed via time-lapse analysis (Fig. 36). In wildtype embryos (Suppl. 
movie 30) as well as in cldn5b+/ubs11 animals (Suppl. movie 31) the ISVs have 
started to grow anteriorly and posteriorly after reaching the roof of the neural 
tube at 26hpf (Fig. 36 A, F). In contrast, in cldn5bubs11/ubs11 animals (Suppl. 
movie 32) the ISVs have not reached the neural tube roof yet and have 
partially grown to the level of the HMS only (compare Fig. 36 K vs A, F). 
When in wildtype and cldn5b+/ubs11 embryos the ISVs start to connect to 
neighboring ISVs, in cldn5bubs11/ubs11 embryos some ISVs still have not grown 
further than the HMS (compare arrows Fig. 36 L vs K, compare Fig. 36 L vs B, 
G). These vessels however do grow further dorsally and start to connect to 
neighboring ISVs (Fig. 36 M, N). However, not all vessels connect within the 
DLAV, which is never observed in wildtype and cldn5b+/ubs11 embryos (arrow 
Fig. 36 O, compare Fig. 36 O vs E, J). As in wildtype and cldn5b+/ubs11 
embryos, secondary sprouts emerge and build a PAC (asterisks in Fig. 36 J, 
O). It should be mentioned that the delay of ISV outgrowth in cldn5b mutants 
cannot be compared to the halting of vessels in cldn5b morphants. In the  
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latter the ISVs halt for a much longer time than in cldn5bubs11/ubs11 embryos. 
More embryos are needed to be looked at for a statistical evaluation to be 
made. 
 
5.9.4 Cldn5b is not required for the organization of ZO-1 
 
As described above ZO-1 binds to the C-terminus of Cldn proteins. The 
localization of ZO-1 to tight junctions depends on Cldn proteins in cell culture 
experiments (Itoh et al., 1999a; McCarthy et al., 2000). To investigate if ZO-1 
localization also depends on Claudin 5 in vivo, I analyzed the ZO-1 
expression in cldn5b mutants (Fig. 37). Wildtype and clnd5b+/ubs11 sibling 
show ZO-1 localization in a junctional fashion within the ISVs as well as the 
axial vessels (Fig. 37 A, B). But also cldn5bubs11/ubs11 animals resemble a ZO-1 
staining that is comparable to wildtype (compare Fig. 37 C vs A). The level of 
expression does not seem to be altered compared to wildtype siblings. 
Furthermore, also 50hpf embryos show a distribution and expression level of 
ZO-1 that is resembling wildtype expression (data not shown). Further 
analysis on Cldn1 for example might indicate if other tight junction 
components are altered in expression in cldn5b mutant embryos. Also, 
stainings for VE-cad will give insights into the role of Cldn5b on adherens 
junction formation in the vasculature. 
The ZO-1 expression also gives information about the architecture of the 
ISVs. In wildtype embryos as well as cldn5b+/ubs11 animals ZO-1 is expressed 
in stripes along the axis of the ISVs. Furthermore at 30hpf it localizes to spots 
and rings within the DLAV. These represent the contact area between two 
neighboring cells that connect to each other (arrows in Fig. 37 A``, B``). In 
cldn5bubs11/ubs11 mutants lines of ZO-1 expression are also visible in the ISVs. 
Also the DLAV resembles dots and rings of ZO-1 expression (arrows in Fig. 
37 C``). Therefore, the cellular architecture and rearrangement within the ISV 
and during the formation of the DLAV in cldn5b mutants is comparable to 
wildtype. Further analysis with markers specifically expressed in the 
vasculature like VE-cad will give further insights into this.  
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5.9.5 The cldn5b mutant phenotype cannot be enhanced by 
additional cldn5b MO knock-down 
 
As shown above cldn5b mutants do present a very weak phenotype during 
the process of angiogenesis, although Cldn5b protein is completely absent 
(see chapter 5.8.1). The knock-down via MO injection, however, shows a 
strong phenotype in ISV formation. This phenotype could be caused by a non-
specific effect of the MO. However, Cldn5b protein expression is lacking in 
cldn5b morphants. Therefore, under the assumption, that the MO knock-down 
phenotype was specific, several scenarios could lead to the absence of a 
phenotype in cldn5b mutants. One of these possibilities is the maternal 
contribution of Cldn5b protein during embryonic development. No cldn5b 
mRNA and protein could be observed in early stages of development or in 
cldn5b knock-out embryos, respectively. However, a weak maternal 
expression that is beneath the detection level of in situs and antibody 
stainings, could be present in later embryos. 
Therefore, I wanted to analyze the effect of inhibiting the putative maternal 
expression of Cldn5b. By using suboptimal concentrations of cldn5b MO (0.05 
mM) this maternal expression is inhibited partially without causing the strong 
phenotype described in Fig. 18. In this experiment, the outgrowth of ISVs as 
well as their fusion in the DLAV was quantified in fli1a:EGFP expressing 
cldn5b mutant siblings (Fig. 38, Fig. 39). Std ctrl MO injected wildtype, 
cldn5b+/ubs11 and cldn5bubs11/ubs11 embryos showed a normal outgrowth of ISVs 
as 100% of the vessels have grown beyond the HMS and connected within 
the DLAV at 30hpf (arrows in Fig. 38 A, C, E; wt: n=10; het: n=60; hom: n=30 
vessels, Fig. 39 A, B). The injection of cldn5b MO causes even at low 
concentrations (0.05mM) a strong phenotype in ISV outgrowth in wildtype 
embryos. Although all vessels counted grew further than the HMS, none of 
these vessels connected within the DLAV (arrow Fig. 38 B, Fig. 39 A, B). In 
contrast, the injection of cldn5b MO in heterozygous and homozygous 
mutants causes on average more vessels do halt at the level of the HMS 
compared to wildtype embryos (arrow Fig. 38 D; 7.7 and 8/10 vessels,  
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respectively; Fig. 39 A). But it causes less vessels to connect to neighboring 
vessels in the DLAV (arrow Fig. 38 F; 2.3 and 6/10 vessels, respectively, Fig. 
39 B). From these experiments so far no conclusions about a putative 
maternal contribution can be made. Further repetitions of this experiment will 
answer the effect of maternal contribution on the development of the ISVs. 
 
5.9.6 Cldn5a knock-down does not cause any angiogenesis 
phenotype in cldn5b mutants 
 
Cldn5a is expressed in the DA for a period of time, when ISVs grow dorsally 
and form the DLAV (see chapter 5.2). As described above, knock-down of 
cldn5a alone does not cause any phenotype during ISV formation. However, 
cldn5a is responsible for CV plexus formation as well as the DA/CV 
separation in conjunction with cldn5b. Therefore, I analyzed the effect of 
cldn5a MO knock-down on ISV and DA/CV formation in cldn5b mutants (Fig. 
40). In std ctrl MO injected embryos ISV outgrowth above the level of the 
HMS occurs the same in wildtype, cldn5b+/ubs11 and cldn5bubs11/ubs11 siblings 
(Fig. 40 A-C, Fig. 41 A). However, at this stage of development not all ISVs 
made connections in the DLAV (arrows in Fig. 40 A; wt 8.5 +/- 0.7; het 9.4 +/- 
1.3; hom 10 +/- 0; Fig. 41 B). Upon cldn5a MO injection, the number of ISVs 
grown beyond the HMS decreases slightly in wildtype embryos (9.8 +/- 0.5 
vessels per 10 vessels). Although cldn5bubs11/ubs11 embryos show a slight 
enhancement of the outgrowth phenotype, the difference to wildtype embryos 
is not significant (arrow Fig. 40 F; 9.3 +/- 0.5 vessels per 10; Fig. 41 A). Also 
the impact of cldn5a MOs on cldn5b mutants on the number connections 
within the DLAV is not significantly different to wildtype or cldn5b+/ubs11 
animals (Fig. 40 F vs D, E; 8.7 +/- 1.9 vs 8.8 +/- 1.3 and 8.2 +/- 2.4 vessels 
per 10, respectively; Fig. 41 B).  
Furthermore, I analyzed the effect of cldn5a MO knock-down on the formation 
of the CV plexus (Fig. 41 A` - F`). For this, the number of embryos with an 
altered CV plexus and a possible fusion between DA and CV was quantified 
(Fig. 41 C). In std ctrl MO injected cldn5bubs11/ubs11 embryos, CV plexus  
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formation occurs in a comparable manner as in wildtype and heterozygous 
animals (compare Fig. 40 C` vs A`, B`; Fig. 41 C). In contrast, the injection of 
cldn5a MO causes a loss of complexity within the CV plexus of all genotypic 
backgrounds analyzed (compare arrows in Fig. 40 D`, E`, F` with arrows in 
Fig. 40 A`, B`, C`, Fig. 41 C). The fusion of DA and CV was never observed in 
either std ctrl MO or cldn5a MO injected mutant siblings. 
Taken together, these data show that cldn5a does not work in conjunction 
with cldn5b in the mutant background during ISV and DA/CV formation.
6. Discussion 
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6. Discussion 
 
During blood vessel development cell-cell contacts mediate adhesion 
between migrating and rearranging endothelial cells during blood vessel 
generation and maturation. Although the cell contacts in endothelial cells 
underlie dynamic changes, the adhesion governed by these cell contacts has 
to be maintained over a certain threshold to ensure tissue integrity. 
Cell contacts in endothelial cells consist to a large extent of adherens 
junctions and tight junctions, which are composed of different protein 
complexes (Bazzoni and Dejana, 2004; Ebnet, 2008). Whereas adherens 
junctions are thought to establish and maintain cellular contacts, tight 
junctions form selective barriers between cells to control paracellular transport 
(Anderson and Van Itallie, 2009; Baum and Georgiou, 2011; Ebnet, 2008; Van 
Itallie and Anderson, 2004a; Van Itallie and Anderson, 2006). Although much 
is known about the molecular composition of junctional protein complexes 
(Ebnet, 2008; Hartsock and Nelson, 2008) and the behavior in cell culture 
experiments has been intensely studied (Matsuda et al., 2004; Perryn et al., 
2008; Sasaki et al., 2003), only little is known about the exact role of adherens 
and tight junctions during development of the vasculature in vivo.  
In this project, I focused on the functional analysis of the tight junction specific 
protein Claudin5b during the formation of intersegmental vessels (ISVs) in the 
zebrafish embryo. Cldn5b is an endothelial specific Claudin and Claudins are 
necessary for the formation and maintenance of tight junctions (Furuse, 2010; 
Krause et al., 2008). 
 
 
6.1 Dynamics of Cldn5b protein expression correlate 
with the need for adhesion during ISV outgrowth 
 
In the first part of this section I will discuss the expression of cldn5b in the 
context of the different stages of ISV development. Later on I will discuss the 
phenotype of the cldn5b knock-down in this process. 
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At sprout formation and early EC outgrowth, the DA epithelium has just 
formed (Herbert et al., 2009; Jin et al., 2005). It is generally assumed that the 
overall adhesion between cells that grow out and cells that remain in the DA 
has to be decreased. Many studies showed the importance of the right level of 
adhesion during migratory behaviors of single cells and groups of cells 
(Arboleda-Estudillo et al., 2010; Jeon et al., 2009; Patel and Brunton, 2009). 
The reduction of adhesion strength between cells could be achieved by the 
downregulation or by the re-localization of junctional components. In sprouting 
ISVs Cldn5b protein is not or only weakly expressed compared to the DA. 
Given the prominent role of Cldn5 as a component of tight junctions in forming 
strong connections between adjacent cells, the temporal downregulation of 
Cldn5b protein in migrating ECs could lead to a lowered cell-cell adhesion as 
suggested in other studies (Furuse, 2010; Krause et al., 2008). Interestingly, it 
was shown that a reduction of Cldn5 protein expression in cultured 
mammalian ECs and in the mouse brain vasculature is triggered by the 
presence of VEGF-A, a key regulator of vessel growth (Argaw et al., 2009). 
The observation that the level of cldn5b mRNA remains the same in the ISV 
sprouts strongly suggests regulation at the protein level in these cells.  
After the initial downregulation of Cldn5b protein expression during sprout 
formation, it gets upregulated again and maintained during ISV formation. 
This upregulation coincides with the further outgrowth of ISVs and the 
entering of more cells from the DA into the ISV. Here, an increase of cell-cell 
contact strength among ISV cells would prevent vessel disruption. Several 
studies showed that a certain level of adhesion is needed for tissue integrity 
and morphogenesis (Classen et al., 2005; Levayer et al., 2011). 
One would assume, that the lack of Cldn5b protein in early ISV sprouts would 
not cause any sprout formation defect as Cldn5b protein expression is 
lowered anyway. Indeed, in cldn5b morphants, early sprout formation and 
outgrowth is not altered. In these animals, the early outgrowth of ECs is 
comparable to wildtype embryos. 
The earliest phenotype observed in cldn5b morphants occurs when in 
wildtype Cldn5b protein expression gets upregulated again. In these embryos, 
ISV outgrowth is arrested for a few hours at the level of the horizontal 
myoseptum (HMS). Stalling of sprout outgrowth has been observed in a 
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number of mutants and morphants (Bignon et al., 2011; Brown et al., 2010; 
Ernkvist et al., 2009; Wu et al., 2011). Therefore, it is likely that many factors 
can cause this phenotype. However, one factor that might have a big impact 
on the halting of ISVs at the HMS is the reduction of total cell number in ISVs 
of cldn5b morphants. It was observed, that fewer cells entered the ISV and 
fewer cells divided within the ISV. Therefore, in cldn5b morphants next to the 
loss of adhesion between the migrating ECs, the ISVs might halt their 
outgrowth, because not enough cells enter the ISV and follow the migration of 
the tip cells.  
How could Cldn5b influence cell proliferation? Several tight junction proteins 
are known to bind to the actin cytoskeleton (Wittchen et al., 1999; Wittchen et 
al., 2000). It was shown in several studies that defects in F-actin formation 
influence cell proliferation and cytokinesis (Pollard, 2010; Skau et al., 2011; 
Sun et al., 2011; Vavylonis et al., 2008). To study whether the actin 
cytoskeleton is altered upon cldn5b knock-down, MO injections into fish 
expressing a live-actin marker can be performed. Interestingly, some tight 
junction proteins such as ZO proteins, JAM-A and ZONAB are known to 
regulate cell proliferation directly (Balda and Matter, 2009; Capaldo et al., 
2011; Nava et al., 2011). In particular, for the ZO-1 associated protein ZONAB 
it was shown, that it translocates to the nucleus and activates the expression 
of cell-cycle dependent genes (Balda et al., 2003; Balda and Matter, 2000; 
Sourisseau et al., 2006). It would be interesting to test, whether in cldn5b 
morphants the localization of these proteins is altered, which would indicate a 
potential link to the observed cell proliferation defect. A very similar phenotype 
as observed in cldn5b morphants was shown for zebrafish embryos depleted 
for Notch-regulated-ankyrin-repeat protein (nrarp) and lymphoid enhancer 
factor 1 (lef1) function (Phng et al., 2009). The ISVs in these embryos show 
detachment and regression from the DA similarly to the observations in 
cldn5b morphants (discussed below). In contrast to Phng et al., I have found 
additionally, that the ISVs in nrarp morphants also halt at the HMS (data not 
shown). Interestingly, nrarp morphants reveal a strong reduction of cell 
number per ISV (Phng et al., 2009). It was shown that Nrarp expression is 
induced by Notch, which in turn inhibits Notch signaling, but also increases 
Wnt signaling by inducing Lef1/βcatenin expression. The authors suggest that 
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nrarp regulates cell proliferation by limiting Notch-dependent cell cycle arrest 
and by increasing Lef1/Wnt signaling-dependent CyclinD1 expression. The 
very similar phenotypes in both nrarp and cldn5b morphant embryos raises 
the possibility that these genes might act synergistically during ISV formation. 
It will be very interesting to study the effect of cell number reduction on the 
architecture and formation of ISVs in wildtype animals. This could be achieved 
by the general block of cell proliferation within an animal or by laser ablation 
of single cells within an ISV. Another less invasive method to reduce cell 
number in the ISVs would be the expression of proapoptotic genes in an EC-
specific manner using for example the Gal4/UAS system. This approach has 
been used successfully in Drosophila by expression of the proapoptotic genes 
hid and reaper (Bergantinos et al., 2010; Wu et al., 2010; Yorozu et al., 2009). 
Furthermore, an increase of cell number could be achieved by the injection of 
a p27 MO, which has been shown to block cell cycle arrest (Komatsu et al., 
2011; Polyak et al., 1994). 
After the initial sprouting of the ISV and the temporary halting of migration in 
cldn5b morphant embryos, the ECs of the ISV do eventually migrate further. 
This indicates, that the attractive signal persists. When migrating into anterior 
and posterior directions above the neural tube, the ISVs do partially not make 
connections between neighboring ISVs in the dorsal-longitudinal-anastomotic 
vessel (DLAV). Also here a reduction of cell number might prevent the ECs 
from joining in the DLAV. However, one can assume that in wildtype embryos 
a certain migratory behavior in these cells ensures the fusion of the 
neighboring ISVs. It was shown for cultured MDCK cells that the lack of the 
tight junction protein Occludin inhibits migration in a wound healing assay. 
Furthermore, this protein is responsible for the polarization of the migrating 
cell (Du et al., 2010). In wildtype zebrafish embryos, Cldn5b localizes to the 
points of first contact between cells migrating towards each other. Therefore, 
the lack of Cldn5b could either directly or indirectly fulfill a similar function as 
Occludin in regulating the migratory behavior of ECs and in guiding the 
connection of ECs in the DLAV.  
It might be assumed, that during ISVs outgrowth in wildtype embryos the tip 
cells creates a pulling force on every cell of the ISV. For the dorsal branch in 
the Drosophila tracheal system strong pulling forces of the tip cells as well as 
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tensile forces on the whole branch were recently shown (Caussinus et al., 
2008). Here, the laser ablation of connections between the stalk cells and the 
main branch caused a fast constriction of the remaining cells. Furthermore, for 
groups of migrating epithelial cells mechanical stress such as pulling forces 
were shown to be distributed over many cells within the epithelium. This 
distribution is mediated by cell-cell contacts between the cells (Tambe et al., 
2011). Similar pulling forces as well as mechanical stress might be assumed 
to be present within the ISV. Especially in ISVs consisting of two cells only, 
these appear very thin and stretched. This might indicate that a high load of 
mechanical tension is imposed on these cells. Finally, cldn5b morphants 
showed a detachment of many ISVs from the DA at a timepoint, when a 
vascular loop of ISV and DLAV has been formed already in wildtype embryos. 
This observation suggests that the pulling forces of the tip cell might 
dramatically increase and a connection between the ISV and DA cannot be 
maintained anymore. 
Interestingly, the level of Cldn5 expression in wildtype embryos is much 
higher at the base of the connection between the ISV and the DA than within 
the ISV itself. Therefore, a loss of Cldn5b protein expression at this 
connection might loosen the contact between ISV and DA. These 
observations correlate with the finding, that in cldn5b morphants a 
detachment of cells always occurs at the contact point between ISV and DA. 
This might indicate an important function for Cldn5 in anchoring the ISV to the 
DA.  
The majority of studies about Cldn proteins as the core components of tight 
junctions have revealed a function in building a sealing barrier of epithelia 
(Alexandre et al., 2005; Amasheh et al., 2002; Anderson and Van Itallie, 2009; 
Furuse, 2010; Furuse et al., 2002; Nitta et al., 2003; Van Itallie and Anderson, 
2006). Interestingly, a few reports also show that Cldn function could be linked 
to morphogenetic processes (Bagnat et al., 2007; Moriwaki et al., 2007; 
Siddiqui et al., 2010). Cldn15 function is necessary for the coalescence of 
lumen of the zebrafish gut and Cldn4 and Cldn6 were shown to be important 
for blastocoel cavity expansion in mouse embryos (Bagnat et al., 2007; 
Moriwaki et al., 2007). However, the morphogenesis defect in the gut is also 
linked to the regulated paracellular ion transport within the epithelium (Bagnat 
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et al., 2007). In cldn5b morphants the defects in ISV formation occur prior to 
lumen formation. This raises the question whether the function in this process 
of cldn5b is mediated by paracellular transport or the more likely direct 
regulation of differential cell adhesion. This for the first time suggests a role 
for a Cldn in a morphogenetic process.  
 
 
6.2 Cldn5b and VE-cadherin have different expression 
patterns and functions 
 
Cadherins were shown to have a function in regulating cell dynamics during 
morphogenetic processes. During the process of tip cell fusion in the 
Drosophila tracheal system, the lack of Drosophila epithelial (DE) - cadherin 
leads to a failure in tip cell adhesion and fusion (Tanaka-Matakatsu et al., 
1996). For vertebrate ECs VE-cadherin was shown to inhibit angiogenesis by 
repressing VEGFR-2 internalization and by limiting Rac1-dependent migration 
of ECs (Abraham et al., 2009; Lampugnani et al., 2006). However, VE-
cadherin also may have proangiogenic functions as it facilitates the EC 
rearrangements in mouse allantoid cultures (Perryn et al., 2008). It can be 
assumed that during zebrafish development VE-cadherin exerts a similar 
function during angiogenic processes. 
In this study as well as in experiments performed by Heinz-Georg Belting in 
the lab, we found, that during ISV formation in VE-cadherin mutant ECs are 
arrested in the ventral part of the ISV. Furthermore, connections between 
cells in the dorsal part of the ISV and the DLAV cannot always be maintained 
and get disrupted. However, the disrupted connection between ISVs re-
established again. Antibody stainings for ZO-1 in VE-cadherin mutants 
showed an absence of ZO-1 localization in the dorsal part of the ISVs, 
indicating that here the ISV is constituted of one cell only compared to 
wildtype (Heinz-Georg Belting, unpublished data). These data suggest that 
VE-cadherin is necessary for the rearrangement of cells during the highly 
dynamic process of angiogenesis. This can be supported by other studies, in 
which VE-cadherin function was analyzed in the vasculature of zebrafish. The 
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knock-down of VE-cadherin via MO injections caused the loss of vessel 
integrity as well as a lack of lumen formation in ISVs (Wang et al., 2010). 
Furthermore, the process of anastomosis in neighboring ISVs is highly 
impaired (Montero-Balaguer et al., 2009). 
In contrast, in cldn5b knock-down embryos such phenotypes could not be 
observed. Here, ZO-1 and VE-cadherin stainings showed that the cellular 
architecture within ISVs resembles that of wildtype embryos. Cells are 
arranged in a side-by-side pattern shown by the linear fashion of junctional 
protein localization along the whole axis of ISVs. These data indicate, that 
Cldn5b and VE-cadherin might have different functions during the highly 
dynamic process of ISV formation. Also, the simultaneous knock-down of VE-
cadherin and cldn5b shown in this study does not reveal any redundant 
functions, but rather leads to additive effects.  
However, in cultured murine ECs a functional connection between the VE-
cadherin and Cldn5 was shown (Taddei et al., 2008). Here, VE-cadherin 
induces Cldn5 expression mediated by the Tcf4/FoxO1/β-catenin-complex 
(Taddei et al., 2008). In vivo in VE-cadherin mutant embryos we still detect 
Cldn5 protein expression that is comparable to wildtype siblings. Therefore, 
significant differences between in vitro and in vivo data for Cldn5 protein 
expression upon VE-cadherin knock-down were observed. They propose that 
another level of complexity might be responsible for the regulation of Cldn5 
protein expression in vivo. 
In summary, the analysis of the adherens junction specific protein VE-
cadherin and the tight junction specific protein Cldn5b suggests different 
functions during the process of angiogenesis (Fig. 42). The DA is a fully 
developed epithelium expressing VE-cadherin as well as Cldn5b. However, 
upon sprout formation, the ECs that sprout form the DA epithelium have to 
loosen their adhesion to the cells of the DA and become migratory. Therefore, 
in these early sprouts Cldn5b gets downregulated compared to the expression 
level in the DA. In early ISV sprouts VE-cadherin mediates the rearrangement 
of ECs for the proper formation of the ISV. Loss of VE-cadherin function 
inhibits this dynamic cell behavior leading to the accumulation of cells in the 
ventral part of the ISV. As ISV formation proceeds Cldn5b gets upregulated  
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again and maintained. At later stages during ISV maturation, Cldn5b might 
mediate the maintenance of vessel stability and connectivity to the DA. 
 
 
6.3 Cldn5b mutants lack a clear angiogenesis 
phenotype 
 
In order to specifically delete cldn5b function, I generated a cldn5b mutant fish 
line using Zinc-Finger Nucleases (ZFN). In these mutants a 2bp deletion leads 
to a frame shift and a premature stop codon, which encodes a strongly 
truncated protein. Interestingly, the exact same 2bp deletion was observed in 
all four mutant fish found as well as in the fish transiently expressing the ZFN. 
The generation of the same mutation has been observed in other instances as 
well (personal communication of Nathan Lawson to H. B.). It may be 
influenced by the nucleotide composition surrounding the cleavage site. It 
would be desirable to use a different ZFN against cldn5b to generate an allele 
different from the existing one. However, due to the small size of the cldn5b 
ORF it may be difficult to find an optimal target sequence. Very recently a 
novel method to generate knock-outs in zebrafish has been described 
(Sander et al., 2011; Zhang et al., 2011). This could also be used to generate 
another allele for cldn5b. 
In agreement with the genetics, a complete loss of Cldn5b protein was 
observed in these mutants. They represent the first knock-out of the key 
component of tight junctions in fish and provide a great tool to study the role 
of a Cldn protein during angiogenesis. Surprisingly, cldn5b zebrafish mutants 
do only show a very weak phenotype regarding the morphogenesis of ISV 
formation. Compared to cldn5b morphants, no delay in outgrowth or vessel 
detachment was observed. Only when analyzing this process via time-lapse 
imaging, a weak delay of outgrowth as well as the lack of a few connections 
between neighboring ISVs was observed. Furthermore, also the expression of 
the junctional component ZO-1 revealed an expression pattern comparable to 
wildtype embryos.  
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Why do the different techniques of cldn5b knock-down/out show such a big 
discrepancy in phenotype penetrance? 
In cldn5b morphants protein expression of Cldn5b is completely absent, while 
Cldn5a protein is still expressed. Furthermore, the knock-down using two 
different MOs for cldn5b generated the same phenotype. These data suggest 
a specific knock-down of cldn5b via MO injection. However, the knock-down 
via MO injections is not always entirely specific. Therefore, I wanted to further 
prove the specificity of the MO-mediated cldn5b knock-down by performing 
rescue experiments. The rescue of MO phenotypes using mRNA injections is 
an established method used in zebrafish developmental biology (Kappler et 
al., 2004; Labalette et al., 2011; Zhang et al., 2010). However, in this study 
Cldn5b could not be successfully expressed from the injected mRNA. 
It was observed that the injection of a MO itself might cause aggravated p53 
levels in the injected embryos (personal communication Nathan Lawson to 
H.B.). This transcription factor induces apoptosis of cells and might therefore 
account for a possible secondary effect of MO injections (Brady et al., 2011; 
Wu and Levine, 1994). However, in this study I observed, that the 
concomitant injection of p53 MO and cldn5b MO does not change the 
phenotype penetrance (data not shown).  
Additionally, the Gal4/UAS system was applied as a second approach to 
rescue the MO-associated defects. By crossing transgenic fish carrying a 
UAS:cldn5b:EGFP construct to fli1ep:Gal4ff fish the specific expression of the 
Cldn5b:EGFP fusion protein in ECs was achieved. Although expression of the 
fusion protein was observed (Suppl. Data 8, Fig. 3), no rescue activity could 
be assigned to the expression of Cldn5b:EGFP. Several reasons might 
account for the missing rescue ability of the cldn5b:EGFP construct. First, the 
construct is driven by the fli1 promoter, whose expression pattern does not 
entirely overlap with the normal cldn5b expression. Second, the expression 
via the Gal4/UAS system might lead to a higher expression level of Cldn5b 
than would be present in wildtype embryos. The exact protein level might be 
important for the rescue of the phenotype. Third, the position of the tag used 
for monitoring the expression might have a big impact on the function of the 
protein by changing its expression pattern or localization. In this case the 
6. Discussion 
 156 
EGFP tag was added to the C-terminus of Cldn5b. It was shown before, that 
fluorescent tags to the C-terminus of Cldn proteins do not to alter their 
localization to the junctions (Furuse et al., 1998). However, compared to 
Cldn5b protein marked via antibody stainings, the Cldn5b:EGFP protein is 
rather expressed in the cytoplasm than at the junctions (Suppl. Data 8, Fig. 3). 
Additionally, it was shown that ZO-1 cannot be recruited to tight junctions, if 
the C-terminus of Cldn proteins is “blocked” by a fluorescent tag (Sasaki et al., 
2003). These data strongly suggest that the Cldn5b:EGFP protein fusion is 
not functional.  
Finally, although Cldn5b protein expression is completely absent in cldn5b 
morphants, it cannot be completely excluded that the MO used in these 
experiments exerts unspecific effects. Furthermore, the presentation of a very 
weak phenotype in cldn5b mutants could indicate, that the gene may not be 
strictly required during ISV formation, but may still have a function.  
 
It should be noted, that Cldn5 is known for its function in forming the blood-
brain barrier (BBB) as well as blood-retinal barrier (BRB) (Jeong et al., 2008; 
Nitta et al., 2003; Virgintino et al., 2004; Xie et al., 2010). One could speculate 
that cldn5b exerts the same function during vessel sealing in the zebrafish 
vasculature. Indeed, a leakage of erythrocytes from the ISVs was observed in 
cldn5b morphant embryos. If this holds true for the mutant embryos has to be 
determined in future experiments using fli1a:EGFP;gata1:dsRed fish. 
Additionally, the injection of fluorescently labeled dextrans or Quantum dots 
into the functional blood vessel system will give further insights into the role of 
cldn5b in vessel sealing.  
 
Assuming however, that the MO-mediated knock-down of cldn5b is specific, 
several reasons might account for the low phenotype penetrance during ISV 
formation in cldn5b mutants. It should be noted that a small part of the Cldn5b 
protein is still expressed in cldn5b mutants. This could adopt a function that 
might partially rescue the phenotype. However, the N-terminus in Claudins 
has not been reported to have any functional relevance. Furthermore, it was 
shown in mice that different strains of mice can exhibit strikingly different 
phenotypes (Baribault et al., 1994; Baribault et al., 1993; Jelcick et al., 2011; 
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Kent et al., 1997; Rozmahel et al., 1996). Also in zebrafish this issue has 
been started to be addressed (Bretaud et al., 2011). Therefore, it will be 
desirable to analyze the cldn5b mutation in a different zebrafish strain. 
Furthermore, in ECs compensatory mechanisms could mask the cldn5b 
knock-out phenotype. An acute knock-down in MO injected embryos could 
lead to a different cellular response than in embryos lacking a gene from the 
beginning. 
A few studies show that the maternal effect of genes can last until late into 
embryogenesis in zebrafish and other model organisms (Franks et al., 2006; 
Kotani and Kawakami, 2008; Wagner et al., 2004). Also in cldn5b mutants a 
maternal contribution could compensate for the loss of zygotic cldn5b 
function. Although no cldn5b mRNA was detected in early stages of 
development, the level of expression could be under the detection threshold 
of the in situ hybridization. Initial experiments inhibiting cldn5b translation of 
potential maternal mRNA in cldn5b mutants did not lead to clear conclusions. 
In this direction, it would be interesting to know, if homozygous cldn5b 
mutants survive until adulthood. If these fish exist, a series of experiments will 
clarify if a maternal contribution exists and what its putative effect on cldn5b 
function during angiogenesis is. 
Another compensatory mechanism that could mask the function of cldn5b 
might be the functional redundancy with other tight junction proteins, 
especially Cldns. These might be either upregulated or function redundantly 
without being upregulated. The compensation for the loss of certain genes 
during development has been observed in several examples (FitzPatrick et 
al., 2002; Gupta et al., 2006; McAnally and Yampolsky, 2009; Stenberg et al., 
2009). Despite the high sequence similarity Cldn5a does not mask cldn5b 
loss of function. Antibody stainings do not show a clear upregulation of 
Cldn5a in cldn5b mutants (data not shown). More importantly, the injection of 
cldn5a MO into cldn5b mutants does not lead to an increase in phenotype. 
Beside Cldn5b other Cldns are among other tissues also expressed in ECs 
such as Cldn1, Cldn3, Cldn12 and Cdln15 (Kiuchi-Saishin et al., 2002; Leach 
et al., 2002; Liebner et al., 2000; Lievano et al., 2006; Wolburg et al., 2003). 
These could therefore be functionally redundant to cldn5b function and mask 
the cldn5b loss of function. Future experiments will determine whether the 
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lack of cldn5b influences the expression level of these Cldns. Furthermore, 
knock-out studies of these cldns will address their putative role during 
angiogenesis.   
 
 
6.4 Conclusions 
 
In this study, I have analyzed the role of cldn5b during the process of ISV 
formation, by anti-sense morpholino injections and by generation of a cldn5b 
mutant. MO-mediated knock-down of cldn5b causes defects in ISV outgrowth 
and blood vessel stability. In addition, I have found that cell proliferation is 
impaired in cldn5b morphants, raising the possibility that the correct cell 
number of ECs is important for ISV formation. These findings for the first time 
point to functions for a Claudin protein in the control of vascular 
morphogenesis.  
Using Zinc-Finger Nuclease technology I was able to generate a fish line that 
contains a lesion in the genomic locus of cldn5b. This frameshift mutation 
leads to the expression of a truncated protein product. Phenotypic analysis 
reveals significant discrepancies between cldn5b mutant and morphant 
embryos. In contrast to the morphants, the claudin mutant phenotype is much 
weaker and less penetrant. The cause of these discrepancies is not known 
but may be accounted for by compensation through protein redundancy or by 
off-target effects of the morpholinos. Further detailed analyses including 
mutants of other tight junction proteins will be required to delineate the exact 
function of tight junctions during vascular morphogenesis. 
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ZebrafishDuring embryonic development, the vertebrate vasculature is undergoing vast growth and remodeling.
Blood vessels can be formed by a wide spectrum of different morphogenetic mechanisms, such as budding,
cord hollowing, cell hollowing, cell wrapping and intussusception. Here, we describe the vascular
morphogenesis that occurs in the early zebrafish embryo. We discuss the diversity of morphogenetic
mechanisms that contribute to vessel assembly, angiogenic sprouting and tube formation in different blood
vessels and how some of these complex cell behaviors are regulated by molecular pathways.
© 2009 Elsevier Inc. All rights reserved.Introduction
Branched tubular organs, such as the insect tracheal system or the
vertebrate cardiovascular system, kidney or lung, are found throughout
the animal kingdom. Formation of such tubular networks from
precursor cells or tissues involves a variety ofmorphogenetic processes,
such as tube formation, elongation, branching and fusion. These
processes are brought about by complex cellular behaviors, which
include cell polarization, cell migration, cell rearrangements, cell shape
changes and cell division. Although tubular organs are extremely
diverse in anatomy and function, the cellular activities that govern tube
formation and branching morphogenesis appear to be quite similar
(Baer et al., 2009; Andrew and Ewald, 2010). In this review,we describe
the current understanding of blood vessel formation in the early
zebrafish embryo. We are placing special emphasis on the morphoge-
netic processes that contribute to vascular development and discuss
the regulatory components that accompany these events.
In vertebrates, the cardiovascular system constitutes a highly
ramified network of tubes that transports gas, nutrients, hormones
and metabolites throughout the body. It also has important roles in
the regulation of homeostasis and wound healing and is involved in
the pathology of numerous diseases including cancer and inflamma-
tion (Carmeliet, 2003). The cardiovascular system emerges as one of
the first organs during embryonic development and retains morpho-. Belting).
ll rights reserved.genetic plasticity in adult life. Blood vessels are an integral component
of all organs and are vital not only for their function but also for their
formation during embryonic development (Nikolova and Lammert,
2003; Red-Horse et al., 2007; Sakaguchi et al., 2008). Blood vessels are
highly diverse: they differ in size and are specialized depending on
their function and the tissue or organ they are embedded in (Aird,
2007; Rocha and Adams, 2009). In general, they consist of an inner
epithelium (endothelium) lining the lumen; depending on the type of
vessel, this endothelium is surrounded by a basal lamina and bymural
cells, such as pericytes and smooth muscle cells, which both support
and regulate the function of the endothelium (Armulik et al., 2005).
Over the last decade, the molecular pathways controlling vascular
development have attracted much attention, and a large number of
key molecules has been identified that regulate different aspects of
blood vessel morphogenesis. The basic frameworks of the vascular
anatomy are conserved among vertebrates, whichmakes it possible to
assign homologies between distinct blood vessels and to directly
compare the formation of these vessels in different vertebrate species
(Isogai et al., 2001; see Fig. 1). The zebrafish embryo has proven to be
a useful model to study vascular morphogenesis in vivo. The vascu-
lature can be easily visualized using a variety of labeling techniques,
such as endothelial specific expression of fluorescent protein or by
microangiography (Fig. 1). Its small size, experimental accessibility,
optical clarity and rapid development allow to observe cellular
activities, such as cell migration, cellular rearrangements and cell
divisions, as they occur during blood vessel formation in the embryo.
It is also possible to follow cardiovascular mutant phenotypes for
several days because oxygenation of the early zebrafish embryo does
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Supplementary Figure 4: Cldn5b MO2 is more efficient than MO1. (A) Schematic 
representation of MO1 and MO2 binding sites to cldn5b translational start site. (B-M) 
Confocal images (B-E; H-L) and statistical comparison (F, G, M) of phenotypic 
strengths in cldn5b MO1 and MO2 injected fli1a:EGFP expressing fish. For 
evaluation of the MO strengths, the halting of ISVs at the level of the HMS (F, 30hpf) 
and the missing connections within the DLAV (G, 36hpf) were counted in 8 vessels 
per animal. Cldn5b MO2 injection causes more vessels with these phenotypes (F, 
G). Also at 52hpf MO2 caused more ISVs per embryo to show a lack of connection 
within the DLAV (M). HMS: horizontal myoseptum 
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9.2 Generation of the fli1ep:nlsmCherry construct 
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